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ABSTRACT 
In this thesis effects of dietary fatty acid 
composition and of positional distribution of fatty acids 
in dietary TAG, on postprandial lipid and hormone 
responses, were investigated. 
A6 week fish oil supplementation period (2.7 g n-3 
fatty acids per day) decreased fasting TAG and increased T- 
C (p<0.05) and LDL-C (p<0.05) levels in normal subjects. 
Postprandial plasma TAG responses to a test meal were also 
significantly reduced following the fish oil supplementa- 
tion period (area under the response curves, p<0.001). 
Apolipoproteins A-I and B responses did not alter in 
response to chronic fish oil supplementation. Type II 
diabetics responded differently to normal subjects to fish 
oil supplementation. Fasting lipid and apolipoprotein 
levels were not significantly altered, and the postprandial 
TAG response to a test meal showed a trend towards higher 
values following the fish oil supplementation period. 
In the study of effects of dietary TAG structure on 
postprandial lipid apolipoprotein (A-I, B), hormone 
(insulin, GIP) and glucose responses, no effect of test 
meals differing in the positional distribution of palmitic 
acid at the sn-2 or the sn-3 positions of the TAG molecule 
were seen. 
In a study of acute effects of dietary fatty acid 
i 
composition in healthy male subjects, a fish oil test meal 
(40 g fish oil concentrate), significantly reduced plasma 
TAG postprandial responses compared with a mixed oil meal 
(containing 40 g of a mixture of oils high in SFA and 
mimicking the current U. K. dietary fat intake), p<0.05. 
Post-heparin LPL activity was also significantly increased 
12 hours following the fish oil test meal (p<0.01). A 40 
g corn oil test meal did not have any significant effect on 
postprandial lipid, hormone (insulin and GIP), and retinyl 
palmitate levels (the latter was administered with each 
test meal-700 I. U. /kg of body weight) compared with the 
other two test meals. 
A feeding study, using a rat model, showed that 
following two weeks of a fish oil diet (5%, w/w) the post- 
prandial incorporation of [U-t4C]glucose into hepatic total 
lipids and TAG measured in vitro, was significantly reduced 
compared with rates measured in animals on a mixed oil diet 
(p<0.05). In the presence of the two anabolic hormones, 
insulin and GIP, in vitro rates of hepatic cholestero- 
genesis increased (p<0.05), and these effects of hormones 
were independent of the type of the diet fed. In addition, 
plasma TAG levels were significantly lower in the fish oil 
group compared with levels in the mixed oil and corn oil 
dietary groups (p<0.05), and plasma insulin levels were 
significantly higher in the mixed oil dietary group than in 
the other two groups (p<0.001). 
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CHAPTER 1 
GENERAL INTRODUCTION 
Coronary heart disease (CHD), is currently the leading 
cause of death in Western industrialized societies. Since 
a correlation between the development of atherosclerosis 
and the levels of lipids in plasma has already been 
demonstrated, research investigating factors which could 
affect these levels is considered to be necessary. 
One major factor which influences plasma lipids levels 
is not only the amount but also the type of fat present in 
the diet. 
1.1. DIGESTION AND ABSORPTION OF LIPIDS 
I. I. I. DIGESTION 
Western man typically ingests approximately 50-100 g 
of triacylglycerol (TAG), per day (Redgrave, 1983; Patsch, 
1987). By the time TAG enters the stomach several 
mechanisms have been initiated: 
- peristaltic action of the stomach and upper jejunum. 
2 
breaks down the TAG droplets into smaller particles, 
- gastrointestinal hormones are secreted. Gastric 
inhibitory polypeptide (GIP), is the most important hormone 
of the enteroinsular axis; it stimulates insulin secretion 
(Brown et al., 1975; Morgan et al., 1988), and may have 
important effects on peripheral lipid metabolism (Oben et 
al., 1991). It has been shown that GIP secretion is 
stimulated by contact with actively absorbed carbohydrates 
and long-chain fatty acids (Morgan et al., 1988), 
- bile salts cause the emulsification of TAG by 
reducing surface tension at the oil/water interface and 
result in the formation of micelles. Even though bile 
salts are poor emulsifiers on their own, combination with 
polar lipids, such as monoacylglycerols and non-esterified 
fatty acids (NEFA), the products of TAG digestion, results 
in a further decrease in the interfacial tension and 
effective micelle formation (Hofmann and Small, 1967; News- 
holme and Leech, 1986), and 
- pancreatic lipase hydrolyses ester links, primarily 
in sn-1 and sn-3 positions of the TAG molecule, yielding 2- 
monoacylglycerol, 1-monoacylglycerol, free fatty acids, and 
free glycerol. Pancreatic lipase acts at the interface of 
the emulsified TAG, and its action increases with 
increasing surface area of the micelle and attacks the 
unsaturated fatty acids in preference to saturated ones 
(Morley et al., 1974). Furthermore, the rate of hydrolysis 
decreases with increasing chain length of the fatty acid at 
3 
sn-3 position (Mattson and Volpenhein, 1964; Newsholme and 
Leech, 1986). 
1.1.2. ABSORPTION OF LIPIDS 
Since the water-solubility of monoacylglycerols and 
fatty acids is low, their rate of transport through the 
unstirred water layer adjacent to the intestinal epithelium 
is low. In order to avoid increased concentrations of the 
products of hydrolysis, which could cause feedback 
inhibition of pancreatic lipase, micelle formation is 
important in delivering the products of fat digestion to 
the absorptive epithelial cell surface. Bile salts are 
formed by the conjugation of bile acids with taurine and 
glycine and are present in the bile, which is made in the 
liver, stored in the gall bladder and passes into the 
duodenum in the presence of food (Hofmann and Small, 1967; 
Zubay, 1988). Micelles of bile salts incorporate 
monoacylglycerols, products of phospholipid hydrolysis, and 
long-chain fatty acids as well as undigested TAG. At the 
epithelial cell, the micelle dissociates, and while bile 
salts remain in the lumen, the other constituents get 
absorbed. In the epithelial cell the re-esterification 
process takes place and TAG are reformed from fatty acids 
and monoacylglycerol through the action of acyl-CoA 
4 
synthetase, monoacylglycerol acyltransferase, and 
diacylglycerol acyltransferase. This pathway is called the 
"monoacylglycerol pathway" (Figure 1.1). However, acyl-CoA 
synthetase is specific for fatty acids with more than 
twelve carbon atoms. Shorter-chain fatty acids enter the 
hepatic portal vein and are trans-ported to the liver for 
further metabolism via ß-oxidation (Nelson and Ackman, 
1988). 
Pancreatic lipase has some hydrolytic activity 
towards phospholipids. Phospholipase A2, which is secreted 
by the pancreas, removes fatty acids from the sn-2 position 
(Nelson and Ackman, 1988). The partially hydrolysed phos- 
pholipids enter the epithelial cells from micelles. 
Resynthesis of phospholipids then takes place within the 
epithelial cells and their function is to stabilize the 
TAG-rich particles (Gurr and Harwood, 1991). 
Most dietary cholesterol is ingested in the form of 
cholesterol esters and cannot be absorbed directly. By the 
action of cholesterol esterase, the esters are hydrolysed 
and some resynthesis of cholesterol esters takes place in 
the epithelial cells, by virtue of the enzyme acyl-CoA 
cholesterol acyltransferase (ACAT). 
Within the enterocyte, TAG, phospholipids, free 
cholesterol, cholesterol esters, and apolipoproteins 
combine to form spherical particles, called chylomicrons 
(CM). The smooth endoplasmic reticulum is the site for TAG 
and cholesterol ester resynthesis, while the rough 
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endoplasmic reticulum is the site for phospholipid 
resynthesis and apolipoprotein (apolipoproteins B-48, A-I, 
and A-IV) synthesis and these provide the outer coat to 
stabilize CM. CM are released by exocytosis into the 
lymphatic system via the lacteals, and pass through the 
thoracic duct into the left subclavian vein. 
1.2. TRANSPORTATION OF LIPIDS 
1.2.1. LIPIDS IN THE BLOOD 
Lipids are present in the blood in three forms: as 
lipoproteins constituents (TAG, free cholesterol, 
cholesterol esters and phospholipids), as NEFA, and as 
ketone bodies. 
As already mentioned, TAG, cholesterol, and NEFA are 
7 
insoluble in water and therefore, to enable effective 
transport through the blood stream, they must be bound to 
particles or molecules which increase their hydrophilic 
nature. TAG and cholesterol esters form the core 
components of complex lipoprotein particles, whose surfaces 
contain molecules with hydrophilic regions (apolipo- 
proteins, free cholesterol and phospholipids). Even though 
there are five classes of lipoproteins, two of them are of 
particular importance in the transportation of TAG; these 
are the CM and the very low density lipoprotein (VLDL). 
However, the other three, intermediate density lipoprotein 
(IDL), low density lipoprotein (LDL), and high density 
lipoprotein (HDL), also play an important role in lipid 
transportation, and the latter two are the major lipo- 
proteins which transport cholesterol in blood. A 
generalised structure of a typical lipoprotein particle is 
given in Figure 1.2. 
NEFA, are transported through the blood stream, bound 
to plasma albumin, a protein synthesized in the liver. 
Ketone bodies are water soluble and, therefore, a 
specific carrier is not necessary for their transportation. 
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1.2.2. CHYLOMICRONS 
CM are the largest of the lipoprotein particles found 
in the blood. They are formed in the gut, contain the 
absorbed dietary fat and, therefore, have the highest 
proportion of TAG of all the lipoprotein classes. 
Ingestion of dietary lipid results in the formation of 
approximately 100 g of CM-TAG per day (Redgrave, 1983). 
Nascent CM protein contains about 30-40% of apolipoprotein 
A-I (synthesized in both intestine and liver), 30-40% of 
apo C's (C-I, C-II and C-III, which are synthesized in the 
liver), whereas apolipoprotein A-IV (synthesized in the 
intestine), and E (synthesized in the liver), each make up 
10-20% of total protein (Redgrave, 1983; Brewer et al., 
1988). Less than 5% of total protein is in the form of the 
hydrophobic apolipoprotein B-48, the major structural and 
secretory protein of CM. Apolipoprotein B-48 is unique to 
intestinal CM and is the only form of apolipoprotein B 
produced by the intestine (Redgrave, 1983). 
CM are released into the lymphatic system via the 
lacteals. After entering the blood stream, there is a 
rapid exchange of their surface components with other lipo- 
protein particles, especially HDL. Usually, there is a net 
loss of phospholipids and apolipoprotein A-I to HDL, and a 
gain of apolipoprotein A-IV and C's from HDL (Imaizumi et 
al., 1978). 
10 
Lipoprotein lipase (LPL), is the enzyme which 
hydrolyzes CM-TAG to glycerol and fatty acids. LPL is a 
glycoprotein (Bensadoun, 1991), synthesised in the 
endoplasmic reticulum of vascular endothelial cells (Eckel, 
1989), and is present at the membranes of the surface of 
the capillary endothelial cells of many tissues notably 
adipose tissue, cardiac and skeletal muscle. It is 
activated in the Golgi apparatus, and transported by 
secretory vesicles to the cell exterior (Eckel, 1989). 
Immobilized LPL has a binding site for apolipoprotein C-II 
which has to be occupied for activity (Matsuoka et al., 
1980; Nelson and Ackman, 1988). It has also been suggested 
that LPL has no effect on 2-monoacylglycerol which is 
further hydrolysed by lipases in the liver (Nelson and 
Ackman, 1988). The fatty acids produced from CM-TAG 
hydrolysis are taken up by the cells of the tissue in which 
hydrolysis occurs and glycerol is transported to liver and 
kidneys for further metabolism. Hydrolysis of CM-TAG is 
terminated when 70-90% of TAG is removed. After the 
termination of hydrolysis, the CM particle becomes smaller 
in size, since it is poor in TAG, and is called chylomicron 
remnant (CM-R). It has been proposed that increased 
cholesterol content of surface lipids reduces the 
interaction of CM with LPL (Fielding, 1970) and that there 
is a loss of surface phospholipids and apolipoproteins A's 
during the conversion of CM to CM-R in rats (Tall et al., 
1979). CM-R are taken up by the hepatic parenchymal cells. 
11 
However, recent evidence indicate that CM-R can also be 
taken up by cells of the arterial wall (Zilversmit, 1979). 
Apolipoprotein C-III may prevent premature removal of 
partially hydrolysed CM by the hepatic remnant receptor, 
whereas apolipoprotein E mediates the recognition of CM-R 
by the receptor (Gotto, 1987). 
1.2.3. VERY LOW DENSITY LIPOPROTEINS 
The second major source of circulating TAG is that 
which is synthesized endogenously in the liver. Fatty 
acids esterified in the liver, can originate from de novo 
synthesis from acetyl-CoA, or from fatty acids taken up 
from blood (released from adipose tissue), or fatty acids 
released from hydrolysis of CM-R TAG. 
TAG are secreted from the liver as VLDL particles, 
which are smaller than CM and have a lower lipid/protein 
ratio. Nascent VLDL, secreted by the liver, has a very 
similar composition to that of CM (Figure 1.2), except that 
the structural and secretory protein is apolipoprotein B- 
100, which is a polypeptide large enough to encircle the 
entire particle (Gibbons, 1990). Formation of VLDL in 
hepatocytes involves synthesis and assembly of TAG, 
phospholipids, free cholesterol, cholesterol esters, and 
apolipoprotein B-100 in the endoplasmic reticulum. Further 
12 
addition of phospholipids and perhaps free cholesterol and 
cholesterol esters occurs in the Golgi. The rate of VLDL- 
TAG output depends on the nutritional state. Conditions 
favouring high rates of TAG synthesis are associated with 
high rates of VLDL output and high sucrose or fructose 
diets have been shown to increase VLDL output (Gibbons, 
1990). The intravascular catabolism of VLDL involves an 
early transfer of apo E and C's from HDL, hydrolysis of 
VLDL-TAG by the action of LPL, and loss of surface lipid 
and protein through the transfer to HDL as well as exchange 
of core lipids (cholesterol esters from HDL and TAG from 
VLDL). As VLDL-TAG hydrolysis proceeds, the VLDL particle 
becomes smaller and forms a remnant or IDL particle. In 
humans, some of the VLDL remnants are taken up by the liver 
but much of it appears to undergo further TAG hydrolysis so 
that LDL particles are formed. The cellular uptake of VLDL 
remnants is mediated through the interaction of its two 
major apolipoproteins (apo E and apo B-100), with the B/E 
receptor (Gotto, 1987). 
Gibbons (1990), in a review, suggested that in the 
short term insulin promotes TAG synthesis but inhibits VLDL 
secretion, whereas, in the long term (periods longer than 
24-48 hours), VLDL secretion is enhanced in response to 
insulin. It is possible, therefore, that insulin 
stimulates synthesis and temporary storage of VLDL-TAG at 
the fed state, which is later secreted to meet the energy 
demands of tissues when food intake, CM-TAG, and plasma 
13 
insulin levels are low. 
1.2.4. INTERMEDIATE AND LOW DENSITY LIPOPROTEINS 
IDL and LDL are formed during the hydrolysis of VLDL- 
TAG by LPL. As hydrolysis continues, the VLDL particle 
loses TAG from its core, and surface lipids (phospholipids 
and free cholesterol) and apo E and C's transfer to HDL. 
VLDL becomes smaller, its density increases, and an 
intermediate particle, IDL, is produced (the latter is also 
called the VLDL remnant) (Steiner et al., 1986). Further 
TAG hydrolysis results in formation of LDL, the lipoprotein 
particle enriched in cholesteryl ester, which is the major 
carrier of cholesterol in fasting plasma. VLDL particle 
size appears to be an important factor in determining 
whether VLDL remnants are removed directly by the liver or 
further catabolized to LDL (Betteridge, 1989). VLDL 
remnants derived from large VLDL particles appear to be 
removed from the circulation by the liver, whereas small 
VLDL particles are more likely to be converted to LDL. The 
effects of VLDL size in determining the metabolic 
processing may be related to apo E content. Large VLDL 
particles contain more apo E than small VLDL and, as a 
consequence, are likely to be more rapidly removed by 
hepatic E or remnant receptor. 
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Hepatic lipase (HL) plays an important role in the 
hydrolysis of remnants to form LDL. It appears that this 
enzyme acts on lipoproteins which are no longer good 
substrates for LPL (Betteridge, 1989). 
Most tissues carry a specific high affinity receptor 
(the B/E or LDL receptor), which is responsible for uptake 
and removal of LDL from circulation; about half of the 
body's complement of LDL receptors is present in the liver. 
The liver is also the major site of non-receptor mediated 
LDL removal, a process which depends on circulating LDL 
concentrations. Apo B-100 is the ligand for the LDL 
receptor. After binding to its receptor, LDL is taken up 
by the cell, forming an endocytotic vesicle which fuses 
with cellular lysosomes. The receptor dissociates from the 
LDL particle and recycles to the cell surface, whereas the 
LDL protein component is hydrolysed by proteases; the 
cholesterol esters are hydrolysed by a lysosomal acid 
lipase (Zubay, 1988). The resulting free cholesterol gains 
access to the cellular compartment by crossing the 
lysosomal membrane. The accumulation of free cholesterol 
in the cell regulates the activities of two microsomal 
enzymes: HMG-CoA reductase and acyl-CoA: cholesterol 
acyltransferase (ACAT), and leads to a reduction in the 
expression of LDL receptors (Betteridge, 1989). 
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1.2.5. HIGH DENSITY LIPOPROTEINS 
HDL plays an important role in the regulation of 
lipoprotein metabolism. HDL participates in the processing 
of CM and VLDL particles as well as in the regulation of 
cholesterol homeostasis by means of its role in reverse 
cholesterol transport. 
HDL are the smallest of lipoprotein particles and 
carry 20-30% of the cholesterol in plasma, principally as 
cholesterol ester in the central lipid core. A small 
amount of free cholesterol may also be carried, as long as 
phospholipids, and apolipoproteins are present (Betteridge, 
1989). There is a considerable compositional heterogeneity 
of particles within the HDL density range. This is a 
consequence of a variety of variable reactions including 
direct synthesis by the liver and intestine, transfer of 
surface components from other lipoprotein particles to HDL, 
and exchange of cholesterol ester for TAG, between HDL and 
lipoproteins of lower density (Betteridge, 1989). 
HDL is the site of activity of lecithin: cholesterol 
acyltransf erase (LCAT), the enzyme synthesized and secreted 
by the liver, which catalyzes the reaction of 
phosphatidylcholine with free cholesterol (coming from 
lipoproteins or efflux from peripheral cells), to yield 
lysolecithin and cholesterol ester. Apo A-I, the major 
protein of HDL, is an important co-factor of LCAT activity 
16 
(Schoenfeld al., 1978; Schaefer et al., 1982). Nascent HDL 
particles, appearing as bilayer discs containing protein 
and phospholipids, accept free cholesterol, which is 
esterified by LCAT, and they become spherical as 
cholesterol esters accumulate in the particle core. This 
reaction is thought to be important in determining the 
extent of removal of cholesterol from cells and the 
subsequent extraction and excretion of cholesterol from 
liver (reverse cholesterol transport). It has also been 
suggested that this reaction may determine the tranfer of 
cholesterol esters between lipoproteins. As HDL3 (a 
subfraction of HDL) , binds free cholesterol, HDL2 is formed. 
Cholesterol ester can then transfer from HDL2 to VLDL or CM 
with TAG transferring onto the HDL particle (Gotto, 1987). 
The reciprocal crossing over of TAG and cholesterol ester 
between TAG-rich lipoproteins (CM and VLDL) and HDL2 is 
mediated by the action of cholesterol ester transfer 
protein (CETP). Enhanced activity of this protein leads to 
considerable cholesterol enrichment of CM and VLDL 
remnants. As a result, cholesterol esters formed in the 
HDL particle, are returned to the liver, as cholesterol- 
enriched VLDL, CM and LDL particles, which are taken up by 
either the remnant or B/E receptor. It is also thought 
that HDL can deliver cholesterol back to the liver 
directly, but this pathway is quantitatively much less 
important than the previous one and no specific HDL 
receptor has yet been identified. However, TAG-rich HDL 
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particles resulting from the exchange process described 
above, are susceptible to the action of HL: TAG is 
hydrolysed, resulting to smaller HDL particles (HDL3), which 
recycle and accept more cholesterol ester. 
HDL particles also serve as a reservoir for apo E and 
apo C. Moreover, as it has already been mentioned, surface 
components (phospholipids, apo A-I and apo A-II) of CM and 
VLDL transfer to HDL during their TAG hydrolysis. 
1.3. CATABOLISM OF LIPIDS 
1.3.1. INITIATION OF LIPID CATABOLISM 
when energy supply from diet becomes limited, the 
animal responds to energy deficit by a release of 
epinephrine, glucagon and other hormones (Zubay, 1988). 
The hormones bind to the plasma membrane of the adipocyte 
and stimulate the production of cAMP for the mobilization 
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of stored TAG. Cyclic adenosine monophosphate (cAMP) 
activates a protein kinase which activates TAG lipase, the 
enzyme responsible for the hydrolysis of TAG to 
diacylglycerol and fatty acid from sn-1 or sn-3 position of 
glycerol backbone. By the action of monoacylglycerol 
lipase glycerol and free fatty acids are formed. The fatty 
acids formed, pass from the adipocyte to the circulation 
and are taken up by the required tissues. 
1.3.2. UTILISATION OF FATTY ACIDS FOR ENERGY: FATTY 
ACID ACTIVATION AND TRANSPORT INTO THE MITO- 
CHONDRION 
Activation of fatty acids involves the formation of 
thioesters with CoA which converts fatty acids to a form 
susceptible to biochemical changes. The most important 
enzymes which participate in the fatty acid activation are 
the acyl-CoA ligases (also known as thiokinases or fatty 
acid synthetases) (Newsholme and Leech, 1986; Zubay, 1988). 
Fatty acids cannot be utilised for energy provision 
until they are transported into the mitochondrion. This 
involves a conversion of fatty acyl-CoA's to their acyl 
carnitine derivatives, [through the action of carnitine 
acyl transferase I (CAT I)] transport of the acyl carnitine 
derivatives across the membrane by a protein carrier, and 
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formation of acyl-CoA and free carnitine by the action of 
CAT II on the inner surface of the membrane. 
1.3.3. FATTY ACID OXIDATION AND KETONE BODY FORMATION 
Fatty acid oxidation involves the progressive removal 
of two-carbon units from the carbonyl end of the acyl-CoA 
and takes place in the mitochondrion. It is also known as 
ß-oxidation since the ß-carbon atom is oxidised. The pro- 
ducts of ß-oxidation are an acyl-CoA, which is two carbon 
atoms shorter than the starting material, and acetyl-CoA. 
The acyl-CoA is susceptible to a new 3-oxidation round, so 
that, finally from saturated fatty acids with even numbers 
of carbon atoms, acetyl-CoA will be formed. Additional 
enzymes are required for the oxidation of fatty acids with 
odd number of carbon atoms. Additional enzymes are also 
required for unsaturated fatty acids to enter the B- 
oxidation process. 
Even though animal mitochondria contain all the 
enzymes necessary, ß-oxidation also takes place in the 
peroxisomes (Figure 1.3). Peroxisomes play an important 
role in hepatic B-oxidation in animals, contributing up to 
50% of the total fatty acid oxidative activity (Gurr and 
Harwood, 1991). However, peroxisomes, oxidize long-chain 
fatty acids only to medium-chain products, which are then 
20 
6 
2 
+ 
_ 
+ 
2 
G 
Q 
Z 
+ 
QQ 
00 
UU 
= O 
U . 
ý'. 
ýy 
UQ 
4 
d 
m 
ý 
X 
O 
O 
U 
U 
ý O 
+ 
0 
U 
ý 
v 
e0 
LL 
ý 
ý 
0 
U 
0 
c 
w 
0 
I 
t 
U 0) ca 
ý rn 
o 
ýt 
4 
.Q 
Q 
Z 
+ 
¢ O 
U 
O 
U 
i 
r S 
U 
2 
O 
U 
OC 
21 
QQ 
00 
UU 
i O 
Uý 
¢ 
m m 
ý 
ö 
L 
H 
Q 
0 
U 
transferred into the mitochondria for further oxidation. 
Under physiological conditions, only the liver is able 
to synthesize ketone bodies. After the formation of 
acetyl-CoA through the ß-oxidation process, ketone bodies 
are formed by a further conversion of acetyl-CoA to aceto- 
acetate and 3-hydroxybutyrate. Some acetoacetate 
decarboxylates to acetone. 
1.4. LIPID BIOSYNTHESIS 
1.4.1. FATTY ACID AND TRIACYLGLYCEROL BIOSYNTHESIS 
Acetyl-CoA is the end product of B-oxidation and the 
starting point of fatty acid synthesis. However, 8- 
oxidation occurs in the mitochondria, whereas fatty acid 
synthesis takes place in the cytosol. Acetyl-CoA, formed 
in the mitochondria, cannot cross the mitochondrial 
membrane and pass to the cytosol. Citrate synthase 
converts acetyl-CoA to citrate, which then crosses the 
22 
mitochondrial membrane into the cytosol, where ATP-citrate 
lyase acts and converts citrate back to acetyl-CoA. 
The first step of fatty acid synthesis is the reaction 
of acetyl-CoA with CO2 to form malonyl-CoA. Acetyl-CoA 
carboxylase is the enzyme responsible for this formation. 
Synthesis of fatty acids from malonyl-CoA involves a series 
of condensations and reductions, which take place on a 
multienzyme complex, called fatty acid synthetase, with 
palmityl-CoA being the end product. However, at least 60% 
of TAG present in adipose tissue contain fatty acids with 
18 carbon atoms, and fatty acids with 20,22, and 24 carbon 
atoms also occur. Therefore, an additional elongation of 
palmityl-CoA also takes place. 
Introduction of double bonds, for the synthesis of 
unsaturated fatty acids, takes place after the formation of 
palmityl-CoA or stearyl-CoA. There are some restrictions 
concerning the desaturations that the mammalian liver can 
carry out: (i) only four desaturases are present (A9, A6, As, 
and L, 4 desaturases), which insert double bonds at positions 
9,6,5, and 4 from the CH3 end of the fatty acid 
respectively. If the substrate is saturated, the first 
double bond is always inserted at position 9, and if the 
substrate is unsaturated, double bonds are inserted between 
the carbonyl group and the double bond nearest to the 
carbonyl group. (ii) Desaturation occurs in such order to 
maintain a methylene-interrupted distribution of double 
bonds. (iii) Desaturation alternates with chain- 
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elongation, and (iv) all double bonds, are in the cis 
configuration. 
In adipose tissue and liver, TAG are formed by 
esterification of glycerol with three fatty acid molecules. 
This de novo pathway is called the "glycerol phosphate 
pathway" (Figure 1.4). It involves the transfer of acyl 
groups from acyl-CoA to glycerol-3-phosphate which comes 
either from phosphorylation of glycerol catalysed by 
glycerol kinase (liver only), or from reduction of 
dihydroxyacetone phosphate catalysed by glycerol-3- 
phosphate dehydrogenase (in both liver and adipose tissue). 
Glycerol-3-phosphate acyltransferase and 1-acylglycerol-3- 
phosphate acyltransferase are the enzymes responsible for 
the transfer of acyl groups to the sn-1 and sn-2 positions 
respectively. It has been suggested that the first enzyme 
is specific for saturated fatty acyl groups, and the second 
one for mono- and dienoic-fatty acyl groups (Gurr and Har- 
wood, 1991). The next step in TAG biosynthesis is 
catalysed by phosphatidic acid phosphohydrolase (PAP), and 
is the rate limiting step that controls the overall rate of 
TAG synthesis. The final step in TAG synthesis involves 
the transfer of a fatty acyl group to the sn-3 position of 
1,2 diacylglycerol, the latter formed by the action of PAP 
on 1,2 diacylglycerol phosphate. The enzyme responsible 
for the final step in TAG synthesis via the glycerol 
phosphate pathway is diacylglycerol acyltransferase. 
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1.4.2. CHOLESTEROL AND PHOSPHOLIPID BIOSYNTHESIS 
The basic starting material for cholesterol synthesis 
is acetyl-CoA. However, unlike fatty acid synthesis, 
cholesterol synthesis does not start from malonyl-CoA, but 
from ß-hydroxy-ß-methylglutaryl-CoA (HMG-CoA), which is 
also the starting point for ketone body formation. 
Cholesterol synthesis begins with a condensation of two 
molecules of acetyl-CoA to yield ß-ketobutyryl-CoA, which 
takes place in the cytosol and is catalysed by thiolase. 
The next step involves a further condensation of a third 
acetyl-CoA with ß-ketobutyryl-CoA, to form HMG-CoA, a 
reaction catalysed by HMG-CoA synthase. HMG-CoA is then 
reduced to mevalonate by the action of HMG-CoA reductase. 
The activity of the latter enzyme is responsible for the 
control of cholesterol biosynthesis. From mevalonate a 
series of enzyme catalysed reactions take place, which 
result in the formation of the intermediates lanosterol and 
squalene, until the final synthesis of cholesterol. 
Phosphatidic acid is the most important intermediate 
for phospholipid biosynthesis. One major biosynthetic 
route is the acylation of glycerol-3-phosphate by the 
action of glycerol-3-phosphate acyltransferase, and 1- 
acylglycerol-3-phosphate acyltransferase. Another route is 
via dihydroxyacetone phosphate, coming from the glycolytic 
pathway. 
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1.5. CONTROL OF LIPID METABOLISM 
1.5.1. CONTROL OF LIPID CATABOLISM 
In conditions of low insulin concentrations, lipid 
biosynthesis ceases and the catabolism of the major adipose 
tissue storage lipid, TAG, is initiated. The enzyme, TAG 
lipase is activated by a CAMP dependent protein kinase and 
a number of hormones including glucagon and catecholamines, 
initiate TAG hydrolysis by activation of the CAMP second 
messenger system. 
The fatty acids released may be directed either into 
the B-oxidation route, or into the TAG synthesis. The 
route into which the fatty acids will be directed is con- 
trolled by the competition for acyl-CoA between the 
acyltransferases involved in TAG esterification, and the 
CAT of the mitochondrial membrane, which regulates uptake 
of acyl-CoA for ß-oxidation. The latter enzyme is 
increased during starvation and, as a consequense, fatty 
acids enter the B-oxidation route, whereas CAT levels are 
low in the fed state and, as a result, fatty acids enter 
the TAG synthesis route. Regulation of CAT activity is 
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determined by the insulin: glucagon ratio. When this ratio 
is high, CAT activity and ß-oxidation rates are suppressed. 
Under conditions of fasting, however, when the ratio is 
low, CAT activity and ß-oxidation are increased. 
The rate of ß-oxidation is controlled by the 
availability of free fatty acids, and the rate of 
utilization of the ß-oxidation products, which, if they 
accumulate, can cause inhibition of particular enzymes or 
"feedback inhibition" of the whole sequence (Gurr and 
Harwood, 1991). An increase in plasma free fatty acid 
(FFA) levels is caused for example by the action of 
glucagon, whereas insulin, which inhibits the TAG breakdown 
in the adipocyte causes a decrease in plasma FFA. The 
relative rates of these pathways depend on the nutritional 
state of the animal. In the fed state and under insulin 
stimulation glucose is converted to acetyl-CoA and then to 
fatty acids, and malonyl-CoA levels are increased. 
Malonyl-CoA is a reversible inhibitor of CAT I, and as a 
result, inhibits the entry of fatty acids to mitochondria 
for oxidation. In the fasting state, high glucagon and low 
insulin levels increase cellular cAMP, and as a result, 
they allow a short-term inhibition of acetyl-CoA 
carboxylase by phosphorylation (Wakil et al., 1983; Gurr 
and Harwood, 1991) and thereby, reduced malonyl-CoA 
concentrations. CAT I is stimulated, since malonyl-CoA 
levels are low, and rates of ß-oxidation and ketogenesis 
are thereby increased. Moreover, citrate acts as a 
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positive feed-forward activator of acetyl-CoA carboxylase, 
polymerizing it. Acyl-CoA's, which can be considered as 
the end product of fatty acid synthesis, act as negative 
feed-back inhibitors of acetyl-CoA carboxylase (Wakil et 
al., 1983). Fatty acid synthetase is influenced by 
nutritional state and hormone secretion in the same way as 
acetyl-CoA carboxylase (Gurr and Harwood, 1991). 
1.5.2. CONTROL OF LIPID BIOSYNTHESIS 
Insulin plays an important role in the control of 
lipid biosynthesis. It increases the activity of the 
glucose transporter in the adipocyte cell membrane, 
allowing rapid passage of glucose in the cell. It 
stimulates the synthesis of LPL, activates rate regulating 
enzymes of lipogenesis and, through inhibition of cAMP 
formation, reduces TAG lipase activity and reduces TAG 
breakdown. 
GIP is involved in the activation of LPL in adipose 
tissue, it inhibits glucagon-induced lipolysis and 
potentiates the effect of insulin on incorporation of fatty 
acids in TAG (Ebert and Creutzfeldt, 1987; Beck, 1989). 
Cellular concentrations of acyl-CoA and glycerol 
phosphate, the precursors for TAG synthesis, are influenced 
by the nutritional state of the animal. 
29 
PAP activity in the liver is controlled by insulin and 
substrate availability. It has been suggested that the 
enzyme is inactive until it tränslocates on the membrane, 
and that on the one hand cAMP displaces the enzyme from the 
membrane and on the other hand, increasing NEFA levels and 
their CoA esters promote its attachment. Moreover, since 
insulin decreases cAMP levels, it makes the translocation 
more effective. As a result, it seems that the membrane 
associated enzyme is active, whereas its cytosolic form 
represents a reservoir of potential activity. Moreover, 
cortisol increases the activity of PAP and causes an 
increase in TAG synthesis. 
Dietary changes can also influence the activity of A9 
desaturase 
, but have little effect on A4, 
A5, and A6 desa- 
turases (Gurr and Harwood, 1991). Insulin has also been 
reported to influence desaturase activity (Wakil et al., 
1983). 
Cholesterol biosynthesis is regulated by two enzymes 
whose activities appear to be controlled by the 
intracellular cholesterol concentrations. Accumulation of 
free cholesterol in the cell influences the activities of 
two microsomal enzymes: HMG-CoA reductase which is 
supressed, and leads to a reduction in cholesterol 
synthesis, and ACAT, which is activated and re-esterifies 
free cholesterol. Moreover, a reduction in the expression 
of LDL receptors occurs when the needs of the cell for 
cholesterol is satisfied (Betteridge, 1989). 
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1.6. LIPIDS AND DISEASE 
1.6.1. LIPIDS AND ATHEROSCLEROSIS 
An important factor in the development of athero- 
sclerotic lesions is the accumulation of cholesterol in the 
arterial wall, and epidemiological studies have correlated 
elevated circulating lipids, and particularly cholesterol 
levels, with CHD (Lapidus et al., 1985; Wilson et al., 
1987; Olsson et al., 1988). Moreover, many studies have 
indicated differences in plasma lipid levels between races 
and sex (Donahue et al., 1989). In addition, Walsh (1990), 
suggested that in Britain much of the sudden increase in 
CHD, reported by Maurice Cassidy in 1945 was due to 
dietary change and especially due to induction of animal 
fat in the diet. 
The atherosclerotic lesion occurs in two forms: the 
fatty streak and the fibrous plaque. Deposition of lipid 
in the arterial wall starts to occur in the first decade of 
life, but with no pathological significance (Fuster et al., 
1992a and b). The fatty streak consists of foam cells, 
most of which are lipid-laden macrophages derived from 
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blood-born monocytes. On the other hand, the fibrous 
plaque is a proliferative smooth muscle lesion which, in 
its advanced form, consists of a fibrous cap comprised 
largely of smooth muscle cells surrounded by connective 
tissue which covers a deeper region of foam cells. These 
foam cells consist of both lipid-laden macrophages and 
smooth muscle cells infiltrated with lipid (Ross, 1986). 
Modified LDL, monocytes, macrophages, and smooth 
muscle cells are thought to be important in the formation 
of the atherosclerotic plaque. Current understanding of 
the mechanism by which circulating cholesterol contributes 
to the development of atherosclerosis is illustrated in 
Figure 1.5. LDL enters the arterial wall by passing 
between adjacent endothelial cells. In the intima of the 
arterial wall, the presence of macrophages is crucial in 
the accumulation of cholesterol and in the production of 
foam cells, and an important initiating event is the uptake 
of cholesterol into the macrophage. However, it has been 
observed that macrophages express a limited total number of 
receptors for native LDL and these receptors can be down 
regulated in the presence of high LDL levels (Steinberg et 
al., 1989). It has also been found in in vitro studies 
that chemical acetylation can convert LDL to a form which 
is readily taken up by macrophages, by receptors specific 
to modified forms of LDL, including oxidised LDL (Brown and 
Goldstein, 1990). Moreover, it has been suggested that 
synthesis of these receptors, also called the scavenger 
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receptors, is not subject to down-regulation when cells 
accumulate cholesterol (Babiak and Rudel, 1987), thus 
enabling uncontrolled cholesterol accumulation via this 
route. Oxidative modification of LDL does not occur in 
plasma or if it does, oxidised LDL is rapidly removed from 
circulation. However, high rates of LDL oxidation may 
occur within and around the endothelial cell particularly 
in the presence of free radicals, produced as a consequence 
of local tissue damage. Steinberg and co-workers have 
proposed a hypothesis on the development of the fatty- 
streak lesion, which depends only on the presence of high 
LDL levels and the oxidative modification of LDL. These 
workers suggest there are four atherogenic effects of 
oxidised LDL: (i) chemotactic activity which facilitates 
the adherence of circulating monocytes to the arterial 
wall, (ii) inhibition of the migration of macrophages from 
the interior of the artery to the plasma compartment, (iii) 
enhanced uptake of LDL by macrophages through the 
"scavenger receptor", leading to the formation of foam 
cells and (iv) cytotoxicity, possibly facilitating the 
entry of more LDL and/or monocytes in the early stages 
(Steinberg et al., 1989). Once in the intima, LDL may also 
be modified by other mechanisms, involving interaction of 
LDL with connective tissue constituents, such as proteo- 
glycans and glycosaminoglycans, and interaction with 
proteases and lipases, which are synthesized by macro- 
phages; both mechanisms are known to enhance LDL uptake by 
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macrophages (Babiak and Rudel, 1987). Smooth muscle cells, 
in the arterial wall, also play an important role in the 
development of the atherosclerotic lesion. Growth factors, 
which induce the proliferation of intimal smooth muscle 
cells, are secreted by macrophages, endothelial cells and 
platelets. Some of the smooth muscle cells develop into 
foam cells, by accumulating cholesteryl esters, and others 
synthesize connective tissue components, which strengthen 
the arterial wall and initiate fibrous plaque formation. 
Once macrophages in the artery are heavily loaded with 
lipid, then, through its cytotoxicity, the oxidised LDL may 
cause the loss of the endothelial cells overlying the fatty 
streak. Loss of the endothelial layer can also take place 
through endothelial injury via the generation of active 
oxygen species or release of lytic enzymes secreted by 
monocytes/macrophages lying in close proximity to the 
endothelial cells (Steinberg, 1986). At this point, 
adherence and aggregation of platelets, release of 
platelet-derived growth factor, and the generation of 
additional growth factors, stimulate the proliferation of 
smooth muscle cells, leading to the thickening of the 
atheroma (Steinberg et al., 1989). 
Until recently, it was thought that only LDL particles 
could be taken up by macrophages and thereby only LDL has 
been implicated in atherogenesis. However, more recent 
studies suggest that cholesterol-enriched CM-R can also 
accumulate in the arterial wall. Zilversmit (1979), pro- 
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vided early evidence that in humans and experimental 
animals, CM-R as well as LDL are taken up by arterial walls 
and cause cholesterol deposition, if enriched by dietary 
cholesterol (Zilversmit hypothesis). TAG-rich lipo- 
proteins, especially CM-R, have also been shown to interact 
with receptors present in cells other than hepatocytes. In 
particular, uptake of remnants by macrophages is capable of 
overloading these cells with TAG and cholesterol. Ells- 
worth et al. (1986), suggested that macrophages express a 
receptor site which recognizes CM-R and which is possibly 
different from the one recognizing LDL. They also 
suggested that CM-R may increase macrophage cholesterol 
synthesis, and as a consequence, these particles may prove 
to be highly atherogenic. Van Lanteen et al. (1985), also 
demonstrated that the human monocyte/macrophage possess CM- 
R receptors, which can be distinguished from the LDL 
receptor. The chylomicron remnant hypothesis therefore, 
provides a mechanism whereby TAG-rich lipoproteins, 
previously thought to be unimportant in atherogenesis, may 
play a part in development of atherosclerosis. 
Another view of the importance of CM and VLDL in 
atherogenesis is that TAG transport, during the 
postprandial state, provides a mechanism for the 
cholesterol enrichment of exogenous (dietary) lipoproteins. 
As has already been mentioned, exchange of TAG and 
cholesterol esters (CE), occurs between the different 
lipoprotein classes, catalysed by CETP. CE transfer to 
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TAG-rich lipoproteins make these particles resistant to LPL 
action, and as a consequence, CE, in enriched intermediates 
of CM-R and IDL, accumulate and may become involved in the 
atherogenic process. In individuals with effective TAG 
metabolism TAG-rich lipoproteins do not accumulate and do 
not become significantly enriched in CE. On the other 
hand, in individuals with high postprandial lipaemia, CM 
accumulate in. thecirculation for a prolonged time, resulting 
in their extensive enrichment with CE. This concept has 
been referred as the "triacylglycerol intolerance" hypo- 
thesis, according to which, a low TAG metabolic capacity 
constitutes a handicap that imparts CHD susceptibility. 
CHD is not linked solely to delayed CM-R clearance in the 
postprandial state, but rather to impaired transport of 
TAG-rich lipoproteins both of intestinal and/or hepatic 
origin. Postprandial lipaemia is perhaps the most dominant 
phase of TAG transport, and thus measurement of its 
magnitude could be a realistic indicator of TAG metabolic 
capacity. 
Epidemiological studies in humans suggest that 
remnants from intestinal and/or hepatic origin are 
predictors of severity or progression of atherosclerosis 
(Nordestgaard and Tybjaerg-Hansen, 1992). Patsch et al. 
1992, suggested that postprandial TAG levels between six 
and eight hours after a test meal are highly discriminatory 
in predicting the presence or absence of CHD. In addition, 
clearance of postprandial lipoproteins in normolipidaemic 
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patients who suffered from coronary artery disease (CAD) 
was reported to have been delayed as compared with that of 
controls without CAD (Groot et al., 1991). On the other 
hand, the LDL fraction seems to remain unaltered by dietary 
fat absorption. Plasma cholesterol remained within the 
range of 183-187 mg/dl but plasma TAG ranged from 96 to 230 
mg/dl following a fatty meal (Cohen et al., 1989). How- 
ever, Karpe et al. (1993), suggested that LPL activity and 
the response of TAG-rich lipoproteins to fat intake are 
major determinants of LDL heterogeneity. 
The majority of myocardial infarction survivors have 
one or more lipoprotein abnormalities (Simopoulos, 1991). 
They usually have increased LDL-C and decreased HDL-C 
levels and recent studies have more strongly implicated 
increased VLDL-TAG and CM-R in atherogenesis. The 
contribution of CM-R to the aetiology of CHD is of 
particular relevance to the present study which will be 
largely concerned with effects of diet on postprandial 
lipoprotein metabolism. 
1.6.2. LIPIDS AND NON-INSULIN DEPENDENT DIABETES 
MELLTTtTS 
Diabetes mellitus is a syndrome due to a variety of 
diseases, mainly characterized by high plasma glucose 
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levels, due to either deficiency or diminished 
effectiveness of insulin (Passmore and Eastwood, 1986; 
Crabbe, 1987). Diabetic patients are divided to two 
categories: Type I or insulin dependent diabetes mellitus 
(IDDM), and type II or non-insulin dependent diabetes 
mellitus (NIDDM) patients. IDDM appears usually in people 
younger than 40 years who are of normal or of less than 
normal weight. Symptoms include severe hyperglycaemia, 
appearance of ketoacidosis and severe insulin deficiency 
(Crabbe, 1987). NIDDM appears in middle age or later, it 
is the most common form of human diabetes, and patients are 
often obese. Hyperinsulinaemia is a symptom character i stIC of 
NIDDM. It may begin with a resistance of peripheral 
tissues to insulin action. As a result, more hormone is 
required to produce a metabolic effect, and pancreatic ß- 
cells begin the hypersecretion of insulin. Hyperglycaemia 
in NIDDM can usually be controlled by dietary means or by 
an oral hypoglycaemic drug. Since NIDDM's are 
hyperglycaemic despite high insulin concentrations, it is 
suggested that inability of insulin to stimulate glucose 
uptake by the cell is due to a defect in cellular level. 
Although NIDDM is considered a less severe disease than 
IDDM, long-term complications occur in both types. 
The most common alteration of lipoproteins in NIDDM is 
an elevation in VLDL, caused by an increase in VLDL 
secretion (Kissebah et al., 1982), a suggestion supported 
by the observed increase in total-TAG and/or VLDL-TAG 
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levels. Increased VLDL-TAG levels in NIDDM are observed 
due to both elevated VLDL-TAG production and decreased 
VLDL-TAG clearance. VLDL-apo B responds similarly, with an 
increase in VLDL-apo B production, and a decrease in VLDL- 
apo B clearance, probably because a greater proportion of 
it is not metabolized through the LDL conversion step 
(Howard et al., 1987), but through direct removal of VLDL, 
which may be related to the larger VLDL particles which are 
found in NIDDM. An increase in VLDL remnants is also 
observed, a factor which has been suggested to explain the 
cardiovascular risk in NIDDM (Kissebah et al., 1982; Joven 
et al., 1989). 
LPL activity may be decreased in NIDDM, and would 
explain the observed decrease in VLDL-TAG clearance 
(Howard, 1987). The effects of NIDDM on LPL activity are 
not consistent since there are studies which showed no 
decrease in postheparin LPL activity in normolipaemic 
NIDDM's (Taskinen et al., 1986). However, an increase in 
CM-apo B, and therefore in CM-R residence time, has been 
shown in untreated lipaemic NIDDM's, and was associated 
with decreased LPL activity in adipose tissue (Haffner et 
al., 1984). 
Abnormalities in plasma LDL levels of subjects with 
NIDDM are not always consistently observed. Howard (1987), 
in her review, mentioned that there are numerous studies 
which have shown elevated LDL-C levels but many others 
which did not. However, consistent observations appear to 
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include: an increase in LDL-TAG, an increase in the ratio 
of cholesterol to apo B, and an increase in LDL particle 
size. Glycosylation of LDL-apo B, which takes place in 
diabetes, due to increased glucose levels, alters LDL 
metabolism, through a decrease in the interaction of LDL 
with the LDL receptor, and through an acceleration in the 
interaction of LDL with endothelial walls, a process which 
increases LDL deposition in arterial walls and may be due 
to uptake of glycosylated LDL by the scavenger receptor. 
It has to be mentioned at this point that decreased 
conversion of VLDL to LDL and decreased LDL clearance, are 
two phenomena observed in NIDDM. Thus although changes in 
LDL concentration may not be consistently observed in all 
subjects, possible defects in LDL metabolism should not be 
excluded. 
HDL-C levels are lower in NIDDM's (Bittolo Bon et al., 
1984; Howard, 1987; Joven et al., 1989). It has also been 
suggested that the rate of HDL synthesis is also decreased. 
As with LDL, an increase in HDL-TAG levels and in the ratio 
of cholesterol to protein has been observed (Howard, 1987), 
which support the findings of Reaven (1987), who observed 
a decrease in apo A-I levels in NIDDM's. The transfer of 
cholesteryl esters, formed by the action of LCAT, to VLDL 
and LDL is also decreased, which results to increased 
cholesteryl ester in HDL particles. As a consequence, 
free cholesterol levels can be raised in VLDL and LDL, a 
fact which can be related to an increased risk for 
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developing atheromatic plaque. An incease in hepatic 
lipase activity has also been reported in NIDDM's (Howard, 
1987). The findings of lower HDL turnover is in accordance 
with lower VLDL clearance and LPL activity, since HDL 
increases during lipolytic activity. Moreover, increased 
hepatic lipase activity can further decrease HDL levels. 
Further studies are required to determine whether CM and CM- 
R metabolism is improved in NIDDM and whether such 
disturbances may contribute to increased CHD risk in this 
group. 
1.7. DIETARY FAT AND LIPID METABOLISM 
1.7.1. SATURATED FATTY ACIDS 
Numerous epidemiological studies have established the 
hypercholesterolaemic effects of saturated fatty acids in 
the diet. In the Seven Countries study, intakes of dietary 
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saturated fatty acids (SFA), correlated highly with serum 
cholesterol levels (Keys, 1970). Saturated fat intake, as 
a percentage of total calories, is correlated not only with 
plasma cholesterol levels but also with CHD incidence rate. 
In their study, Keys et al. (1965), compared responses to 
saturated fatty acids (SFA), monounsaturated fatty acids 
(MUFA) and polyunsaturated fatty acids (PUFA). with those to 
low-fat, high carbohydrate intakes. They observed an 
increase in serum cholesterol with SFA and a "neutral" 
effect of MUFA. Moreover, they also concluded that SFA 
raise serum cholesterol levels twice as much as PUFA lower 
them. The hypercholesterolaemic effect of SFA (mainly 
present in animal fat, coconut fat, and palm and kernel 
oils), was shown by the equation: 2S-P where S and P 
represent the quantity of SFA and PUFA, respectively, as a 
percentage of total calories. A recent study (Mattson and 
Grundy, 1985), indicated that LDL-C, as well as T-C levels, 
are increased by dietary SFA. The major mechanisms by 
which SFA affect lipoprotein metabolism are through a 
decrease in hepatic LDL receptor synthesis and activity, 
the induction of compositional changes in VLDL and HDL 
(increase in apo E and cholesteryl esters), a general 
increase in all plasma lipoprotein concentrations, and a 
decrease in CM size (Kris-Etherton, et al., 1988). 
However, Grundy and Denke (1990), suggested that SFA do 
not, generally, increase TAG concentrations, even though 
synthesis of VLDL may be stimulated. Furthermore, Spady 
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and Dietschy, in 1988 and 1989, suggested that dietary SFA 
do not increase apo B-containing lipoprotein synthesis in 
the liver in hamsters. As a consequence, the main reason 
for the LDL-raising effect of SFA may be through the 
decreased LDL clearance. Loscalzo et al. (1987), suggested 
a mechanism by which SFA inducesthe hypercholesterolaemic 
effect. This involves the enrichment of cell-membrane 
phospholipids with SFA, which interfere with the normal 
function of LDL receptors within the cell membrane, 
possibly by reducing binding of circulating LDL. 
The diet associated with the development of 
atherosclerosis contains about 200 mg cholesterol and 
approximately 40% of calories are derived from fat, with 
15% of calories from SFA (Feldman et al., 1987). The lipid 
hypothesis states that increases in plasma lipids lead to 
hyperlipoproteinaemia and atherosclerosis. However, it has 
also been reported that one or two eggs in the customary 
diet does not alter significantly plasma T-C and TAG levels 
(Porter et al., 1977; Flynn et al. 1979). It has to be 
mentioned at this point that not all the SFA affect T-C and 
LDL-C levels to the same extent. Palmitic acid, which is 
the major SFA in animal fat but is also present in 
vegetable oils, increases T-C and LDL-C levels when it is 
substituted for carbohydrates or monounsaturates in the 
diet (Grundy and Vega, 1988; Grundy and Denke, 1990). In 
contrast, stearic acid does not seem to increase T-C 
levels. This suggestion is supported by the findings of 
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Ahrens et al. (1957), who showed that cocoa butter, which 
is rich in stearic acid, was less hypercholesterolaemic 
than butter fat. Two possible mechanisms have been 
proposed in order to explain the action of stearic acid on 
T-C levels. The first one is that stearic acid is less ab- 
sorbed due to its high insolubility. However, this 
explanation needs further consideration since it has been 
shown that even though tristearin resists hydrolysis in the 
intestine, stearic acid in mixed TAG is generally well 
absorbed (Mattson, 1959), but to a lesser extent than other 
fatty acids (Apgar et al., 1987; Grundy and Denke, 1990). 
The second explanation is based on the conversion of 
stearic acid to oleic acid through desaturation. It has 
been suggested that elongation is relatively slow and 
desaturation rapid, and as a result, stearic acid can 
convert quickly to oleic acid, through only the 
desaturation step, whereas, palmitic accumulates in the 
tissues (Grundy and Denke, 1990). Effects of lauric acid 
on T-C levels is still unclear (Grundy and Denke, 1990). 
However, since coconut oil and kernel oil are considered 
hypercholesterolaemic and are both rich in lauric acid, 
there is currently much enthusiasm for suggesting reduced 
intakes of this fatty acid (Hostmark et al., 1980). 
Myristic acid is also considered to be hypercho'lesterolaemic 
(Keys, 1965). However, diets of most people contain little 
of this fatty acid, which mainly comes from butter (Grundy 
and Denke, 1990). Finally, even though Ahrens et al. 
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(1957), suggested that medium-chain fatty acids increase T- 
C levels, others (Hashim et al., 1960) suggested exactly 
the opposite. However, these fatty acids seems to act like 
carbohydrates (Hill et al., 1989), and their main effect is 
to increase fasting TAG levels. 
Interest in the possible effects of fatty acid 
positional distribution, in the TAG molecule, in lipid 
metabolism has also been stimulated recently (Small, 1991). 
Rat studies have indicated that a saturated or a trans 
unsaturated long-chain fatty acid, present at the sn-2 
position of the dietary TAG molecule, could slow CM-R 
removal from the blood (Mortimer et al., 1988; Redgrave et 
al., 1988). However, the mechanism responsible for this 
decrease in remnant removal is not yet known, and further 
studies are needed to investigate and confirm these effects 
of fatty acid positional distribution in lipid metabolism, 
using not only animals but also human volunteers. 
1.7.2. POLYUNSATURATED FATTY ACIDS OF n-6 SERIES 
Two types of polyunsaturated fatty acids (PUFA) occur 
in the diet, n-6 and n-3 fatty acids and the major fatty 
acid of the n-6 series is linoleic acid, which is mainly 
present in vegetable oils. The hypocholesterolaemic effect 
of n-6 fatty acids has been indicated for almost 40 years. 
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First Kinsell and his collegues in 1952, and then Ahrens 
and his in 1954, demonstrated that not only the amount but 
also the type of dietary fat affect plasma T-C levels. 
From that point, numerous studies indicated the 
hypocholesterolaemic effect of PUFA from the vegetable 
origin, in normal human subjects. The extent of 
cholesterol lowering is related mainly to two factors: the 
magnitude of the difference between the P/S ratios and the 
presence of cholesterol in the diet (Goodnight et al., 
1982). Moreover, the magnitude of plasma lipid response is 
also related to the initial lipid levels of the volunteers. 
People with high plasma lipid levels are the ones who show 
the greatest plasma lipid response to dietary modification 
(Kris-Etherton et al., 1988). Mechanisms by which n-6 
fatty acids affect plasma lipids include: a decrease in 
cholesterol absorption, an increase in fecal cholesterol 
excretion, a decrease in cholesterol synthesis, an 
induction of compositional changes in LDL and other 
lipoproteins, and a decrease in VLDL and HDL synthesis in 
the liver (Goodnight et al., 1982; Kris-Etherton et al., 
1988). In addition, changes in fatty acid composition of 
cell membranes can influence lipoprotein metabolism by 
making lipoproteins better substrates for catabolic enzymes 
and/or by increasing their interactions with the receptors 
(Goodnight et al., 1982). Nestel et al. (1974), failed to 
show differences in cholesterol absorption in normal 
volunteers and Vega et al. (1982), suggested that the 
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major portion of cholesterol lowering effects of n-6 PUFA's 
occurs in the LDL fraction. In particular, LDL particles 
may have less cholesterol and/or their number may decrease. 
Spritz and Mishkel (1969) suggested that PUFA occupy more 
space within the lipoprotein particle and, as a result, 
fewer cholesteryl esters can be present in the core of LDL 
particles. Moreover, since a reduction in LDL-apo B levels 
has also been observed (Kuksis et al., 1982), reduced LDL 
number has been proposed to occur in response to n-6 PUFA. 
Another suggestion, of lowering LDL levels via a reduction 
in VLDL synthesis, needs further exploration since the 
effects of PUFA on VLDL-apo B and VLDL-TAG synthesis are 
not consistent. It has been suggested that n-6 fatty acids 
lower VLDL-apo B levels (Cortese et al., 1983), and VLDL- 
TAG concentrations (Chait et al., 1974), but others found 
little or no effect on VLDL levels (Mattson and Grundy, 
1985). Moreover, Goodnight et al. (1982), also suggested 
condradictory effects of vegetable oils on plasma TAG 
levels. Another possible mechanism by which n-6 fatty 
acids decrease LDL levels may be through an increase in LDL 
receptor activity. However, Grundy and Denke (1990), 
suggested in their review that the effects of linoleic acid 
could be passive, which means that even though SFA can re- 
duce the LDL receptors activity, linoleic acid may be 
neutral. Recent studies have come to support this latter 
view, since it was suggested that the hypocholesterolaemic 
effects of n-6 fatty acids are similar to those of oleic 
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acid (Mattson and Grundy, 1985; Mensink and Katan, 1989). 
Moreover, in contrast to MUFA, n-6 fatty acids reduce HDL-C 
levels and apo A-I synthesis (Shepherd et al., 1978; 
Mattson and Grundy, 1985). However, Goodnight et al. 
(1982) reached a different verdict, since these authors 
suggested that no change in plasma HDL levels occurs during 
n-6 fatty acid feeding, and Grundy and Denke (1990), 
suggested that substitution of n-6 fatty acids must be 
substantial before a decrease in HDL can be detected. 
Moreover, it seems that whenever there is a reduction in 
HDL concentrations there is also a similar, or a more 
profound reduction in LDL levels, and as a result, the 
LDL/HDL ratio remains fairly constant (Goodnight et al., 
1982). However, Grundy and Denke (1990) indicated that in 
large populations, even a small reduction in HDL-C levels 
could produce a slight increase in CHD risk. Results from 
another study suggested that heparin releasable liver 
lipase is more reactive towards more fluid lipoprotein 
particles, a fact which implies that n-6 fatty acid- 
enriched lipoproteins may be cleared more rapidly (Hulsmann 
et al., 1980). Moreover, an increase in unsaturation of 
membrane phospholipids can lead to an increase in the 
activity of membrane-bound enzymes (MacMurchie et al., 
1979), and the activity, but not the number, of LDL 
receptors (Gavigan and Knight, 1981). 
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1.7.3. POLYUNSATURATED FATTY ACIDS OF n-3 SERIES 
Interest in the effects of n-3 PUFA's on lipid 
metabolism began when Bang and Dyerberg (1972), suggested 
that there was a possible correlation between the presence 
of these fatty acids in the normal diet, and the rare 
incidence of CHD, observed in Greenland Eskimos. They 
observed only two deaths from CHD and no incidence of 
diabetes in a population of 1300 people between the years 
1963 and 1967. In two more recent studies of theirs (1975 
and 1976), they indicated that the Eskimo's unusual diet, 
rich in fish, whale and seal, and consequently rich in n-3 
fatty acids, may be responsible for the low plasma lipid 
levels observed in this population. 
The main n-3 fatty acids present in these fish oils 
are eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA), and they are both characterized by long carbon chain 
lengths, 20 and 22 carbon atoms respectively, and by a high 
degree of unsaturation (five and six double bonds 
respectively). Both fatty acids are present in the diet in 
two forms: as TAG in fish adipose tissue and between muscle 
fibers, and as constituents of muscle membrane phospho- 
lipids (Connor and Connor, 1990). They are mainly present 
at the sn-2 position of the glycerol moiety of both TAG and 
phospholipids and they are readily absorbed in the entero- 
cyte (Connor and Connor, 1990). EPA and DHA are readily 
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incorporated into cell membranes and are present in chole- 
sterol esters, FFA, TAG, and phospholipids, which are 
contained in lipoprotein particles and in cell membranes. 
Possible effects of fish oils on lipid metabolism include 
increases in fecal steroid excretion, decreases in plasma 
T-C and TAG levels, reduction in VLDL and LDL synthesis, 
changes in fatty acid composition of lipoprotein particles, 
and increased CM, VLDL, and LDL clearance. 
of cholesterol 
A slightly greater fecal excretionAhas been observed, 
with n-3 fatty acids, than with saturated or n-6 fatty 
acids (Connor et al., 1981). These authors indicated that 
this difference observed in fecal excretion was due to 
increased bile acid excretion, with n-3 fatty acids. 
It has been suggested that even though plasma EPA and 
DHA levels increase in plasma, these fatty acids are not 
esterified into all lipid classes to the same extent 
(Harris, 1989). TAG and phospholipids contain 
approximately equal amounts of EPA and DHA, whereas, in 
cholesteryl esters,. - EPA is more abundant (Simo- 
Poulos, 1991). However the reason for this preference is 
not yet known (Harris, 1989). 
It has also been suggested that fish oils may reduce 
postprandial lipaemia (the extent and duration of the TAG 
increase following meal ingestion), due to reduced rates of 
CM resynthesis in the enterocyte. Diacylglycerol acyl- 
transferase (Figures 1.1 and 1.4) , may play an 
important 
role in the decrease in lipolysis, since n-3 fatty acids 
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are suggested to cause a reduction in the activity of this 
enzyme in the liver (Rustan et al., 1988a) (Figure 1.4). 
Hepatic VLDL synthesis can be inhibited through 
reductions in TAG, cholesterol and apo B synthesis, and 
ketogenesis can be increased, through increased peroxisomal 
8-oxidation by n-3 PUFA's. EPA and DHA are thought to be 
poor substrates for esterification to glycerol since apart 
from their effects on diacylglycerol acyltransferase 
(Figure 1.4), they also inhibit PAP activity in hepatocytes 
(Marsh et al., 1987) (Figure 1.4). EPA has also been shown 
to inhibit de novo fatty acid synthesis and to reduce the 
amount of acetyl-CoA carboxylase and fatty acid synthetase 
in liver (Yang and Williams, 1978; Iritani et al., 1980a 
and b; Clarke and Clarke, 1982a and b). EPA has also been 
suggested to inhibit cholesterol esterification in rat 
hepatocytes (Rustan et al., 1988b) and Wong and Nestel 
(1987), observed an inhibition of secretion of TAG and apo 
B due to the presence of EPA; they also noted that plasma 
T-C levels were not affected. on the other hand, acyl-CoA 
oxidase activity is increased (Yamazaki et al., 1987), and 
through a rise in peroxisomal ß-oxidation (Figure 1.3), an 
increase in ketogenesis can also be observed (Bergseth et 
al., 1986). 
The decrease in hepatic TAG synthesis resulting from 
n-3 PUFA feeding, has been suggested to result in formation 
and secretion of small VLDL particles. These small VLDL 
particles have approximately the same size of the remnants 
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which arise from the LPL-mediated catabolism of large VLDL 
particles (Harris, 1989). It has also been suggested that 
remnant particles are not converted into LDL as readily as 
small VLDL are, possibly because they are richer in apo E 
than small VLDL and thus get removed, through the action of 
hepatic apo B/E receptor, before they convert to LDL. 
Although there is some evidence of increased LDL levels 
through fish oil consumption (Harris, 1989), it has also 
been suggested that fish oils incorporate large amounts of 
EPA into LDL-cholesteryl esters which can lead to an 
alteration of the lipid core and a decrease in the LDL 
transition temperature and, as a consequence, to greater 
fluidity of these lipoprotein particles, an effect which is 
associated with decreased atherogenicity of LDL. Simo- 
Poulos (1991), also reported that EPA and DHA may alter the 
rate of LDL oxidation in vivo, and as a result, cause a 
reduced atherogenic potential of LDL. Moreover, an 
increase in binding of LDL with the LDL receptor has also 
been observed (Tripodi et al., 1991), but on the other 
hand, Wong and Nestel (1987), observed an inhibition of LDL 
binding but no effect on CM remnant binding by EPA. 
Increased VLDL clearance due to reduced competition 
from CM is another possibility by which fish oils can 
affect lipid metabolism. There is insufficient research in 
this area, since there are not enough postprandial studies 
which have investigated the effect of fish oil on 
postprandial lipid levels. However, Harris and Connor 
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(1980), observed a smaller rise in postprandial plasma TAG 
levels, after a salmon oil test meal, than after a 
saturated fat test meal. They concluded that the CM 
clearance may increase, following meals rich in n-3 fatty 
acids. Other investigators suggested that the possible 
increased CM and/or VLDL clearance cannot be due to 
increased LPL activity (Goodnight et al., 1982; Harris, 
1989), but is probably due to increased accessibility of 
the enzyme to the substrate, since the fatty acid profile 
of the lipoprotein particles alter with n-3 fatty acids 
(Goodnight et al., 1982). On the other hand, Haug and 
Hostmark (1987), observed lower LPL activity in rats fed 
diets rich in fish oil than in rats fed diets rich in 
coconut oil. Furthermore, Melin et al. (1991), indicated 
that LPL hydrolyzes EPA at a slower rate than the C14-C18 
acid esters. In addition, although studies have 
investigated effects of fish oils on CM-TAG clearance, few 
studies have evaluated effects of n-3 PUFA's on CM-R 
clearance. Since the implications of CM-R in atherogenesis 
have already been discussed, there is an urgent necessity 
for further research into postprandial lipid metabolism and 
the effects of dietary fatty acid composition on 
postprandial lipoprotein levels. 
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1.8. AIMS OF THE STUDY 
It becomes apparent that the effects of different 
types of dietary fatty acids on postprandial lipid 
metabolism is not yet clear. Even though there are 
numerous studies which have investigated effects of the 
amount and type of dietary fat on fasting lipid levels, and 
possible mechanisms involved in the differences observed, 
there is only a limited number of studies which have 
considered the implications of dietary fat on postprandial 
lipid levels. The need for further work on postprandial 
lipid metabolism becomes even more urgent since a 
correlation between CM-R and atherogenesis has been 
recently demonstrated. 
As a consequence, the main purpose of the present 
study was to shed some more light into the effects of 
dietary TAG composition and structure on postprandial lipid 
metabolism. Because of the strong evidence suggesting 
beneficial effects of n-3 fatty acids on plasma lipid 
levels and notably on plasma TAG levels, the present study 
has concentrated on the comparison of the effects of three 
different types of dietary fatty acids, saturated, n-6, and 
n-3, on fasting and postprandial lipid levels in normal and 
55 
NIDDM human volunteers. Effects of dietary fatty acid 
composition on hormones (insulin and GIP), and enzymes 
(LPL), which are involved in lipid metabolism, have also 
been investigated since there has been little attempt in 
the literature to relate effects of dietary fatty acids to 
possible changes in hormones which regulate lipid 
metabolism. Furthermore, since there is some evidence, 
from animal studies, to suggest that dietary TAG structure 
may influence postprandial lipid metabolism, in this thesis 
the first human study was carried out which investigated 
possible effects of fatty acid positional distribution on 
postprandial plasma lipid and hormone levels. Finally, in 
order to investigate possible hepatic mechanisms by which 
dietary fatty acid composition could influence lipoprotein 
levels, an animal study was carried out to investigate 
effects of dietary saturated, n-6, and n-3 fatty acids on 
hepatic lipogenesis with animals being in the fed state. 
56 
CHAPTER 2 
MATERIALS AND METHODS 
2.1. HEPATIC LIPID SYNTHESIS 
2.1.1. INTRODUCTION 
A method was developed which would enable the 
investigation of the effects of three different types of 
diet on hepatic lipid synthesis in rats (Chapter 6). The 
design of the study required that the method should be 
reliable and enable the processing of a large number of 
tissue samples at the same time. 
An in vitro ex vivo method for measuring hepatic lipid 
synthesis was used in order to exclude other physiological 
mechanisms, apart from the activities of the pathways of 
hepatic lipid metabolism (for example altered hormone 
concentrations or substrate availability) which could 
influence hepatic lipid and fatty acid synthesis. 
In vitro methods used by previous authors, employ 
either hepatocytes (Berry and Friend, 1969; Davis et al., 
1979) or liver slices (Iritani et al., 1980; Hood, 1990). 
Even though it has been reported that hepatocytes remain 
viable for a longer period of time than liver slices 
(Gustavsson and Morland, 1980), a method similar to the 
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liver slicing technique (liver pieces), was decided upon 
for the purpose of the present study. The time required 
for the preparation of isolated hepatocytes, and the 
special equipment required for their incubation, precluded 
use of the procedure in the present study. The use of a 
modified liver slices method enabled the investigator to 
measure hepatic lipogenesis in livers obtained from three 
animals sacrificed at the same time. 
The labelled substrate which was used in the study was 
[U-14C]glucose. The use of tritiated water as the labelled 
substrate was found to be unreliable, since high counts in 
the blank samples (dead tissue), were observed (section 
2.1.7). Hood (1990), also suggested that [U-14C]glucose is 
the most suitable for measuring incorporation of the radio- 
active substrate into both the fatty acid and the glycerol 
moiety of TAG. 
For the extraction of the total lipids, a modified 
method of Bligh and Dyer (1959), was followed. Thin layer 
chromatography (TLC) was also applied in order to isolate 
cholesterol (CHOL), FFA, and TAG from the total lipids 
(Nossen et al., 1984). 
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2.1.2. REAGENTS 
[U-14C]glucose (288 mCi/mmol), [9,10 (n)-3H]palmitic 
acid (52.8 Ci/mmol), and 
3 H20 (5 Ci/ml) were supplied by 
Amersham International plc, Buckinghamshire. 
Bovine Serum Albumin (BSA)(Fraction V, fatty acid 
free), lipid standard for TLC, bovine insulin, and Medium 
199 (with Earle's salts, 5.6 mmol/l glucose, 25mM HEPES and 
sodium bicarbonate, without L-glutamine), were supplied by 
Sigma Chemical Co., Poole, Dorset. 
Porcine GIP was donated by Prof. J. C. Brown, Univer- 
sity of British Colombia, Vancouver, BC, Canada. 
Perchloric acid (60%), and iodine crystals were 
supplied by BDH Chemicals Ltd., Poole, Dorset. 
Chloroform, methanol, hexane, diethyl ether, acetic 
acid, optiphase (scintillant), were supplied by Fis;. ons 
Laboratory Supplies, Loughborough. 
Precoated silica gel TLC plates were supplied by 
Merck, Darmstadt, Germany. 
2.1.3. WORKING REAGENTS 
Incubation buffer was prepared fresh every study day 
by dissolving BSA in medium 199 to achieve a concentration 
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of 2% (w/v). Once prepared, incubation buffer was kept at 
37°C until use. 
[U-14Clglucose was added in each incubation flask to 
achieve 1.5 &Ci per 2 ml incubation. 
Perchloric acid was used at a concentration of 1.54 
g/ml. 
Saline solution was used at a concentration of 0.9%, 
cWN" 
The mobile phase for the separation of the lipid 
fractions constituted of hexane/diethyl ether/acetic acid, 
80/20/1. 
2.1.4. INCUBATION PROCEDURE 
The outline of the incubation procedure is given in 
Figure 2.1. Initially, incubation buffer was kept at 37°C 
under an atmosphere of 95% 02 and 5% CO2 for an hour, prior 
to collection of the tissue. 
At 09: 00 hours a male Wistar Albino rat was anaesthe- 
tised using ether and sacrificed by cervical dislocation. 
The liver was removed and placed into incubation buffer, 
kept at a temperature of 37°C. The liver was cut into 
pieces, each weighing approximately 200-300 mg. One piece 
of tissue was used as blank (placed in perchloric acid and 
treated exactly as the viable tissue), and another piece 
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was put in 2 ml of incubation buffer. Each piece of liver 
was then cut into very small pieces. The pieces of liver 
were transferred in 25 ml Erlenmeyer flasks, and 2 ml of 
incubation buffer, to which 1.5 ACi [U-14C]glucose per flask 
were added. The concentration of the unlabelled glucose in 
the Medium 199 was 5.6 mmol/l. Hormone additions were also 
made at this point when required. Incubation took place 
for 3 hours, in a shaking water bath at 37°C; the atmo- 
sphere was gassed (95% 02,5% C02) . 
2.1.5. EXTRACTION AND SEPARATION PROCEDURE 
The outline of the extraction and separation procedure 
is given in Figure 2.2. In particular, 1 ml of perchloric 
acid was added to the flasks in order to terminate the 
assay. The liver pieces were then transferred onto a 
filter paper (Whatman no. 1), incubation buffer and per- 
chloric acid were removed under vacuum, and the liver was 
washed with 20 ml saline solution (addition of 5 ml ali- 
quots to a total volume of 20 ml). Saline was also removed 
under vacuum. The filter paper was weighed before and 
after transferring the pieces of liver into a Sovril tube 
to obtain the total weight of liver used. 
For the extraction of the total lipids, the method of 
Bligh and Dyer (1959), was followed, with slight modifica- 
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tion. After transferring the liver pieces in a sovril 
tube, 200 µl of chloroform and 400 Al of methanol were 
added. A glass rod was used to homogenise the liver pieces 
in the organic solvents. The contents were vortex mixed 
for 1 minute. A further 200 Al of chloroform was then 
added and the contents vortex mixed for 30 seconds. 200 Al 
of distilled water was added; the content was vortex mixed 
for 30 seconds and the homogenate was centrifuged at 1500 
g for 5 minutes in order to separate the aqueous and the 
chloroform phases. The aqueous phase was discarded and 150 
Al of the chloroform phase was pipetted in a glass tube. 
A 50 pl aliquot of the chloroform phase was transferred 
into a scintillation vial, 4 ml of optiphase added and the 
radioactivity was counted using a Wallac 1410 Liquid Scin- 
tillation Counter (Wallac Oy, Finland). The programme 
"Easy Count" was used to measure the radioactivity in the 
scintillation vials. This is a feature of the counter, 
using a 60 second counting time. Chemical, colour and 
chemiluminescence correction are carried out automatically, 
using an external standards channel ratio method. 
100 Al of the chloroform phase from the blanks and 
tests, was dried down under nitrogen and stored at 4°C for 
later separation of the lipid subfractions by TLC. On the 
day of separation, the dried sample was reconstituted in 40 
Al of chloroform and spotted onto 2 cm region at the origin 
of a precoated TLC plate for the separation of CHOL, FFA, 
and TAG. The TLC plate was dried with a cold air hair 
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drier, placed in a tank presaturated with the mobile phase 
(hexane/diethyl ether/acetic acid; 80/20/1). The plate was 
run until it was seen that the solvent front had reached 1 
cm from the top of the plate (approximately one hour). The 
plate was removed, left to dry, and placed into a tank, 
containing iodine crystals. The iodine vapour stained the 
separated lipid classes yellow. The bands corresponding to 
the CHOL, FFA, and TAG classes were marked and left to 
destain overnight. Bands were removed directly to 
scintillation vials and 4 ml of optiphase was added and the 
radioactivity counted. 
All incubations were carried out in duplicate, and 
blanks were included in each assay. 
2.1.6. CALCULATIONS 
The specific activity of [U-14C]glucose was 288 mCi/ 
mmol, so that in each incubation 1.5 ACi provided 5.0 nmol 
glucose. The glucose concentration in medium 199 was 5.6 
mmol/l, providing 11.2 µmols glucose in 2 ml of incubation 
buffer. As a result, the total glucose present in 2 ml of 
incubation buffer was: 11.2 µmol + 5.0 nmol = 11,205 nmol. 
The incorporation of [U-14C]glucose into a) total 
lipids and b) individual lipid classes was calculated by 
using the following formula: 
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ax0.3 x 10-6 x 11,205 = nmols glucose/g wet tissue 
weight/3 hours 
where 1.5 iCi corresponds to 3.33 x 106 dpm and 
a) a= (sample dpm - blank dpm) x8x 1000 x 
[sample weight(mg)]'1 
when calculating incorporation in total lipids, since 
8= 400/50, where 4O0µ1 is the total volume of the 
chloroform phase in µl and 50 the volume put in the 
scintillation vial, or, 
b) a= (sample dpm - blank dpm) x4x 1000 x 
[sample weight(ing)]-' 
where volume of the chloroform phase which was put on 
the TLC plate corresponded to 100 µl of a total 400 
Al volume. 
2.1.7. VALIDATION EXPERIMENTS 
In order to validate the method for the determination 
of hepatic lipid synthesis, a number of validation exper- 
iments were carried out. From the results obtained from 
the validation experiments (given in detail below), the use 
of [U-14C]glucose was found to provide more reliable 
measurements than 3H20, and a3 hour incubation (2% w/v BSA 
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added), was found to provide plateau rates of incorpora- 
tion. The most appropriate insulin and GIP concentrations 
for stimulating hepatic lipogenesis, were found to be 4 and 
6 nmol/1 respectively. 
2.1.7.1. RECOVERY OF LABELLED LIPIDS 
In order to ensure that the procedure used for the 
extraction of tissues lipids was reliable, a recovery 
experiment was carried out, using liver pieces spiked with 
[9,10 (n)- H]palmitic acid (Table 2.1). 
Pieces of fresh liver, removed from an animal, 
sacrificed under anaesthesia, were placed immediately into 
perchloric acid and five samples (approximately 200 mg) 
were weighed, and put in separate Sovril tubes. 10 Al of 
[9,10 (n)3H]palmitic acid (32,477,499 dpm), were added into 
each tube and the extraction procedure, described above, 
was followed. 20 gl of the chloroform phase was spotted 
onto a TLC plate for separation of the lipid classes. The 
visualised spots were marked and scraped off, into 
scintillation vials. 4 ml of optiphase was added, and 
radioactivity was counted. Recovery was found to vary from 
61.8 to 72.8% with an average of 66.0±4.9 % (mean ± SD) . 
The average level of recovery on the TLC is acceptable. 
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2.1.7.2. TIME-COURSE FOR INCORPORATION OF 
TRITIATED WATER INTO HEPATIC LIPIDS 
In order to establish the time when the incorporation 
of 3H20 into hepatic lipids reaches its plateau, liver 
TABLE 2.1 
Validation experiment for hepatic lipogenesis study: 
recovery of the extraction procedure using 
[9,10 (n)- H]palmitic acid. 
Sample No Lipid dpm FFA (dpm) Recovery 
Subtraction x2o (%) 
CHOL 9840 
1 FFA 1075721 21514420 66.2 
TAG 15294 
CHOL 10415 
2 FFA 1022251 20445020 63.0 
TAG 10021 
CHOL 9761 
3 FFA 1002864 20057280 61.8 
TAG 9045 
CHOL 12790 
4 FFA 1182404 23648080 72.8 
TAG 5335 
t 
20 µ1 of the total 400µ1 of the chloroform phase was put 
on the TLC plate. 
pieces were incubated with the labelled substrate (section 
2.1.4. ), for 60,120,180,240, and 300 minutes. 
Incubations were carried out in duplicate and the results 
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are given in Table 2.2. From the results obtained it can 
be suggested that even though a3 hour incubation was the 
most appropriate for the study, the counts in the blanks 
were unacceptably high. 
TABLE 2.2 
Validation experiment for hepatic lipogenesis study: 
effect of different incubation periods on incorporation of 
100 'Ci H2O into rat liver total lipids. 
INCUBATION TIME 
(min) 
INCORPORATED 3H20 
(d m/ ) 
INCORPORATED 3H20 
(d m- blank) 
Blank 67128 
60 135584 68456 
120 194156 127028 
180 289640 222512 
240 305100 237972 
300 240416 173288 
2.1.7.3. EFFECT OF DIFFERENT WASHING AND ORGANIC 
PHASE TRANSFERRING PROCEDURES DURING THE LIPID 
EXTRACTION PROCESS ON RADIOACTIVITY PRESENT IN 
BLANK SAMPLES 
The presence of high counts in the blank samples was 
problematical and a number of approaches were used in an 
attempt to overcome this: (a) increasing the amount of 
saline solution used for the washing of the tissue, after 
the end of the incubation period, and (b) discarding the 
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aqueous phase first, before transferring the organic phase 
from the lipid extraction tube to the radioactivity 
counting vials (Table 2.3). Neither of the procedures 
resolved the problem. 
TABLE 2.3 
Validation experiment for hepatic lipogenesis study: 
effect of use different saline amounts during washing and 
different procedure of transfer of the chloroform layer, 
on the presence of radioactivity on samples from 
dead rat liver (blanks). 
PROCEDURE INCORPORATED 3R 0 (d m) 
4 ml saline 16 ml saline 32 ml saline 
(0.9% W /V) (0.9% w v) (0.9% V /V) 
Pipetting 24438 2824 29430 
through 9091 88435 
aqueous 
layer 
Discarding 13674 27049 129371 
aqueous 18867 40052 127079 
layer 
first 
2.1.7.4. EFFECT OF INCUBATION TIME AND INCUBATION 
MEDIUM ON THE RADIOACTIVITY PRESENT IN BLANK 
SAMPLES 
In order to establish whether incubation time (1 and 
3 hours), and incubation medium (Krebs-Ringer, and medium 
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199 with 2% w/v BSA, either ungassed or gassed with 95% 02 
and 5% C02), have any effect on the presence of radio- 
activity in the blank samples, dead liver pieces were 
incubated for either 1 or 3 hours in the incubation media 
mentioned above (Table 2.4). In all the incubations, the 
radioactivity present in the blanks was still unacceptably 
high. Because none of the approaches used were successful 
in reducing background counts, it was decided to investi- 
gate the use of an alternative substrate, [U-14C]glucose. 
TABLE 2.4 
Validation experiment for hepatic lipogenesis study: 
effect of different incubation time periods in 
different incubation media on the blank counts 
(mean ± SD, n=4). 
INCUBATION MEDIUM 3820 IN 
(d m 
BLANKS 
wet tissue) 
Krebs-Ringer 
1 hour incubation period 736756 ± 55841 
3 hours incubation period 720732 ± 101256 
Medium 199 with 2% BSA w/v 
1 hour incubation period 529627 ± 93995 
3 hours incubation period 660770 ± 148410 
Medium 199 with 2% BSA w/v 
(gassed with 95% 02 and 5% CO2) 
1 hour incubation period 817351 ± 177439 
3 hours incubation period 575443 ± 271164 
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2.1.7.5. TIME-COURSE FOR INCORPORATION OF 
[II-14C] GLUCOSE INTO HEPATIC LIPIDS 
In order to establish the appropriate incubation time 
for the experiment, liver pieces were incubated with [U-14C) 
glucose, as described in 2.1.4., for various time periods 
(60,120,180,240, and 300 minutes). Incubations were 
carried out in duplicate and the results, which are given 
in Table 2. a (see appendix I) and Figure 2.3, showed that 
a 180 minute incubation period would be the most 
appropriate, since incorporation at this time reached a 
plateau before rates of incorporation began to decline 
towards 300 minutes. 
2.1.7.6. VIABILITY OF TISSUE PRIOR TO 
EXPERIMENTAL INCUBATION 
A viability experiment was carried out, using pieces 
of liver left in unlabelled warm buffer for 30,90,120, 
and 180 minutes after the sacrifice of the animal. The 
purpose of this experiment was to determine for how long 
after removal from the animal, the tissue remains viable. 
It was important to ensure that the tissue could be left 
for some period of time without affecting the incorporation 
of the label in the lipids, because some delay was in- 
evitable due to the time taken for sacrifice, and tissue 
and blood removal from three animals. 
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After leaving the tissue in the incubation buffer, a3 
hour incubation was carried out at 37°C with 1.5 ACi [U-14C] 
glucose as described in 2.1.4. The radioactivity was 
counted after extracting the total lipids. Results are 
given in Table 2. b (see appendix I), and Figure 2.4. From 
the results obtained, it can be concluded that the tissue 
remains viable and active for up to 90 minutes after the 
sacrifice of the animal, after which there appears to be a 
gradual decline in metabolic activity. 
2.1.7.7. REPRODUCIBILITY VALIDATION EXPERIMENT 
In order to assure that the method was reproducible, 
a reproducibility experiment was carried out, using liver 
pieces (6 basal and 2 blank incubations). Tissue was 
incubated for 3 hours at 37°C with 1.5 MCi [U-14C]glucose, 
as described in 2.4.1. The intra-assay c. v. was found to 
be 8.4% (Table 2.5). 
74 
Fig. 2.3 Incorporation of [U-14C1glucose in rat liver 
total lipids: time-course validation experiment 
300 rlU-14CIGLUCOSE INCORPORATED 
(nmol/g wet tissue) 
250 
200 
150 
100 
50 
I1IIIII 
0 50 100 150 200 250 300 350 
INCUBATION TIME (min) 
Fig. 2.4 Incorporation of [U-14C]glucose in rat liver 
total lipids: viability validation experiment. 
400 rU 
14CIGLUCOSE INCORPORATED (nmol/g wet tissue) 
300 
200 
100 
0 
0 50 100 150 200 
PRE-INCUBATION TIME (min) 
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TABLE 2.5 
Validation experiment for the hepatic lipogenesis study: 
reproducibility experiment. 
Incubation Inc? rporated mean±SD 
number 4 [U- C]glucose (c. v. ) 
(nmmol/g 
wet tissue) 
1 170.5 
2 162.2 
3 175.9 175.8±14.8 
4 192.5 (8.4%) 
5 159.4 
6 194.1 
2.1.7.8. INSULIN AND GIP DOSE RESPONSE CURVES 
To establish the optimal dose of insulin and GIP for 
the stimulation of lipogenesis, liver pieces were incubated 
with different concentrations of these two hormones, and a 
dose response curve plotted. In particular: 
li) Insulin: A stock solution of 0.05 mM bovine insulin in 
0.1N HC1, kept frozen at -20°C was used to prepare a top 
solution (1000 nmol/1), in incubation buffer. Dilutions in 
incubation buffer were also undertaken in order to achieve 
insulin concentrations of 1,2,4,8,10, and 16 nmol/l, 
and made up on the day of the experiment. 
Iii) GIP: From a stock solution of porcine GIP (5 gg/ml), 
kept frozen at -20°C, dilutions in incubation buffer were 
undertaken in order to achieve GIP concentrations of 1,3, 
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6,12, and 20 nmol/l. 
(iii) Insulin and GIP: Solutions with concentrations of 2 
nmol/l insulin and 3 nmol/1 GIP (2+3), 4 nmol/1 insulin and 
6 nmol/l GIP (4+6), and 8 nmol/l insulin and 10 nmol/1 GIP 
(8+10), were produced. 
Incubations were carried out in duplicate, using 
approximately 200 mg of liver pieces for each hormone con- 
centration, and two blank and two basal incubations were 
also included. Initially, a wide range of hormone concen- 
trations were investigated using ranges as mentioned in the 
literature by other investigators. However, in the present 
experiment it was finally decided to use more physiological 
concentrations which reflect postprandial levels and which 
were found by another investigator in our laboratory to 
produce significant stimulation in adipose tissue lipo- 
genesis. 
From the results obtained (Tables 2. c, 2. d, and 2. e in 
appendix I, and Figures 2.5,2.6, and 2.7 respectively), it 
was observed that stimulation of lipogenesis was highest in 
the presence of 4 nmol/l insulin, 6 nmol/1 GIP, and in the 
presence of both 4 nmol/1 insulin and 6 nmol/l GIP. 
2.1.7.9. REPRODUCIBILITY VALIDATION EXPERIMENT IN 
TOTAL LIPIDS AND SEPARATE LIPID CLASSES IN THE 
PRESENCE OF 4 nmol/1 INSULIN 
Incorporation of [U-14C]glucose in total lipids and 
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lipid subfractions (CHOL, FFA, and TAG), in 4 liver pieces, 
incubated without hormone additions and 5 liver pieces, 
incubated with insulin (4 nmol/1), were carried out. 
Results are given in Tables 2.6 and 2.7. Interassay 
variability cannot truly be assessed because the procedure 
must be carried out on fresh tissue; therefore, use of 
different tissue preparations introduces an additional 
variable. Intra-assay c. v. varied between 19.1% (basal 
TAG), and 42.6% (Insulin FFA). The mean c. v. was 27.0± 
8.3%. The high intra-assay c. v. could not be reduced by 
the use of more stringent experimental procedures than 
those described and was found to be similar to that 
reported by workers in other laboratories and a co-worker 
in the present laboratory. The highest variability was 
found with the FFA fraction in which incorporation of the 
substrate was least. In order to exclude the possibility 
of assay variability introducing a bias into the experimen- 
tal data (Chapter 6), the feeding study was designed to 
ensure that one animal from each dietary group was 
sacrificed on each day of study, enabling samples from 
these animals to be treated as part of a single lipogenic 
assay. Some comment, however, on total variability (inter- 
and intra-assay and inter-animal) can be made from the 
experimental data in Chapter 6, e. g. the c. v. for the 
substrate incorporation into hepatic TAG for mixed oil 
treated animals (n=7), was found to be 51.6%. Therefore, 
the total assay and biological variability is in the region 
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Fig. 2.5 Incorporation of (U-"C]glucose in rat liver total lipids: effect of insulin concentration. 
250 . 
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200 
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02468 10 
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Basal incorporation: 172.7 nmol/g wet tissue 
Fig. 2.6 Incorporation of [U-"Clglucose in rat liver 
total lipids: effect of GIP concentration. 
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Fig. 2.7 Incorporation of (U-"Clglucose in rat liver 
total lipids: effect of both insulin and GIP. 
400 JU-"C)GLUCOSE INCORPORATED (nmol/g wet tissue) 
300 
200 
100 
0 2+3 4+6 
INSULIN+GIP (nmol/I) 
Basal incorporation: 854.8 nmol/g wet tissue 
8+10 
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TABLE 2.6 
Validation experiment for the hepatic lipogenesis study: 
effect 91 insulin (4 nmol/1) on 
incorporation of [U- C]glucose in rat liver total lipids. 
Incubation medium In4orporated 
[U- C]glucose 
(nmol/g 
wet tissue) 
mean±SD 
(c. v. ) 
Insulin 177.8 
219.9 241.3±56.3 
269.7 (23.3%) 
323.5 
215.6 
Basal 211.0 
257.3 218.5±50.1 
255.2 (22.9%) 
150.5 
TABLE 2.7 
Validation experiment for hepatic lipogenesis study: 
effect of insulin c4 nmol/1) on 
incorporation of [U-4C]glucose in 
rat liver lipid subfractions (Chol., FFA, and TAG). 
Incorp? 
orated Incorp? orated 
Incorp? orated 
[U- C] [U- C] [U- C] 
glucose glucose glucose 
in CHOL. in PPA in TAG 
(nmol/g (nmol/g (nmol/g 
wet tissue) wet tissue) wet tissue) 
Insulin 13.3 6.4 70.1 
20.2 12.3 91.5 
25.8 8.9 114.1 
25.7 5.9 124.0 
17.9 4.0 104.2 
mean±SD 20.6±5.3 7.5±3.2 100.1±20.9 
(c. v. ) (25.7%) (42.6%) (20.8%) 
Basal 14.8 7.0 81.4 
18.0 4.8 101.7 
16.8 6.4 99.7 
9.4 3.6 66.3 
mean#SD 14.7±3.8 
L 
5.4±1.5 87.2±16.7 
(c. v. ) (25.8) (27.7%) (19.1%) 
81 
of 50% with assay variability contributing approximately 
one half of this variability. 
2.2. RETINYL PALMITATE 
2.2.1. REAGENTS 
Retinyl palmitate (1800000 USP units/g), and retinyl 
acetate (synthetic, 2900000 USP units/g), were supplied by 
Sigma Chemical Co., Poole, Dorset. 
Silver nitrate was supplied by Vickers Laboratories 
Ltd., Yorkshire. 
Methanol and chloroform, both HPLC grade, were 
supplied by Fisons Laboratory Supplies, Loughborough. 
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2.2.2. WORKING REAGENTS 
Stock solutions of retinyl acetate (RA), which was 
used as internal standard, and retinyl palmitate (RP), both 
having concentrations 10 mg/ml, were prepared by accurately 
weighing 200 mg of the solid standard and dissolving each 
in chloroform/methanol (1/1, v/v), and stored at 4°C. On 
the day of the assay, working reagents were prepared by 
diluting 10 gl of each of the stock solutions in 10 ml of 
chloroform/methanol (1/1, v/v), to achieve concentrations 
of 10 µg/ml (RA), and 10 µg/ml (RP). For the preparation 
of the standard curve both RP and RA were used. 0.2 ml of 
RA (10 Ag/ml) was diluted to 5 ml to give a concentration 
of 0.4 Ag/ml, and 0.1 ml of RA (10 µg/ml) and 0.5 ml of RP 
(10 µg/ml) were mixed and diluted to 2.5 ml to give a top 
standard concentration of 0.4 hg/ml RA and 2 gg/ml RP in 
chloroform/methanol (1/1, v/v). The other standards were 
prepared by mixing 1 ml of the internal standard (0.4 
µg/ml), and concentrations of RP of 2.0 gg/ml, 1.0 µg/ml, 
0.5 gg/ml, 0.25 µg/ml, and 0.125 Ag/ml. The standards were 
prepared fresh in each day of the assay. A typical 
standard curve is given in Figure 2.8. 
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Figure 2.8 
Typical standard curve from retinyl palmitate assay. 
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2.2.3. PRINCIPLE 
The retinyl palmitate loading technique was used to 
determine, indirectly, plasma CM and CM-R levels. In human 
volunteers it has ben stated that, once in the circulation, 
retinyl esters remain in the CM until they are taken up by 
the liver (Goodman et al., 1966; Olson et al., 1969). In 
the liver, retinyl esters either enter a storage pool, or 
they are secreted in their unesterified form, bound to 
retinol binding protein (Goodman, 1980). As a consequence, 
retinyl esters are considered to be bound only to the CM 
and CM-R and not to other lipoprotein particles. Retinyl 
palmitate is the major retinyl ester, and together with 
retinyl stearate (in an average ratio of 2.4 to 1), con- 
sistently comprise approximately 80% of retinyl esters 
(Goodman et al., 1966). 
The method for retinyl palmitate analysis is based on 
the Reversed-Phase High-Performance Liquid Chromatography 
procedure described by deRuyter and deLeenheer (1978, 
1979), modified by Ah-Sing . 
in our laboratory. The pro- 
cedure allows resolution of a mixture of compounds as a 
consequence of the different rates at which they move 
through a stationary phase under the influence of a mobile 
phase. In the present study, silver nitrate was used in 
the mobile phase in order to avoid the coelution of retinyl 
palmitate and retinyl oleate by forming complexes with the 
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double bonds of the oleate, hence decreasiugits retention 
time (DeRuyter and deLeenheer, 1979). A typical chroma- 
togram is given in Figure 2.9. 
2.2.4. INSTRUMENTATION 
Pump: Waters 510 and Waters 712W1SP 
Column: Stainless steel [150 mm x 4.6 mm (i. d)), 
packed with 10 µm C18 particles (Phase 
Separation Ltd., Deeside). 
Mobile phase: CH3OH/ 58.9 x 10-3M [Ag+] . 
Flow rate: 1 ml/min. 
Detection: 330 nm (Pye Unican LC-UV detector). 
2.2.5. EXTRACTION 
200 µl of plasma were pipetted into a glass centrifuge 
tube and 0.6 ml of water, 200 Al of RA (0.4 µg/ml) solution 
in chloroform/methanol (1/1, v/v), and 1 ml of chloroform 
were added. After mixing thoroughly for 1 minute and 
allowing to stand for 5 minutes, 1 ml of water and 1 ml of 
chloroform were also added. The sample was mixed gently 
and centrifuged at 1500 g for 5 minutes in a bench cen- 
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Figure 2.9 
Typical chromatogram from retinyl palmitate assay. 
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trifuge. The obtained chloroform phase was transferred to 
a clean tube and evaporated to dryness using a vacuum eva- 
porator (Gyro Vap., V. A. Howe and Co. Ltd., U. K. ). The 
lipid residue was reconstituted in 200 µl of methanol/ 
chloroform (1/1, v/v), and 50 Al aliquots injected onto the 
HPLC column. 
2.2.6. CALCULATIONS 
A data handling software was used (Waters Maxima 820 
software), for the calculation of plasma RP concentrations, 
based on peak area ratios. In particular, the peak area 
ratio of the RP standards to the internal standard was 
calculated and a standard curve was plotted, each day of 
the assay, using the peak area ratios against the expected 
RP concentrations of the standards. Peak area ratios of 
the samples were also calculated and the RP levels in the 
samples were calculated from the plotted standard curve. 
2.2.7. VALIDATION EXPERIMENTS 
In order to standardise the method, validation 
experiments were carried out in conjunction with a co- 
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investigator who was a final year undergraduate project 
student. 
2.2.7.1. LINEARITY 
Standard curves, with RP concentrations ranging from 
0 to 2.5 µg/ml and RA of 0.3125 µg/ml, were compared for 
regression coefficients and it was found that standard 
curves, freshly prepared every day, had r values greater 
than 0.981 (peak height ratio value). The interassay c. v. 
for the r values was found to be 0.8% (n=7). 
In order to investigate the linearity after the 
extraction procedure 200 pl of plasma were also spiked to 
give a constant concentration of RA (0.3125 µg/ml), and the 
following concentrations of RP: 2.5,1.25,0.625,0.3125, 
and 0 µg/ml. The extraction procedure was carried out and 
the linearity (r value), was checked and was found to be 
greater than 0.996 with average value of 0.9971±0.0005 
(n=2). 
2.2.7.2. PRECISION 
Precision of manual injection was calculated by 
preparing a set of standards and injecting each standard 
five times onto the HPLC column. The intra-assay c. v. was 
found to be less than 5% for each standard. 
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2.2.7.3. REPRODUCIBILITY 
Four sets of standards were prepared and compared, in 
order to calculate the within day reproducibility. Three 
days standards were also compared in order to calculate the 
between days reproducibility. 
The intra-assay c. v. for the top standard (2.5 µg/ml) , 
was found to be 6.1%, for the 1.25 µg/ml was 8.5%, for the 
0.625 pg/ml was 8.4%, and for the 0.3125 µg/ml was found to 
be 5.9%. 
The interassay c. v. were found to be 13.1,5.0,9.5, 
and 30.8% respectively. 
Interassay c. v. was also calculated for extracted 
plasma and were found to be 5.0% for the top concentration 
(2.5 /1g/ml), 6.5% for the 1.25 gg/ml, 7.9% for the 0.625 
µg/ml, and 32.1% for the 0.3125 µg/ml (n=3). Thus 
reliability was poor for the lowest concentrations, and 
values falling into this range should be interpreted with 
caution. 
In the human studies, all plasma samples, obtained 
from a single individual on different days of study, were 
analysed within a single run to minimise effects of 
between-assay variability. 
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2.3. CHYLOMICRON SEPARATION 
The Grundy and Mok, (1976), method was used, with some 
modification, for the separation of plasma CM. In 
particular, 3.5 g of plasma was placed in a 38 ml thick- 
walled Beckman ultracentrifuge tube, and was overlayered 
with 3.5 g saline solution (d=1.006 g/ml). The saline 
solution was prepared by dissolving 10.49 g of NaCl in 11 
of distilled water and the density was adjusted by the use 
of a hydrometer. Tubes were ultracentrifuged at 2.2x106 
g. min. in a Beckman 50.2 Ti rotor. The obtained CM layer 
(supernatant), was carefully removed, using a glass pasteur 
pipette. It should be mentioned at this point that this 
preparation allows the flotation of larger TAG-rich lipo- 
proteins whose densities are less than 1.006 g/ml. It can- 
not therefore guarantee complete separation of CM and VLDL 
particles whose density ranges overlap. In addition, this 
preparation will result on loss of some, though not all of 
the smaller CM-R particles. 
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2.4. TRIACYLGLYCEROL 
2.4.1. REAGENTS 
The reagents required were supplied as a kit by Roche 
Diagnostics Ltd., Welwyn Garden City (Uni kit II or III) 
and contained lipoprotein lipase (>1.25 gkat), glycerol 
kinase (>0.33 µkat), glycerol phosphate oxidase (>0.63 
Akat), peroxidase (>0.13 gkat), ATP (>25 µmol), 4-chloro- 
phenol (>150 Amol), 4-aminophenazone (>12.5 µmol), 
magnesium (>0.25 mmol), and PIPES (>1.05 mmol) in each 
vial. Seronorm Lipid (Nycomed, Birmingham), was used as 
calibrator with expected value of 2.2 mmol/1, and Precinorm 
L (Boehringer Corporation London Ltd., London), as quality 
control with an acceptable range from 1.37 to 2.09 mmol/l. 
2.4.2. PRINCIPLE AND PROCEDURE 
Plasma TAG concentrations were measured using an 
enzymatic colorimetric method based on the following 
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principle: 
Triacylglycerol ------> Glycerol + Fatty acids 
Glycerol + ATP ------> Glycerol-3-P + ADP 
Glycerol-3-P + 02 ------> dihydroxyacetone phosphate + H202 
The first reaction is catalysed by lipoprotein lipase, 
the second by glycerol kinase, and the third by glycerol 
phosphate oxidase. In the presence of peroxidase, the 
hydrogen peroxide formed effects the oxidative coupling of 
4-chlorophenol and 4-aminophenazone to form a red colored 
quinoneimine derivate. The color intensity is proportional 
to the TAG concentration and is determined by monitoring 
the absorbance in 500 nm. 
Seronorm Lipid and Precinorm L were included in each 
run, and for each human study, blood samples, taken from 
individuals following different meals, were analysed 
within the same assay. 
The Cobas bio centrifugal analyser (Roche) was used 
for the TAG assay and its linearity limit is 8 mmol/l. The 
assay parameters are given in Table 2. f in appendix I. 
Intra-assay c. v's were found to be less than 4.3% and 
interassay c. v at 1.54 mmol/l was 4.4% (n=5). 
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2.5. CHOLESTEROL 
2.5.1. REAGENTS 
The reagents required were also supplied as a kit (Uni 
kit II or III), by Roche Diagnostics Ltd., Welwyn Garden 
City and contained cholesterol esterase (>0.04 Akat), 
cholesterol oxidase (>0.03 Akat), peroxidase (>0.55 Akat), 
sodium phenolate (165 gmol), 4-aminophenazone (9.3 Amol), 
and phosphate (3.3 mmol). As in the TAG assay, Seronorm 
Lipid and Precinorm L were used as calibrator, with 
expected value 7.8 mmol/l, and quality control, with 
acceptable range from 3.89 to 5.59 mmol. l, respectively. 
2.5.2. PRINCIPLE AND PROCEDURE 
An enzymatic colorimetric test was also used to 
determine plasma cholesterol levels. The principle of the 
method is as follows: 
Cholesterol ester + H20 ------> Cholesterol + Fatty acids 
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Cholesterol + 02 ------> 04-cholesten-3-one + H202 
The first reaction was catalysed by cholesterol 
esterase and the second by cholesterol oxidase. In the 
presence of peroxidase, the hydrogen peroxide formed, 
effects the oxidative coupling of phenol and 4-amino- 
phenazone to form a red colored quinoneimine derivate. The 
intensity of the color is proportional to the cholesterol 
concentration and is determined by monitoring the 
absorbance at 500 nm. 
As in triacylglycerol assays, Seronorm Lipid and 
Precinorm L were included in each run. 
Cholesterol assays were carried out using the Cobas 
bio centrifugal analyser (Roche), and the linearity limit 
is 18 mmol/l. The assay parameters are given in Table 2. f 
in appendix I. 
Intra-assay c. v's were less than 2.8% and interassay 
c. v at 4.46 mmol/l was 4.1% (n=5). 
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2.6. APOLIPOPROTEIN A-I 
2.6.1. REAGENTS 
Anti-human-apolipoprotein A-I antiserum, 
apolipoprotein Al, All, B calibration serum, and Precinorm 
L were supplied by Boehringer Corporation London Ltd., 
London. 
KH2PO4, Na2HPO4, and sodium azide were supplied by BDH 
Chemicals Ltd., Poole, Dorset. 
NaCl was supplied by Fissons Laboratory Supplies, 
Loughborough. 
Polyethylene Glycol (PEG), and Tween 20 were supplied 
by Sigma Chemicals Co., Poole, Dorset. 
2.6.2. WORKING REAGENTS 
Details of the method are given elsewhere (Mount et 
al., 1987). Serum samples were diluted (20: 1), in 
phosphate buffer saline (PBS), pH 7.4, containing KH2PO4, 
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0.270 g/l; Na2HPO4,1.330 g/l; NaCl, 9 g/l; Sodium azide, 1 
g/l. Anti-human-apo A-I antiserum was diluted (41: 1), in 
PBS containing 5g PEG and 200 µl Tween 20 per 100 ml. 
Calibration serum was also diluted in PBS in order to cover 
the range between 58 and 251 mg/dl. Precinorm L was used 
as quality control with acceptable range from 96 to 144 
mg/dl. 
2.6.3. PRINCIPLE AND PROCEDURE 
An immunoturbidimetric method was used to determine 
serum or plasma apo A-I concentrations, based on the 
following principle: when a beam of light is directed 
through a liquid containing a suspension of particles, some 
of the light will be scattered, a small amount will be 
absorbed, and the rest of it will be transmitted through 
the medium. The decrease in light transmitted, is 
proportional to the concentration of the particles in 
suspension. A specific increase in light scattering, 
related to the concentration of the substance under 
investigation, is caused by adding antiserum directed 
against the test substance. The antibodies form large 
complexes with the antigen under investigation, whose light 
scattering properties are directly related to the 
concentration of the antigen. 
97 
The Cobas bio centrifugal analyser (Roche), was used 
for assaying plasma apo A-I levels. The optical system 
comprised of a xenon lamp, producing a narrow light beam, 
an interference filter and a photomultiplier. The 
monitoring wavelength was found to offer maximum 
sensitivity at 340 nm depending in both the light source 
and the material in the reaction cuvette. 
The followed procedure is described by Mount et al., 
(1988), and the assay parameters are given in Table 2. g in 
the appendix. 
Intra-assay c. v's were found to be always less than 
9.4%, and interassay c. v. at 125.0 mg/dl was 14.5% (n=9). 
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2.7. APOLIPOPROTEIN B 
2.7.1. REAGENTS 
As in section 2.6.1. In addition, anti-human-apo B 
antiserum was also supplied by Boehringer Corporation 
London Ltd., London. 
2.7.2. WORKING REAGENTS 
The method used for the determination of apo A-I was 
also used for the determination of apo B concentrations, 
but different apo B antiserum dilution was used (17.3: 1), 
and the apolipoprotein calibration serum was diluted in 
order to cover the range between 40 and 208 mg/dl. 
Precinorm L was also used as quality control with 
acceptable range from 56.7 to 85.1 mg/dl. 
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2.7.3. PRINCIPLE AND PROCEDURE 
The principle is the same as in section 2.6.3. 
The Cobas bio centrifugal analyser (Roche) was also 
used for apo B measurements, and the absorbance was 
monitored at 340 nm. The procedure is described as with 
apo A-I by Mount et al., (1988), and the assay parameters 
are given in Table 2. g in the appendix. 
Intra-assay c. v's were found to be less than 9.4%, and 
the interassay c. v at 83.0 mg/dl was 10.3% (n=8). 
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2.8. GIP 
2.8.1. REAGENTS 
Natural porcine GIP was donated by Prof. J. C. Brown, 
University of British Columbia, Vancouver, BC, Canada, and 
antisera were raised by Morgan et al. (1988). 
Human synthetic GIP was supplied by Peninsula 
Laboratories, St. Helens. 
Donkey anti-rabbit IgG was provided by Guildhay 
Antisera Ltd., Guildford, Surrey. 
125 I sodium iodide was supplied by Amersham 
International plc., Aylesbury. 
KH2PO4, and Na2HPO4, were supplied by BDH Chemicals 
Ltd., Poole, Dorset. 
Human serum albumin (fraction V), Sephadex-G-25, and 
PEG were supplied by Sigma Chemicals Co., Poole, Dorset. 
Aprotinin was supplied by Novo Biolabs, Bagsvaerd, 
Denmark. 
Charcoal (Norit OL), was supplied by Hopkin and 
Williams, Chadwell Health. 
LP3 test tubes were supplied by Luckham Ltd., Burgess 
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Hill. 
Seitz filters (Filtrox (W-Steril) filters] were 
supplied by H. Erben Ltd., Ipswitch. 
Lithium heparin tubes were supplied by Griffiths and 
Nielson, Billingshurst. 
2.8.2. WORKING REAGENTS 
Stock phosphate buffer 0.4 M, vH 6.5 was produced by 
adding 0.4 M KH2PO4 to 0.4 M Na2HPO4 until the required pH 
was achieved. 
Assay buffer was produced on the first day of the 
assay by adding human serum albumin (0.5%, w/v), and 
aprotinin [50,000 kallikrein inhibitory units (KIU)/dl], to 
0.04 M phosphate buffer, pH 6.5 (stock phosphate buffer 
diluted 10 times). 
Anti-Porcine GIP was used at an initial dilution of 
9,000-fold in assay diluent. 
125I-GIP was prepared by a ch]oramine-T technique which 
involved a reaction of 5 µg of porcine GIP (stored in 
autoanalyzer cups at -20°C in 10 Al of 0.4 M phosphate 
buffer, pH 7.4, and defrosted and brought to room 
temperature on the day of the iodination) with 10 µl (1 
mCi) of carrier-free 125I sodium iodide in sodium hydroxide 
solution, and chloramine-T (15 µg in 10 Al of 0.4 M 
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phosphate buffer, pH 7.4). The reactants were mixed for 15 
seconds and the reaction was then stopped by the addition 
of sodium metabisulphate (40 pg in 20 Al of 0.4 M phosphate 
buffer, pH 7.4). 200 Al of column buffer (0.1 M sodium 
acetate, pH adjusted to 5.0 with glacial acetic acid and 
0.5% w/v HSA and 50,000 KIU/1 aprotinin) was added to an 
autoanalyzer cup and the mixture was applied to the top of 
a Sephadex G-25 column. Fractions were collected and 10 µl 
of each were counted using an LKB 1260 Multigamma counter. 
The fractions containing the greatest amount of radio- 
activity corresponded to the radiolabelled hormone and were 
split into 20 Al aliquots and stored at -20°C. The 
specific activities obtained were usually between 120 and 
150 pCi/µg. Details of the iodination procedure are 
described elsewhere (Elliott, 1992). 
The tracer was affinity purified on the day that it 
was added to the assay tubes (Elliott, 1992). A solid 
phase of sheep anti-GIP antibodies, chemically coupled to 
silica beads, was used, stored in a small plastic column. 
Before use, the contents of the column were washed with 
0.5% HCL, pH 1.5, followed by distilled water. After 
equilibrating the column with assay diluent, one aliquot of 
the radiolabelled hormone is added to the top of the column 
together with 5 ml of assay diluent. The column was 
stoppered and the solid phase and tracer mixed for 30 
minutes at room temperature. The buffer was allowed to 
drip out and the column was washed with distilled water. 
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The tracer was then eluted by the addition of 5 ml of 0.5% 
w/v HC1. The column was further washed with HC1 and 
distilled water and was stored at 4°C under bicarbonate 
buffer (1.59 g/l Na2CO3,2.93 g/1 NaHCO31 pH 9.8). After the 
affinity purification, the GIP tracer was diluted to 
approximately 5,000 cpm/l00µ1 before adding to the assay 
tubes. 
GIP standards were prepared as described by Elliott, 
(1992). 20-40 µg of synthetic GIP was dissolved in buffer 
consisting of 0.14 M lactose, 0.04 M HSA, 11 nM citric 
acid, 6 nM cysteine hydrochloride and 1600 KIU/ml aprotinin 
in formic acid. Aliquots of 100 Al containing 100 ng of 
GIP were were lyophylized and stored at -20°C under vacuum 
and used as stock standards. On the day of the assay, a 
working standard concentration of 800 pmol/1 was prepared 
and doubling dilutions were undertaken to give levels of 
400,200,100,50, and 25 pmol/l. Tubes which contained 
GIP-free serum but no unlabelled GIP were also included in 
the standard curve. 
GIP-free serum(CSS), was prepared by treating normal 
fasting serum with charcoal (Elliott, 1992). Several 
hundred grams of charcoal was suspended in 3 volumes of 
distilled water. The slurry was swirled briefly and 
allowed to settle for 10 minutes. The water above the 
charcoal was decanted off and the procedure of swirling, 
sedimenting and decanting was carried out twice more to 
ensure the removal of fine particles. Charcoal was dried 
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overnight in an oven at 70°C. 20 g of it was added to 
every 100 ml of serum and the slurry was left overnight at 
4°C with constant stirring. The following day, the slurry 
was centrifuged at 1850 g for 30 minutes at 4°C to sediment 
as much of the charcoal as possible. The supernatant was 
separated and passed through Seitz filters under vacuum 
using a Buchner flask and Buchner funnel and this process 
was repeated until no visible charcoal was deposited on the 
filters. The CSS was then divided into aliquots and stored 
at -20°C. 
Donkey anti-rabbit IgG (DAR), was used at an initial 
dilution of 1: 20. In addition to DAR, normal rabbit serum 
NRS , at an initial dilution of 1: 135 in assay diluent, 
and PEG (14%. w/v in assay diluent), were also prepared. 
2.8.3. PRINCIPLE AND PROCEDURE 
GIP was measured by a double-antibody radioimmunoassay 
technique (Morgan et al., 1978), the basis of which 
involves the incubation of a restricted quantity of poly- 
clonal antiserum directed against GIP and a fixed quantity 
of radiolabelled GIP together with the sample under 
analysis. Competition between radiolabelled and unlabelled 
antigen will reduce the amount of antibody-bound label to 
a degree relative to the concentration of unlabelled 
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antigen. 
At the first day of the assay, assay diluent, GIP 
standards, CSS, samples, and antiserum were added to the 
assay tubes, which were vortexed and left overnight at 4°C 
(Table 2.8). 
At the second day of the assay, affinity purified GIP 
was added to all tubes. The tubes were vortexed and left 
for 48 hours at 4°C (Table 2.8). 
At the fourth day of the assay, NRS, DAR, and PEG were 
added to all tubes except totals (Table 2.8). The tubes 
were again vortexed. After a4 hour incubation at 4°C, the 
tubes were centrifuged in a Beckman J-6B at 2,600 rpm for 
20 minutes at 4°C. The supernatant obtained was aspirated 
and the pellets in the tubes were count on a gamma 
radiation counter (Wallac 1260 Multigamma II, Wallac Oy, 
Finland). 
The interassay c. v at 53.5 pmol/l was 43.7%, at 242.3 
pmol/1 was 20.2% and at 434.6 pmol/1 was 13.3% (n=6). 
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TABLE 2.8 
GIP assay: additions to the tubes. 
TOTALS NSB ZERO STD'S NSB UK 
STD STD UK 
(µl) (µl) (µl) (91) (µl) (µl) 
DAY I 
A. B. --- 300 200 100 300 200 
GIP STD --- --- --- 100 --- --- 
CIS --- 100 100 100 --- --- 
SAMPLE --- --- --- --- 100 100 
ANTISERUM --- --- 100 100 --- 100 
VORTEX ALL TUBES AND LEAVE FOR 24hrs AT 4°C 
DAY II 
GIP TRACER 100 100 100 100 100 100 
VORTEX ALL TUBES AND LEAVE FOR 4shrs AT 4°C 
DAY IV 
NRS --- 50 50 50 50 50 
DAR --- 50 50 50 50 50 
PEG --- 100 100 100 100 100 
VORTEX ALL TUBES AND LEAVE FOR 4hrs AT 4°C 
IL 
NSB : Non-specific binding standard. 
UK : Unknown sample. 
A. B.: Assay buffer. 
CSS : Charcoal stripped serum. 
NRS : Normal rabbit serum. 
DAR : Donkey anti-rabbit second antiserum. 
PEG : Polyethylene glycol. 
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2.9. INSULIN 
2.9-1. REAGENTS 
Guinea pig anti-insulin antiserum, donkey anti-guinea 
pig second antiserum, and Wellcome insulin standard were 
provided by Guildhay Antisera Ltd., Guildford, Surrey. 
125I-insulin 
was supplied by Amersham International 
plc., Aylesbury. 
Na2HPO4 anhydrous, Na2HPO4 enhydrous, and EDTA, were 
supplied by BDH Chemicals Ltd., Poole, Dorset. 
Bovine serum albumin (fraction V) , thiomersal, and PEG 
were supplied by Sigma Chemicals Co., Poole, Dorset. 
Charcoal supplier is given elsewhere (section 
2.8.1. ). 
2.9.2. WORKING REAGENTS 
Stock phosphate buffer 0.4 M. pH 7.4. was prepared by 
mixing 0.4 M Na2HPO4 anhydrous, and 0.4 M Na2HPO4 enhydrous 
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until the required pH was achieved. Thiomersal (0.25 g/1), 
was also added as preservative. 
Assay buffer was prepared by adding bovine serum 
albumin (0.5%, w/v), and EDTA (3.64 g/1), to 0.04 M 
phosphate buffer, pH 7.4 (stock phosphate buffer diluted 10 
times). 
Assay diluent + Normal guinea pig serum (NGPS), was 
prepared by adding NGPS to assay diluent to achieve a 
dilution of 1: 500. 
125 I insulin solution was prepared by diluting 
125 I- 
insulin to assay diluent (1: 80). This dilution yield 
approximately 5,000 cpm/200 Al. 
Anti-insulin antiserum solution was prepared by 
adding 1 ml assay diluent+NGPS to the lyophilized content 
of a vial, containing guinea pig anti-insulin antibodies, 
and further diluting it (1: 25). 
Insulin-free serum (CSS) was prepared by treating 
normal fasting serum with charcoal (section 2.8.1. ). 
Insulin standards were prepared initially by 
dissolving the content of the ampoule provided in 1.0 ml 
0.07 M bicarbonate buffer pH 8.6 and making it up to 30 ml 
with 0.04 M phosphate buffer pH 7.4 containing 0.5% BSA 
(w/v). 1.0 ml aliquots of this stock solution (100 mU/ml) 
are stored frozen. This stock solution is further diluted 
with assay buffer to give the top working standard of 200 
MU/1.1.0 ml aliquots of this stock solution are stored 
freeze dried at -20°C. At the day of the assay 1 ml CSS is 
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added to each aliquot to achieve the top working standard 
solution (200 mU/1). Double dilutions were then carried 
out, beginning from the top working standard solution, to 
give concentrations of 100,50,25,12.5,6.25, and 3.13 
MU/1. 
Donkey anti-cruinea pig second antiserum solution 
was prepared by diluting the one provided in assay diluent 
(1: 64), and by mixing it with an equal volume of PEG (15%, 
w/v). 
2.9.3. PRINCIPLE AND PROCEDURE 
Plasma insulin was measured by a double-antibody 
radioimmunoassay technique, the principle of which is 
described in section 2.8.2. 
At the first day of the assay, assay diluent+NGPS, 
insulin standards, CSS, insulin tracer, samples, and anti- 
serum were added to the assay tubes, which were vortexed 
and left overnight at room temperature (Table 2.9). 
At the second day of the assay, second antiserum/PEG 
reagent was added to all tubes except totals (Table 2.9). 
The assay tubes were vortexed and incubated for 2 hours at 
room temperature. The tubes were then centrifuged in a 
Beckman J-6B at 2,500 rpm for 30 minutes at room 
temperature, the supernatants obtained, were aspirated off, 
110 
and the pellets in the tubes were counted as in section 
2.8.2. 
The interassay c. v. at 9.33 mU/l was 27.3% (n=8), at 
37.2 mU/1 was 23% (n=7), and at 70.3 was 18.0% (n=5). 
TABLE 2.9 
Insulin assay: addition to the tubes. 
TOTALS NSB ZERO STD's NSB UK 
STD STD UK 
( 1) (µl) (Al) (µl) (µl) (µl) 
DAY I 
A. B. + --- 200 100 100 200 100 
NGPS 
STANDARD --- --- --- 50 --- --- 
CTS --- 50 50 --- --- --- 
TRACER 200 200 200 200 200 200 
SAMPLE --- --- --- --- 50 50 
ANTISERUM --- --- 100 100 --- 100 
VORTEX ALL TUBES AND LEAVE FOR 24hrs 
DAY II 
DAG+PEG --- 200 200 200 200 200 
VORTEX ALL TUBES AND LEAVE FOR 2hrs 
NSB : Non-specific binding standard. 
UK : Unknown sample. 
A. B. +NGPS: Assay buffer + normal guinea pig serum. 
CSS : Charcoal stripped serum. 
DAR+PEG : Donkey anti-guinea pig second antiserum + 
polyethylene glycol. 
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2.10. LIPOPROTEIN LIPASE 
LPL activity was determined using triolein as 
substrate and was carried out by another investigator. The 
original method is described by Nilsson-Ehle and Schotz, 
(1976) and has recently modified by Knapper et al., (1993). 
Briefly, LPL activity was assayed in centrifuge tubes 
containing 0.1 ml of diluted emulsion. The triolein 
emulsion was prepared by mixing 50 Al of [3H]triolein, 250 
Al of cold triolein, and 80 Al of phosphatidyl choline, and 
5 ml glycerol). At the time of the assay, this was diluted 
with 50 MM Tris (containing 3% BSA and either 0.2 M NaCl or 
4M NaCl and 2 U/ml heparin) and pre-incubated with 
inactivated human serum in a ratio of emulsion: Tris/BSA: 
serum of 4: 1: 1 at 37°C for 10 minutes. The reaction is 
started by the addition of 20 Al of plasma and 80 Al of 50 
mM tris buffer. After incubating for 30 minutes at 37°C, 
the reaction was terminated by the addition of 3.25 ml of 
a fatty acid extraction mixture, chloroform/methanol/ 
heptane (1.25/1.41/1), as described by Belfrage and Vaughan 
(1969). Separation of phases was aided by the addition of 
1.05 ml of 0.1 M K2CO3, adjusted to pH 10.5 with boric acid. 
The tubes were mixed and centrifuged in a Beckman J-6B at 
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3,000 rpm for 10 minutes. 0.5 ml of the upper phase, 
containing the free fatty acids, was transferred into 
scintillation vials, containing 4 ml optiphase and 
acidified with 80 Al glacial acetic acid. After vortexing 
the vials, radioactivity was counted in the dark. 
Enzyme activity (µmol oleate released at 37°C/min) is 
calculated from the following formula: 
(DPM-blank) x 1/30 x 1/sp. activity of triolein x3x4.9 
x 1/0.76 
where 
30 : incubation time in minutes 
3: 3 moles oleate are liberated from 1 mole of triolein 
4.9: 0.5 ml are sampled from a total volume of 2.45 ml 
aqueous methanolic phase 
76 : 76% oleate extracted into aqueous methanolic phase. 
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CHAPTER 3 
THE EFFECT OF CHRONIC 
FISH OIL SUPPLEMENTATION ON 
FASTING TRIACYLGLYCEROL 
CHOLESTEROL APOLIPOPROTEIN 
A-I AND B AND POSTPRANDIAL 
TRIACYLGLYCEROL AND 
APOLIPOPROTEIN A-I AND B 
LEVELS IN 
HEALTHY SUBJECTS AND NIDDMS 
3.1. INTRODUCTION 
The first indication that fish oils may have some 
beneficial effects on blood lipid levels came in 1959 from 
Ahrens and his collegues who observed a lowering effect of 
dietary menhaden oil on serum TAG in two patients (Ahrens 
et al., 1959). However, it took approximately fifteen more 
years before the first epidemiological study was under- 
taken. In the 1970s Bang and his collegues reported that 
even though Greenland Eskimos consumed a diet high in 
animal fat, the incidence of coronary heart disease (CHD), 
was lower than in Danes who also used to eat a high fat 
diet (Bang and Dyerberg, 1972; Bang et al., 1973; Dyerberg 
and Bang, 1979). The main difference between the Eskimo 
diet and other diets was that in the Eskimo, dietary fat 
was mainly from fish, seal, and whale, whilst in other 
societies, dietary fat was largely of animal origin and 
rich in saturated fatty acids. The same investigators 
observed that Greenland Eskimos had low levels of fasting 
plasma TAG. From that point, hundreds of studies have been 
or are being undertaken, mainly investigating effects of 
fish oils on fasting blood lipid levels in healthy people 
as well as in subjects suffering hyperlipidaemia and 
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diabetes. 
The most profound metabolic effect of fish oils 
appears to be the decrease in fasting TAG concentrations 
observed within weeks of increased consumption (Nestel et 
al., 1984; Sanders et al., 1985; Illingworth et al., 1984; 
Bonaa et al., 1992). It also seems that there is a dose- 
dependent response of TAG concentrations to increased fish 
oil consumption. Sanders et al. (1983), reported a sub- 
stantial decrease in TAG levels in response to 10 and 20 g 
MaxEPA (a fish oil supplement)/day, but not in response to 
5g/day. Hanninen et al. (1989), observed a tendency towards 
lower TAG levels in healthy volunteers eating 1.5 and 2.3 
fish meals/week (according to volunteers compliance), and 
a significant fall in TAG concentrations in the group 
eating 3.8 fish meals/week. Blonk et al. (1990), con- 
cluded, after investigating the dose-response effects of 
daily supplementation of 1.5,3, and 6g n-3 fatty acids 
for 12 weeks in healthy human subjects, that 3g n-3 fatty 
acids appear to be the appropriate supplementation dose in 
humans, at least regarding lipid-profile changes. On the 
other hand, Bronsgeest-Schoute et al. (1981), after inve- 
stigating changes in blood lipids due to various intakes 
(1,2,4, and 8 g) of n-3 fatty acids in healthy humans 
over a period of 4 weeks, reported that the decrease in 
serum TAG and VLDL occurred only at a daily intake of 8 g. 
Diabetes mellitus is nearly always associated with 
changes in plasma lipoproteins. The most common form of 
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diabetes is non-insulin dependent diabetes (NIDDM). Com- 
pared to healthy humans, NIDDM's are often obese and 
generally have high fasting and postprandial TAG levels 
(Howard, 1987). Since, therefore, NIDDM's usually have 
high TAG levels and fish oils decrease TAG concentrations, 
it was suggested that fish oil supplementation could have 
beneficial effects on TAG levels in NIDDM's. Popp-Snijders 
et al. (1987), came to support the above suggestion, since 
they observed a decrease in fasting plasma TAG levels after 
an eight week supplementation of NIDDM patients with 3g n- 
3 fatty acids/day. On the other hand, Borkman et al. (1989) 
after a three week fish oil supplementation period (10 g 
fish oil concentrate - 30% n-3 fatty acids - daily), of ten 
NIDDM's, observed a reduction of fasting plasma TAG levels 
in four subjects with hypertriglyceridaemia, but in the 
group as a whole, TAG levels were not significantly re- 
duced. In support of the previous observation, Kasim et 
al. (1988), reported no changes in fasting serum TAG in 
twenty two NIDDM's after a fish oil supplementation (2.7 
g n-3 fatty acids/day), for 4 and 8 weeks. 
Fasting plasma T-C, LDL-C, and to a lesser extent TAG, 
were considered, until recently, the main predictors of 
risk of developing CHD. However, there are some findings 
which suggest that apolipoproteins A-I and B may be better 
predictive factors than TAG, T-C, and LDL-C. Avogaro et 
al. (1979), studied plasma lipid and apolipoprotein levels 
of 218 survivors of myocardial infarction and 160 controls. 
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When patients and controls with similar plasma levels of 
TAG and T-C were compared, survivors showed significant 
differences from controls in their values of apo A-I and 
apo B. Furthermore the lipid values lost their discrimi- 
nating power with advancing age, whereas apolipoproteins 
remained significant risk factors even in the oldest de- 
cade. As a consequence, it was suggested that apolipo- 
proteins were as good as lipids in discriminating subjects 
at risk of CHD under the age of 50, and better in the sixth 
to eighth decades. Sniderman et al. (1980), reported that 
not only does LDL-apo B better separate coronary and non- 
coronary groups than other lipid parameters (e. g. TAG, T- 
C), but also, among those with CHD, there exists a group 
with normal LDL-C, but with levels of LDL-apo B similar to 
those observed in type II hyperlipoproteinaemia. Kesaniemi 
et al. (1985), observed an enhancement in VLDL-apo B and 
LDL-apo B in five patients with CHD, but, on the other 
hand, the VLDL-TAG secretion rates were not increased. 
Bold (1990), reported that many patients had been found 
with coronary atheroma in whom apo B levels were high, but 
LDL-C levels were normal. Majejko et al. (1983), after 
measuring apo A-I and HDL-C levels from people who have 
suffered a myocardial infarction, observed lower levels of 
apo A-I but no differences in HDL-C. However, Fager et al. 
(1980), have not shown apo A-I to be better than HDL at 
predicting the risk of CHD. 
An important consideration is the extent to which 
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dietary fat intake can influence apo A-I and apo B con- 
centrations. Hanninen et al. (1989), reported a signifi- 
cant fall in serum apo B concentrations in the group of 
volunteers eating 3.8 fish containing meals/week for 12 
weeks. They also observed no changes at lower doses (1.5 
and 2.3 meals/week), and no changes in apo A-I levels. No 
significant changes in both apo A-I and apo B were observed 
by Thorngren et al. (1986), in healthy men who were on 
fatty fish diet (150-200 g/day), for 11 weeks. However, 
Nestel et al. (1984), reported a decrease in VLDL-apo B and 
HDL-apo A-I levels in volunteers who were put on a high 
fish oil diet (30% of daily energy needs came from a fish 
oil preparation), for 3 weeks compared with a diet similar- 
ly enriched with safflower oil. LDL-apo B levels, in a 
study undertaken by Sullivan et al. (1986), were found to 
be increased after treating both normals and hypertrigly- 
ceridaemics with 15 g/day of a fish oil concentrate (Max- 
EPA), for either 4 or 8 weeks. In contrast, Illingworth et 
al. (1984), reported a reduction in the rate of synthesis 
of LDL-apo B and no change in fractional catabolic rate 
(FCR), in normal human subjects after being on a fish-rich 
diet (24 g n-3 fatty acids/day), for 4 weeks compared with 
a diet containing predominantly saturated SFA, and MUFA. 
Nenseter et al. (1992), observed an increase in the ratio 
of apo B to cholesterol in the LDL particles of normal 
human subjects under a fish oil diet (6 g n-3 fatty acids 
per day for 4 months), compared with a corn oil diet. 
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Bonaa et al. (1992), came to the conclusion that compared 
to fish oil (6 g per day n-3 fatty acids for 10 weeks), apo 
A-I rises after corn oil intake. Sanders (1991), mentioned 
that very high intakes of fish oil (24 g n-3 fatty acids 
per day), can lower LDL-apo B levels. 
The effects of fish oils on plasma lipid and apolipo- 
protein levels in normals cannot be assumed to apply to the 
diabetic patient. A study carried out by Kasim et al. 
(1988), indicated that apo A-I levels did not change and 
apo B levels increased significantly in NIDDM's on a fish 
oil supplementation (2.7 g/day n-3 fatty acids for 8 
weeks). However, Axelrod (1989), pointed out that enthu- 
siasm displayed initially for n-3 fatty acids in the treat- 
ment of diabetes, was premature considering the potential 
deleterious effects of these agents, including increases in 
serum apo B levels. Simopoulos (1991), suggests that the 
magnitude of these effects is generally small, but on the 
other hand, Borkman et al. (1989), would use fish oil with 
caution in patients with NIDDM, after observing an increase 
in fasting glucose levels and no significant beneficial 
effects of fish oil supplementation on plasma lipids in 
these patients. 
All the investigations mentioned above, were under- 
taken using volunteers in their fasting state because it 
was believed, until recently, that fasting lipid values re- 
present better the 24-hour mean, are easier to standardise 
for comparative purposes, and are better indicators of the 
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risk of developing CHD. However, most people are in the 
fed state for a long period during the day, as a result of 
eating meals at frequent intervals. Interest in post- 
prandial lipid levels started after Zilversmit (1979), pre- 
sented evidence which showed that in humans and experimen- 
tal animals, CM-R, the partially hydrolysed products of CM 
particles, can be taken up by arterial walls more readily 
than can LDL-C. As a consequence, he concluded that lipo- 
protein research should concentrate on studies of post- 
prandial as well as fasting lipoproteins. However, only 
three studies have investigated the effects of fish oil 
supplementation on postprandial lipid levels. Weintraub et 
al. (1988), found a decrease in fasting TAG, apo A-I and 
apo B levels, in normal volunteers, following a 25 day n-3 
PUFA diet (approximately 3.2% of energy intake came from n- 
3 fatty acids). However, even though postprandial TAG 
levels showed lower increments for the n-3 PUFA diet, post- 
prandial apo A-I and apo B levels were not assessed. In 
the other two studies (Harris et al., 1988a; Brown and 
Roberts, 1991), apolipoprotein levels (both fasting and 
postprandial), were not assessed either, but they suggested 
that fish oils may decrease CM synthesis and/or secretion. 
Further investigation in the effects of fish oil supplemen- 
tation on both fasting and postprandial lipid and apolipo- 
protein levels is necessary not only because of a lack of 
postprandial studies but also because of the fact that the 
existing studies give conflicting results, particularly as 
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far as effects of fish oils on the fasting lipid levels are 
concerned. Furthermore, previous postprandial studies were 
conducted during the daytime, even though usually the 
greater proportion of the daily nutrient intake is consumed 
in the evening. Since postprandial responses at this time 
of the day could prove to be more important, both daytime 
and overnight postprandial studies were included in the 
present investigation, and normal foods, rather than liquid 
meals, were also used in order to stimulate the usual phy- 
siological responses. The aims, therefore, of the present 
study were: 
- to investigate effects of fish oil supplementation 
on fasting TAG, T-C, HDL-C, LDL-C, apo A-I and apo B levels 
in both normal subjects and NIDDM patients, 
- to investigate any differences in postprandial res- 
ponses of TAG, apo A-I and apo B to a standard test meal, 
before and after fish oil supplementation in the same 
subjects, 
- to investigate any possible differences in post- 
prandial responses due to the time of the day when the meal 
was consumed compared with other postprandial studies. 
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3.2. STUDY DESIGN 
The investigations described in the following sections 
were carried out in two phases: 
Study I, in which fasting T-C, HDL-C, LDL-C, TAG and 
apolipoprotein, as well as postprandial TAG and apolipo- 
protein responses to a standard test meal were measured 
(after an overnight fast) for a period for 210 - mina, 
before, and six weeks after, fish oil supplementation. Two 
experiments were carried out, one in a group of young 
healthy volunteers, and one in a group of middle aged 
subjects with NIDDM. 
Study II, which was designed to overcome some of the 
limitations of study I. In particular, postprandial res- 
ponses were monitored overnight for 12 hours, following 
consumption of an evening meal. Daytime nutrient intake 
prior to the test meal was standardised and only normal 
healthy volunteers were investigated. 
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3.2.1. SUBJECTS 
3.2.1.1. STUDY I 
Two groups of subjects were recruited for this study: 
Group I consisted of six normal subjects who were recruited 
from the student population of the University. All the 
subjects were under 25 years of age, and apparently 
healthy, taking no medication. Their average age was 22.8± 
1.1 years (mean±SD), ranging from 22 to 25 years. Their 
average body mass index (BMI) was 22.3±2.4 kg/m2, ranging 
from 20.1 to 26.8 kg/m2. 
The subjects satisfied the following exclusion crite- 
ria for the study: 
They should be between 18 and 40 years of age, with 
BMI not less than 19 and not more than 27 kg/m2. Their 
habitual fat consumption should not be less than 30 and 
more than 45% of the total energy. They should not have 
any previous history of endocrine or liver disease, hyper- 
lipidaemia or known alcoholism, and they should not exceed 
alcohol consumption of 30 units per week. Finally, they 
should not exercise vigorously more than 10 hours per week, 
and should not have been following any form of reducing or 
exclusion diet or be taking dietary supplements of evening 
primrose oil, fish oil, or sunflower oil in the month pre- 
ceding the study. 
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Group II consisted of seven NIDDM's who were recruited 
from patients attending the diabetic outpatients clinic of 
St. Lukes Hospital, Guildford. The subjects were under 70 
years of age and being treated for the diabetes with oral 
hypoglycaemic agents or by diet alone (insulin treatment 
excluded). Their average age was 64.3±5.3 years, ranging 
from 53 to 69 years and their average BMI was 33.2±8.3 
kg/m2, ranging from 25.5 to 43.1 kg/m2. 
The subjects satisfied the following exclusion crite- 
ria for the study: 
They were not grossly hyperlipidaemic, and were not 
suffering from any form of liver disease, or known alco- 
holism. They had not experienced any recent weight change, 
and they were not taking oestrogens or lipid lowering 
drugs. 
Subjects details of both normals and NIDDM's are given 
in Table 3.1. 
3.2.1.2. STUDY II 
Six healthy subjects were recruited from the under- 
graduate population of the University on a volunteer basis. 
Their average age was 21.0±0.6 years, ranging from 20 to 22 
years and their average BMI was 22.4±1.9 kg/m2, ranging from 
19.8 to 25.5 kg/m2. 
The subjects satisfied the same exclusion criteria as 
the normal subjects in study I. 
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Subjects details are given in Table 3.2. 
TABLE 3.1 
STUDY I: chronic fish oil supplementation study. 
Subject details. 
Subject Sex Age N /D BMI 
1 F 22 Normal 20.2 
2 M 23 Normal 21.5 
3 F 25 Normal 22.9 
4 F 23 Normal 20.1 
5 F 22 Normal 23.6 
6 F 22 Normal 21.0 
7 F 63 Diabetic 43.1 
8 F 53 Diabetic 26.8 
9 F 67 Diabetic 40.8 
10 F 65 Diabetic 42.5 
11 F 65 Diabetic 27.2 
12 F 68 Diabetic 27.0 
13 F 69 Diabetic 25.5 J1 
TABLE 3.2 
STUDY II: chronic fish oil supplementation study. 
Subject details. 
Subject Sex Age BMI Dietary Habits 
1 M 21 22.1 Omnivarian 
2 F 20 19.8 Vegetarian 
3 F 21 23.0 Vegetarian 
4 M 22 22.8 Omnivarian 
5 M 21 21.4 Omnivarian 
6 F 21 25.5 Omnivarian 
Ethical consent for the studies were obtained from the 
University of Surrey Ethics Committee and the Ethics 
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Committee of St. Luke's and the Royal Surrey County Hos- 
pitals. The subjects were requested to attend Royal Surrey 
County Hospital Investigation Unit on two separate 
occas. ions (morning in study I and evening in study II) , 
and to comply to a six week course of fish oil supplementa- 
tion. 
3.2.2. DIETARY ASSESSMENT 
In order to determine the usual fat intake of the 
volunteers, each subject was requested to complete a food 
diary for three weekdays and one weekend day both before 
the fish oil supplement was given and during the period of 
fish oil supplementation (during the week preceding each 
visit to the Investigation Unit). The 24-hour recall was 
also used on each visit to the Investigation Unit in order 
to confirm the information obtained of portion sizes and 
food consumed, with that given in the three day dietary 
records. The dietary assessment was necessary in order to 
allow any change in dietary habits, as a result of taking 
the supplement, to be observed. Dietary assessment data 
for study I and study II are given in Tables 3.3 (normals), 
3.4 (NIDDM's), and 3.5 (study II). 
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TABLE 3.3 
STUDY I: chronic fish oil supplementation study. 
Dietary assessment of normal subjects 
prior to and after the fish oil supplementation period. 
PARAMETER PRE-FISH OIL 
SUPPLEMENTATION 
POST-FISH OIL 
SUPPLEMENTATION 
Pat (g) 85.0 ± 36.0 
CHO (g) 226.6 ± 78.3 
Protein (g) 68.7 ± 22.5 
Cholesterol (mg) 211.4 ± 100.6 
P/S ratio 0.4 ± 0.1 
Energy (kcal) 1 1998.8 ± 762.4 
90.0 ± 33.1 
199.0 ± 47.8 
64.1 ± 18.6 
256.1 ± 114.7 
1.0 ± 0.5 
1937.2 ± 567.8 
Fat intake from the fish oil capsules is not included. 
TABLE 3.4 
STUDY I: chronic fish oil supplementation study. 
Dietary assessment of NIDDM patients 
prior to and after the fish oil supplementation period. 
PARAMETER PRE-FISH OIL 
SUPPLEMENTATION 
POST-FISH OIL 
SUPPLEMENTATION 
Fat (g) 44.4 ± 17.3 53.5 ± 20.8 
CHO (g) 127.5 ± 44.3 144.5 ± 43.0 
Protein (g) 66.2 ± 12.1 71.1 ± 15.5 
Cholesterol (mg) 239.1 ± 80.9 272.6 ± 59.8 
PS ratio 0.4 ± 0.3 0.9 ± 0.3 
Energy (kcal) 1147.7 ± 288.7 1388.5 ± 269.6 
Fat intake from the fish oil capsules is not included. 
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TABLE 3.5 
STUDY II: chronic fish oil supplementation study. 
Dietary assessment of normal subjects 
prior to and after the fish oil supplementation period. 
PARAMETER PRE-FISH OIL 
SUPPLEMENTATION 
POST-FISH OIL 
SUPPLEMENTATION 
* 
Fat (g) 
CHO (g) 
Protein (g) 
Cholesterol (mg) 
Energy (kcal) 
94.8 ± 17.6 
248.9 ± 42.1 
65.7 ± 12.4 
174.2 ± 109.9 
2145.0 ± 271.0 
80.2 ± 15.8 
220.6 ± 44.4 
61.8 ± 16.2 
159.4 ± 74.9 
1874.0 ± 303.0 
r 
Fat intake from the fish oil capsules is not included. 
3.2.3. FISH OIL SUPPLEMENT 
In both studies each subject was asked to take a fish 
oil supplement (MaxEPA), for six weeks in addition to their 
normal diets. The fish oil supplement was in the form of 
capsules (provided by British Cod Liver Oils, Hull), and 
the subjects were required to take nine capsules per day, 
three after each meal. 
The total daily fatty acid intake, provided by the 
fish oil capsules was 2.7 g. The nutrient composition of 
the supplement is given in Table 3.6 and its fatty acid 
composition in Table 3.7. 
129 
TABLE 3.6 
STUDIES I and II: chronic fish oil supplementation studies. 
Composition of the fish oil supplement. 
Per capsule Per daily dose 
Energy (kcal) 12 108 
Cholesterol (mg) 7 63 
P/S ratio 0.62 0.62 
TABLE 3.7 
STUDIES I and II: chronic fish oil supplementation studies. 
Fatty acid composition of the fish oil supplement (MaxEPA). 
Patty acid ($) Weight 
Myristic C14: 0 7.1 
Palmitic C16: 0 15.8 
Palmitoleic C16: 1 (n-9) 10.0 
Stearic C18: 0 3.2 
Oleic C18: 1 (n-9) 15.2 
Linoleic C18: 2 (n-6) 3.2 
Gadoleic C20: 1 (n-9) 2.3 
Arachidonic C20: 4 (n-6)* 2.1 
Eicosapentaenoic C20: 5 (n-3) 18.6 
Cetoloic C22: 1 (n-11) 1.1 
Docosatetraenoic C22: 4 (n-6) 1.8 
Docosapentaenoic C22: 5 (n-6)* 3.3 
Docosahexaenoic C22: 6 (n-3) 12.1 
- Total n-3 fatty acids per capsule: 30.7% (w/w). 
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3.2.4. TEST MEAL 
3.2.4.1. STUDY I 
In the morning of the first attendance, subjects were 
given a standard test meal, following an overnight fast, 
before begir+iing the fish oil supplementation period. The 
same test meal was also given at the end of the fish oil 
supplementation period (6 weeks). The composition of the 
test meal is given in Table 3.8. 
TABLE 3.8 
STUDY I: chronic fish oil supplementation study. 
Nutrient composition of the test meal. 
Food Weight Energy Protein Fat CHO 
(g) (kcal) (g) (g) (g) 
White bread 105 245 8.2 1.2 52.2 
Butter 24 178 0.1 19.7 Tr 
Cheddar 60 244 15.6 20.1 Tr 
cheese 
Cornflakes 22 81 1.9 0.4 18.7 
White sugar 15 59 0.0 0.0 15.8 
Whole milk 300 195 9.9 11.4 14.1 
TOTAL 1001 36.0 53.4 100.8 
% ENERGY 
ME= 
14.0 48.0 38.0 
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3.2.4.2. STUDY II 
On the morning of each study day, the subjects were 
required to attend for a blood sample after an overnight 
fast. In order to ensure a standardised nutrient intake on 
each day of the study subjects were provided with breakfast 
consisting of toast, butter, marmalade and coffee, and with 
a packed lunch, consisting of ham or cheese sandwiches, 
crisps, digestive biscuits and an apple. Subjects were 
required not to consume any other food except tea or coffee 
with a minimum amount of milk, and sugar-free drinks. On 
the evening of each study day, each subject attended the 
Investigation Unit, where they consumed a standard test 
meal, in order to monitor the postprandial responses. The 
test meal provided 1004 kcal, 32.1 g of protein, 57.8 g of 
fat, and 95.3 g of carbohydrate (Table 3.9). 
3.2.5. PROCEDURE 
3.2.5.1. STUDY I 
In the morning of each study day, subjects were 
transferred to the Investigation Unit of Royal Surrey 
County Hospital and they were given a standard test meal, 
following an overnight fast. Blood samples were taken: 
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prior to the meal (0 minutes), and at 15,30,45,60, 
90,120,150,180, and 210 postprandially. 
TABLE 3.9 
STUDY II: chronic fish oil supplementation study. 
Nutrient composition of the test meal. 
Food Weight Energy Protein Fat CHO 
(g) (kcal) (g) (g) (g) 
Boiled 200 160 2.8 0.2 39.4 
potatoes 
Cheddar 70 284 18.2 23.5 0.0 
cheese 
Butter 10 74 0.0 8.2 0.0 
Whole milk 300 195 9.9 11.4 14.1 
Peaches in 180 157 0.7 0.0 41.2 
syrup 
Double cream 30 134 0.5 14.5 0.6 
TOTAL 1004 32.1 57.8 95.3 
$ ENERGY 13.0 52.0 38.0 
Approximately 10mi of blood were taken at each time 
point, and immediately centrifuged at 4°C at 2500 rpm for 
15 minutes (7000 g. min. ), to separate the plasma. The 
plasma was then transferred into LP3 tubes and stored 
frozen until the TAG, apo A-I, and apo B assays were 
performed. A summary of the procedures and the design of 
the study is given in Figure 3.1. 
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3.2.5.2. STUDY II 
In the morning of each study day a fasting venous 
blood sample was taken from the forearm, in the seated 
position, from each subject. Breakfast and lunch were 
provided as previously described. 
In the evening of each study day, the subjects were 
transferred to the Investigation Unit at Royal Surrey 
County Hospital. After a period of rest, subjects were 
cannulated, using an indwelling cannula, and one blood 
sample was taken before the consumption of the meal (0 
minutes). Blood collection continued for twelve hours 
postprandially. Approximately 10 ml of blood was taken 
every half hour for the first three hours, and hourly 
thereafter, until the end of the time period. Seventeen 
blood samples were taken on each study day at the following 
time points: 
-10,0 (immediately before the test meal), 30,60,90, 
120,150,180,240,300,360,420,480,540,600,660, and 
720 min. 
Most blood samples were collected with the subjects in 
the supine position, as the study was carried out over- 
night. The design of study II is given diagramatically in 
Figure 3.2. 
The blood samples, approximately 10 ml each, were put, 
after collection in 10 ml heparinised tubes, and separated 
and stored as before. 
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3.3. METHODS OF ANALYSIS 
The following analyses were undertaken: 
Plasma triacylglycerol 
Plasma apolipoprotein A-I, and 
Plasma apolipoprotein B. 
Fasting plasma T-C, HDL-C, and LDL-C. 
The methods used for the analysis of the above 
parameters are described in detail in Chapter 2. Briefly: 
1. The assay of TAG is an enzymatic, colorimetric, 
using glycerol-phosphate oxidase and 4-aminophenazone (test 
kit supplied by Roche) (section 2.4). 
2. The methods for assaying apo A-I and apo B are 
based on immunoturbidimetry and described by Mount et al. 
(1988) (sections 2.6 and 2.7 respectively) . 
3. The assay for T-C is an enzymatic, colorimetric, 
using cholesterol oxidase and 4-aminophenazone (test kit 
supplied by Roche). 
4. For the HDL-C assay, plasma samples were first 
pretreated with magnesium chloride, in order to precipitate 
VLDL- and LDL-C, and HDL-C was determined on the superna- 
tant fraction. 
5. LDL-C was calculated using the Friedwald equation 
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(Friedwald et al., 1972). 
Fasting T-C and HDL-C levels were assayed in the 
Department of Clinical Biochemistry, St. Luke's Hospital, 
Guildford. 
3.4. STATISTICAL ANALYSIS 
All data in the tables are presented as mean values 
and standard deviations whereas individual time-points on 
figures are given as mean values with their standard errors 
to facilitate clarity of presentation. Logarithmic 
transformation of fasting and postprandial TAG levels 
(normals-morning study), was carried out to normalize data 
distribution. Comparisons of apolipoprotein and TAG 
responses to the two meals, before and after fish oil 
supplementation, were carried out using an analysis of 
variance repeated measures test, and by calculation of 
incremental areas under the curve. 
The Duncan's Range test and the Student's t test were 
also used to test the level of significance of any 
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difference found in the responses to the test meal, before 
and after the fish oil supplementation period. p<0.05 was 
accepted as the level of statistical significance. 
3.5. RESULTS 
3.5.1. FASTING APOLIPOPROTEINS AND LIPID LEVELS: 
STUDY I AND II 
3.5.1.1. APOLIPOPROTEINS A-I AND B 
Fish oil supplementation did not have any effect on 
apo A-I and apo B fasting levels (Table 3.10). No signi- 
ficant differences were observed in the apo A-I and apo B 
fasting levels of all the volunteers (normals or diabe- 
tics), in both studies, before and after fish oil supple- 
mentation. 
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3.5.1.2. CHOLESTEROL AND TRIACYLGLYCEROL 
Although fish oil supplementation did not affect 
fasting TAG levels in the diabetic subjects, it had a 
significant effect on fasting TAG levels of normals, in 
both studies (Table 3.10). In particular, fasting TAG 
concentrations were significantly reduced with fish oil 
supplementation from 1.23±0.54 mmol/l before, to 0.68±0.19 
mmol/l after fish oil supplementation (p<0.05), in study I, 
and from 0.82±0.09 mmol/l before, to 0.68±0.17 mmol/1 after 
fish oil supplementation (p<0.001), in study II. Moreover, 
fasting T-C and LDL-C levels significantly increased 
(p<0.05), with fish oil supplementation in study II (T-C 
from 4.23±0.82 mmol/l to 4.82±0.90 mmol/l, and LDL-C from 
2.52±0.69 mmol/l to 3.08±0.65 mmol/l, respectively). How- 
ever, fasting cholesterol levels (T-C, HDL-C, and LDL-C), 
were not significantly changed with fish oil supplementa- 
tion in study I, in either normal or diabetic subjects. 
3.5.2. POSTPRANDIAL APOLIPOPROTEINS AND LIPID LEVELS: 
STUDY I AND II 
3.5.2.1. APOLIPOPROTEINS A-I AND B 
No significant difference was observed in the apo A-I 
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and apo B responses to the test meals before and after fish 
oil supplementation in any of the groups studied (see 
Tables 3. a, 3. b, 3. c, 3. d, 3. g, and 3. h in appendix II, and 
Figures 3.3,3.4,3.5,3.6,3.7, and 3.8). However, it has 
to be mentioned that a small trend towards 
TABLE 3.10 
STUDIES I and II: chronic fish oil supplementation studies. 
Fasting TAG, cholesterol and apolipoproteins levels 
(mean±SD) before and after fish oil supplementation period. 
PARAMETER PRE-FISH OIL 
SUPPLEMENTATION 
POST-FISH OIL 
SUPPLEMENTATION 
STUDY I (normal) 
Apo A-I(mg/dl) 156.60 ± 53.90 148.40 ± 62.40 
Apo B(mg/dl) 82.70 ± 32.90 84.10 ± 34.30# 
TAG(mmol/1) 1.23 ± 0.54 0.68 ± 0.19 
T-C(mmol/1) 4.80 ± 1.49 4.40 ± 1.69 
HDL-C(mmol/1) 1.46 ± 0.65 1.46 ± 0.42 
LDL-C(mmol/1) 2.75 ± 1.30 2.61 ± 1.34 
STUDY I (NIDDM's) 
Apo A-I(mg/dl) 137.80 ± 45.80 139.80 ± 42.00 
Apo B(mg/dl) 136.40 ± 32.50 145.80 ± 36.80 
TAG(mmol/1) 2.32 ± 1.45 3.08 ± 1.72 
T-C(mmol/1) 6.97 ± 1.41 7.08 ± 1.35 
HDL-C(mmol/1) 1.17 ± 0.49 1.10 ± 0.40 
LDL-C(mmol/1) 4.73 ± 1.07 4.58 ± 0.97 
STUDY II (normal) 
Apo A-I(mg/dl) 118.20 ± 26.30 125.50 ± 16.40 
Apo B(mg/dl) 51.00 ± 19.40 67.30 ± 28.30*, 
TAG(mmo1/1) 0.82 ± 0.09 0.68 ± 0.17# 
T-C(mmol/1) 4.23 ± 0.82 4.82 ± 0.90 
HDL-C(mmol/1) 1.33 ± 0.14 1.42 ± 0.33, E LDL-C(mmol/1) 2.52 ± 0.69 3.08 ± 0.65 
P<0.05 compared with the pre-fish oil supplementation 
level. 
- p<0.01 compared with the pre-fish oil supplementation 
level. 
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Fig. 3.3 STUDY I: effect of fish oil supplementation on 
Apo A-I in response to test meal in normals(mean+/-SEM, n-6) 
APOLIPOPROTEIN A-I(mg/dl) 
200 r 
150 
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50 
0 
0 100 200 300 
TIME (min) 
-x-- pre-FOS 
Wir- post-FOS 
Fig. 3.4 STUDY I: effect of fish oil supplementation on 
Apo A-I in response to test meal in NIDDM's(mean+/-SEM, n-7) 
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142 
Fig. 3.5 STUDY I: effect of fish oil supplementation on Apo B in response to test meal in normals (mean+/-SEM, n-6) 
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Fig. 3.6 STUDY I: effect of fish oil supplementation on Apo B in response to test meal in NIDDM's (mean+/-SEM, n=7) 
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Fig. 3.7 STUDY II: effect of fish oil supplementation on 
Apo A-I in response to test meal in normals(mean+/-SEM, n=6) 
APOLIPOPROTEIN A-I(mg/dl) 
200 
0 100 200 300 400 500 
TIME(min) 
A pre-FOS --, Gl- post-FOS 
700 800 
Fig 3.8 STUDY II: effect of fish oil supplementation on 
Apo B in response to test meal in normals (mean+/-SEM, n-6) 
APOLIPOPROTEIN B(mg/dl) 
100 200 300 400 500 
TIME(min) 
600 
600 
pre-FOS post-FOS 
700 800 
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higher apo B (study I), and lower apo A-I responses to the 
meals after the fish oil supplementation period was 
observed in the diabetic subjects. 
3.5.2.2. TRIACYLGLYCEROL 
Fish oil supplementation did not have any significant 
effect on fasting or postprandial TAG levels in the dia- 
betic subjects (study I), and there was a trend towards 
higher TAG levels in these subjects after fish oil sup- 
plementation (Table 3. f in appendix II and Figure 3.10). 
On the other hand, fish oil supplementation did have 
an effect in TAG postprandial levels in the normal subjects 
(Tables 3. e and 3. i in appendix II, and Figures 3.9 and 
3.11). In particular, as far as TAG levels of the normal 
subjects in study I are concerned, even though the mean 
values were lower at all time points, they reached stati- 
stical significance at only three time points [30,60, and 
90min. (p<0.05)]. However, the postprandial TAG response 
to the test meal was significantly lower (p<0.001), in the 
normals taking fish oil supplements in the study II (Table 
3. i in the appendix, and Figure 3.11). A blunting of the 
postprandial TAG peak was particularly noticeable between 
180 and 420min compared with the response of TAG to the 
meal before the fish oil supplementation. 
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Fig. 3.9 STUDY I: effect of fish oil supplementation on 
TAG in response to test meal in normals (mean+/-SEM, nab) 
TRIACYLGLYCEROL(mmol/I) 
2.5 r 
2 
1.5 
Pre FOS. 
$ Post FOS. 
" p<0.05 compared to post-fisn oil supplementation level 
0.5 
0 
0 100 200 300 
TIME(min) 
Fig. 3.10 STUDY I: effect of fish oil supplementation on 
TAG in response to test meal in NIDDM's (mean+/-SEM, n=7) 
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Fig. 3.11 STUDY II: effect of fish oil supplementation on 
TAG in response to test meal in normals (mean+/-SEM, n-6) 
TRIACYLGLYCEROL(mmoi/I) 
0 100 200 300 400 500 
TIME(min) 
600 700 800 
Pre-FOS -41- Post-FOS 
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3.6. DISCUSSION 
The most important finding in both studies is that 
fish oils supplementation reduced fasting TAG levels in the 
normal volunteers. Although in study II, postprandial TAG 
concentrations were significantly reduced in response to 
the test meal, in study I, TAG concentrations were signi- 
ficantly reduced only up to 90 minutes after the consum- 
ption of the test meal. However, it is clear that there 
was a strong trend towards lower values at all time points. 
As it has already been mentioned, effects of fish oil 
supplementation on TAG responses to test meals administered 
in the evening, have not been previously studied. The 
results of the present study suggest that even though the 
TAG-lowering effect of fish oil supplementation was similar 
at both times of the day (morning and evening), these 
effects were more pronounced in the evening, since 
differences in TAG response not only reached higher levels 
of significance, but also lower TAG levels were observed at 
each time point, until the end of the postprandial study 
time period. Moreover, the pattern of the TAG curves 
differed between the two studies. In study I, because of 
the short period of postprandial blood collection, TAG 
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levels did not reach a plateau by the end of the period of 
sampling, and values rose continuously from 0 to 210 
minutes. In study II, postprandial TAG responses showed 
two di istinct peaks, one at 60 minutes and one at 240 
minutes, and this different pattern probably reflects the 
fact that subjects were not in a fasted state at the time 
of the study. In study II, the effects of fish oil supple- 
mentation on postprandial lipid levels were able to be 
investigated for a longer period of time, and in particular 
until TAG values returned to their fasting levels, and was 
designed because of the limited conclusions which could be 
drawn from study I. The study was carried out overnight 
and the subjects were already in their late postprandial 
state from their last meal (lunch). One reason which could 
have caused a difference in the pattern of TAG responses to 
meal consumption in the two studies is differences in the 
nutrient composition of the meal administered. However, 
even though the foods which were used for the two test 
meals were different, the nutrient composition of the meals 
was similar and the mixture of solid and liquid foods was 
also similar. As a consequence, it would be unlikely that 
the different TAG response to the test meals was as a 
result of the different nature of the test meals. A 
possible explanation of the first peak, observed in the TAG 
response in study II, could be an effect of the late part 
of the lunchtime postprandial TAG response. It is notice- 
able that the first peak was smaller and sharper than the 
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second, possibly because the fat composition of the lunch 
was much lower than that of the evening meal. An observa- 
tion, however, which could challenge that explanation is 
that the interval between the time when lunch was admi- 
nistered (13: 00 hours), and the time when the first peak 
appeared (19: 00 hours) was different from the interval 
between the time when the evening test meal was admini- 
stered (18: 00 hours) and the time when the second peak was 
observed (22: 00 hours). 
Another more likely explanation for the appearance of 
the first peak could be the mobilization (occurring due to 
effects of gut motility) of already existing CM in the 
enterocyte from the lunch time meal, due to the administra- 
tion of the evening meal. It is noticeable that the first 
peak was more pronounced following the test meal before 
fish oil supplementation, than after the second meal when 
subjects were taking fish oils. A possible explanation is 
that the effect of n-3 fatty acids on enterocyte CM forma- 
tion decreased the re-esterification of dietary TAG, 
reflecting a decreased diacylglycerol acyltransferase 
activity. Rustan et al. (1988a), observed that fish oils 
reduce hepatic synthesis and secretion of TAG by decreasing 
the activity of this enzyme. Diacylglycerol acyltrans- 
ferase though, plays a key role in the TAG resynthesis in 
the enterocytes during fat absorption. Moreover, Strum- 
Odin et al. (1987), observed an enrichment of membrane 
phospholipids, in hepatocytes, with n-3 fatty acids, after 
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incubating hepatocytes with these fatty acids, and a 
suppression of hepatic TAG production, which drove them to 
the conclusion that the modification of the fatty acid 
composition of membrane phospholipids may have caused a 
decrease in diacylglycerol acyltransferase activity. A 
similar mechanism may be taking place in the enterocyte as 
well. As a consequence, the inhibition of this enzyme 
activity could lead to a reduced rate of CM formation and 
produce a lower postprandial chylomicronaemia. In 
addition, Hall et al. (1991) reported that incorporation of 
13Hjoleic acid into secreted TAG decreased in intestinal 
cells chronically incubated with fish oil fatty acids and 
Murthy et al. (1990), concluded that in human intestinal 
cells, EPA decreases the synthesis and secretion of newly 
synthesized TAG. However, the present study can only 
speculate about CM formation and CM and CM-R clearance 
rates since these particles were not assayed directly, and 
TAG concentrations were only measured in plasma and not in 
the CM fraction. 
Numerous mechanisms have been suggested to be involved 
in the decrease of fasting TAG concentrations observed with 
n-3 fatty acid supplementation. Many of these, emphasise 
inhibitory effects of n-3 fatty acids on hepatic lipogene- 
sis: 
- decreased fatty acid and TAG synthesis via decreased 
acetyl CoA carboxylase, glucose-6-phosphate dehydrogenase, 
phosphatidic acid phosphohydrolase, and diacylglycerol 
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acyltransferase in the liver (Iritani et al., 1980a and b; 
Marsh et al., 1987), 
- decreased VLDL-TAG secretion by the liver into the 
circulation (Rustan et al., 1988a; Nossen et al., 1986). 
However, Nossen et al. (1986), mentioned that the mechanism 
for the inhibitory effect ofeicosapentaenoic acid on TAG 
secretion is propably via reduced TAG synthesis, and 
- increased peroxisomal ß-oxidation (Christiansen et 
al., 1981), via an increase in fatty acyl-CoA oxidase and 
catalase activities (Yamazaki et al., 1987), and increased 
ketogenesis through the induction of peroxisomal ß-oxida- 
tion (Bergseth et al., 1986). 
On the other hand, in the present study the decreases 
in the postprandial TAG responses to the test meal could 
have occurred due to effects on pathways of lipid metabolism 
other than those in the liver: 
- due to reduced competition for LPL between VLDL-TAG 
and CM-TAG, and 
- increases in postprandial TAG clearance rates caused 
by a possible increase in LPL activity, due to long term n- 
3 fatty acid feeding. 
For both pathways, evidence is conflicting (Harris, 
1989), and therefore, more research needs to be done to 
investigate effects of fish oil supplementation on clear- 
ance of postprandial lipoprotein levels, and in particular, 
to examine whether CM and CM-R clearance rates are 
accelerated by fish oil consumption. 
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In NIDDM's fish oil supplementation did not signifi- 
cantly alter the TAG response to the test meal. Post- 
prandial TAG responses had a trend towards higher levels, 
following the fish oil supplementation period. Lipid 
metabolism in NIDDM's differs to that of healthy humans. 
As a consequence, a combination of increased dietary fat 
intake during the fish oil supplementation period (due to 
the fish oil capsules) , and a defect in either LPL acti- 
vity, or LPL synthesis (due to diabetes), could have caused 
this trend. 
Apo A-I and apo B levels in the healthy subjects were 
unaffected by fish oil supplementation. Both fasting and 
postprandial apolipoproteins levels were not statistically 
significant, following the fish oil supplementation period. 
However, a small trend can be observed, in study I towards 
a higher apo B (in normals), and lower apo A-I (in NIDDM's) 
response to the test meals, following the fish oil supple- 
mentation. A possible explanation could be the fact that 
the total amount of n-3 fatty acids (2.7 g/day), was not 
adequate to cause a major effect on apo A-I and apo B 
levels. Bronsgeest-Schoute et al. (1981), came to the con- 
clusion that only fairly large amounts of n-3 fatty acids 
in the diet (>8 g/day), will cause a decrease in plasma 
lipid concentrations. Sullivan et al. (1986), reported, 
after treating hypertriglyceridaemic patients with 15 g/day 
of fish oil (MaxEPA), for 8 weeks, a decrease in serum TAG, 
but an increase in LDL-apo B levels. Illingworth et al. 
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(1984), came to the conclusion that n-3 fatty acids lower 
plasma LDL levels in normal human subjects by reducing the 
rate of synthesis of apo B, after treating their volunteers 
with 24 g n-3 fatty acids per day, for 4 weeks. Further- 
more, Nestel et al. (1984), reported a fall in VLDL-apo B 
concentrations as well as a decrease in apo A-I levels of 
normal subjects, followed a fish oil diet (30% of daily 
energy needs came from the fish oil preparation), for 3 
weeks. Thorngren et al. (1986), also reported no changes 
on apo A-I and apo B levels in healthy men, followed a 150- 
200 g of fatty fish per day for 11 weeks. 
The trend towards an increase in apo B levels associa- 
ted with a decrease in TAG levels, which was observed in 
normal subjects by other investigators (Sullivan et al., 
1986), following fish oil supplementation could suggest an 
increase in the number of LDL particles, and a shift in the 
lipoprotein pattern from VLDL to LDL. The observed in- 
crease in fasting T-C (p<0.05) and LDL-C (p<0.05) levels, 
with fish oil supplementation, of the normal subjects in 
study II come to support this view. A reason for the 
possible increase in LDL particles has already been given 
(Sullivan et al., 1986; Harris, 1989), and this is a 
combination of increased LDL production, and/ or decreased 
LDL removal. The decrease of TAG content of VLDL, caused 
by fish oil supplementation, could result in a larger con- 
version of VLDL to LDL since large TAG-enriched VLDL are 
directly removed by the circulation by hepatic uptake, 
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whereas TAG-poor VLDL particles are converted to LDL. On 
the other hand, a lower LDL receptor activity can be a 
result of a high cholesterol diet. However, the total fat 
consumption was decreased in study II (p<0.05), with fish 
oil supplementation and the 63 mg of cholesterol, provided 
every day by the supplement, is unlikely to have caused 
this tendency, since the daily dietary cholesterol intake 
of the subjects was not altered (Table 3.5). It has to be 
mentioned once more at this point that in both studies, 
there were observed trends which did not reach statistical 
significance; a higher daily fish oil dose, for a longer 
period of time, administered in a larger number of volun- 
teers, could probably have more profound effects on both 
fasting and postprandial apolipoprotein levels. 
Fish oil supplementation did not affect the apolipo- 
proteins and TAG responses to the test meal in the diabetic 
subjects. However, a noteworthy trend towards higher TAG 
and lower apo A-I as well as a small trend towards higher 
apo B responses to the test meal at the end of the fish oil 
supplementation period was observed. Axelrod (1989), 
pointed out that even though beneficial effects of n-3 
fatty acids on platelet function, eicosanoid formation, 
plasma TAG, and blood pressure levels have been described 
in diabetic patients, enthusiasm has been dampened by 
reports of potentially deleterious effects of these agents, 
including increased apo B levels. On the other hand, even 
though Kasim et al. (1988), reported an increase in fasting 
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apo B levels in their NIDDM's, they also reported no change 
in fasting plasma TAG and apo A-I levels. In addition, 
Borkman et al. (1989), reported no overall change in 
fasting TAG levels in NIDDM's after a fish oil supplement- 
ation period (10 g/day for 3 weeks). In NIDDM's, the con- 
centration of LDL and, subsequently, apo B, can be in- 
fluenced by two opposing phenomena: on the one hand altered 
VLDL particles (larger in size), may be converted to a 
lesser extent to LDL, and on the other hand, decreased LDL 
receptor activity can result to lower LDL clearance (Howard 
et al., 1987). Fish oils and cholesterol, present in the 
supplement, could have, in a small extent, affected both 
phenomena. It is suggested that fish oils decrease VLDL 
particle size (Harris, 1989); however, this is unlikely in 
the present study, since TAG levels were not altered. 
Dietary cholesterol may have also decreased LDL receptor 
activity but the amount of cholesterol present in the 
supplement, makes this assumption to be unlikely. Further- 
more, total dietary fat and cholesterol consumption were 
not changed either (Table 3.4). 
It must be mentioned at this point that the background 
diet, the reliability of the volunteers, and the small 
number of subjects participated in the present study, limit 
the interpretation of the findings to some extent. It has 
been observed that changes in the background diet may 
affect lipid levels, and therefore, possible changes or 
even non-changes in them may not be only due to the fish 
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oil supplementation (Harris, 1989). Also the fact that the 
volunteers compliance to the capsules cannot be readily 
estimated, and that some of them may have not taken all the 
capsules, should not be ignored. Finally, trends at 
several time points might have reached statistical signifi- 
cance if the number of volunteers was larger. 
The findings of the present study come to support the 
view that the most profound effect of fish oil supplement- 
ation is the decrease in plasma TAG levels in normal 
subjects. However, the trend towards higher apo B levels 
needs more exploration and, therefore, the application of 
fish oil diets to patients with high LDL levels, should be, 
for the time being, not recommended. From the plasma TAG 
postprandial levels, it can also be concluded that in order 
to have a clear view of the lipid postprandial response, 
which includes observation of the appearance of the post- 
prandial peak and the time when it drops down to the 
fasting levels, a 10 hour postprandial blood sampling is 
required. Having that as a starting point, study I failed 
to show a complete view of the postprandial response in 
both normal subjects and NIDDM patients. On the other 
hand, both apo A-I and B postprandial concentrations seem 
to be unaffected by meal ingestion. The present study did 
not investigate the possible mechanisms by which n-3 fatty 
acids reduce fasting and postprandial lipid concentrations. 
As a consequence, further work needs to be done in this 
area, involving, as far as the plasma lipids are concerned, 
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research over longer postprandial periods, and measurements 
of not only plasma TAG and T-C, but also CM-TAG and CM- 
cholesterol levels, and LPL, the enzyme which is directly 
involved in CM-TAG hydrolysis, and therefore, in CM and CM- 
R clearance rates; effects of fish oil supplementation on 
insulin and GIP, the two hormones influencing directly and/ 
or indirectly LPL activity, should be also investigated in 
order to obtain a clearer view of the effects of fish oils 
on plasma lipid levels. Finally, since CM and CM-R clear- 
ance cannot be measured directly, due to a lack of an 
appropriate assay measuring plasma CM concentrations, the 
application of the retinyl palmitate loading technique, 
which is currently used as a marker of CM and CM-R, could 
also give useful information concerning CM and CM-R clear- 
ance rates. In the present study, the only information 
about CM and CM-R clearance was obtained by the post- 
prandial TAG levels which represent plasma total TAG and 
not CM-TAG, and therefore, possible interferance with VLDL- 
TAG, could lead to false interpretations. As far as the 
effects of fish oils on lipid synthesis are concerned, 
further work on hepatic lipid synthesis needs to be done, 
to investigate whether liver plays a major part in lowering 
plasma TAG levels, following a fish oil diet. 
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CHAPTER 4 
THE EFFECT OF 
TRIACYLGLYCEROL FATTY ACID 
POSITIONAL DISTRIBUTION ON 
POSTPRANDIAL LIPID AND 
HORMONE RESPONSES 
IN 
HEALTHY MALE SUBJECTS 
4.1. INTRODUCTION 
It has already been established that the composition 
of dietary fat affects lipoprotein metabolism and hence, 
plasma lipid levels (Kris-Etherton, 1988). Until recently, 
the most important effect of dietary fat, especially on 
fasting plasma cholesterol levels, related to the amount 
and type of fatty acids fed. Because of previous emphasis 
on the effects of dietary fats on fasting lipid levels, 
notably T-C and LDL-C levels, dietary TAG, were usually 
defined in terms of the types and amounts of fatty acids 
present, and the relative abundance of saturated, monoun- 
saturated, and polyunsaturated acyl groups. However, in 
the late 1980's interest started to shift from fasting 
lipid levels to postprandial lipoprotein levels, because of 
evidence for involvement of the latter in the pathogenesis 
of atherosclerosis (Zilversmit, 1979). Zilversmit pre- 
sented evidence which showed that in humans and experimen- 
tal animals, CM-R can be taken up by arterial walls more 
readily than LDL-C. His suggestion, that CM-R are poten- 
tially atherogenic particles, was based on the following 
observations: 
- the cholesterol content of CM, and CM-R increases 
160 
with the cholesterol content of the diet, 
- rabbits which developed atherosclerosis rapidly in 
response to cholesterol feeding developed hypercholeste- 
rolaemia, primarily as a result of accumulated CM-R, 
- patients with type III hyperlipoproteinaemia have an 
increased risk of CHD, with normal T-C and LDL-C but high 
levels of circulating CM-R, even in the postabsorpive 
state, and 
CM-cholesteryl ester is taken up by extrahepatic 
tissues. 
Therefore, he concluded that if CM and CM-R are poten- 
tially atherogenic, lipoprotein research should concentrate 
on studies of postprandial as well as fasting lipoproteins. 
The recognition of the potentional importance of post- 
prandial lipid levels as factors influencing the develop- 
ment of CHD has led to interest in characteristics of diet- 
ary TAG other than fatty acid composition which may in- 
fluence the extent and the duration of postprandial 
lipaemia, and Myher et al. (1978), suggested that native 
peanut oil may be more atherogenic than its interesterified 
form because it contains a greater proportion of TAG with 
acid 
linoleicnin sn-2 position and arachidic, behenic and ligno- 
ceric acids in sn-3 position which could increase the un- 
availability of linoleic acid due in part to the presence 
of long chain SFA in the outer position. 
Recent studies in rats have suggested that not only 
the composition of dietary TAG, but also the structure of 
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TAG could affect CM clearance, and therefore, postprandial 
lipaemia. In particular, Mortimer et al. (1988), and Red- 
grave et al. (1988), reported that when dietary TAG con- 
taining a saturated fatty acid at the sn-2 position were 
ingested or injected in rats, rates of TAG hydrolysis and 
removal, and rates of CM-R clearance were slower than when 
a saturated fatty acid was located at sn-1 or sn-3 
position. In addition, Kodali et al. (1987), reported that 
the presence of unsaturated fatty acids in the TAG mole- 
cule, makes its structure less stable and decreases its 
melting point. 
When ingested, TAG molecules are digested in the small 
intestine; pancreatic lipase hydrolyzes the primary ester 
bonds, yielding 2-monoacylglycerol, and two fatty acid 
molecules. The acyl chain at sn-2 position is relatively 
resistant to the lipolytic actions of pancreatic lipase so 
that approximately 75% of fatty acids at sn-2 position 
remain intact as monoacylglycerols (Mattson and Volpenheim, 
1964). These monoacylglycerols provide the basic structure 
for the resynthesis of CM-TAG in the enterocyte so that sn- 
2 located acyl chains are conserved and incorporated into 
circulating CM-TAG. 
A main factor which could influence the rate of CM and 
CM remnant clearance, which are enriched with saturated 
fatty acids at the sn-2 position, is the positional speci- 
ficity of LPL, the enzyme which regulates TAG hydrolysis in 
circulation, and Assmann et al. (1973), extended this 
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suggestion to all TAG lipases in post-heparin plasma. 
Additionally, effects of dietary fat structure on the 
secretion of hormones which alter the activity of LPL could 
also result in differences in clearance rates of CM and CM- 
R. It is known that secretion of the insulinotropic 
hormone GIP, is brought about by absorption of fatty acids 
into the enterocyte, following hydrolysis of dietary TAG 
(Ebert and Creutzfeldt, 1987). Dietary TAG can also 
influence the secretion of not only GIP, but also insulin, 
and therefore the two main lipogenic hormones. Insulin and 
GIP are hormone regulators of LPL, and, as a consequence, 
their secretion in response to fat ingestion, is an impor- 
tant determinant of the rate of postprandial TAG clearance. 
Lardinois et al. (1988), reported markedly different post- 
prandial GIP responses to test meals varying in their fatty 
acid compositions. However, even though effects of diet- 
ary TAG, different in fatty acid composition on post- 
prandial GIP response, have been established, it is not yet 
known whether TAG structure can influence the nature of the 
GIP response, and subsequently, insulin postprandial 
levels. 
It is, also important, in the present study, to evalu- 
ate possible effects of dietary TAG structure on post- 
prandial glucose concentrations, because if GIP and insulin 
respond differently to dietary TAG's of different 
structure, this will possibly result in a different glucose 
response, since glucose uptake by the tissues depends pri- 
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marily on insulin secretion. 
Fasting cholesterol levels, as already mentioned, have 
been used as risk indicators of development of CHD, and 
they are related to the type of fat fed. Dietary saturated 
fatty acids have a profound hypercholesterolaemic effect, 
they increase the concentrations of LDL-C. In order to 
have a more complete picture of the implications of dietary 
TAG structure on postprandial lipoprotein metabolism, 
measurements, apart from CM and CM-R clearance, such as 
postprandial T-C, LDL-C, HDL-C, apo A-I, and apo B levels 
are necessary. 
Ketone bodies are synthesized in the liver, and can be 
used by most aerobic tissues except the liver as a lipid 
fuel during starvation. Furthermore, NEFA levels also 
increase during starvation, and, generally, decrease during 
feeding, a fact which suggests that they are not involved 
in lipid transport from the gut, but in the mobilization of 
lipids stores when required. Postprandially, since insulin 
inhibits the breakdown of depot TAG, within the cell, NEFA 
levels do not increase until the postprandial insulin 
levels fall to their fasting values. NEFA in the liver can 
subsequently used for oxidation and for ketone body forma- 
tion. In order, therefore, to have a clearer view of the 
effects of meals, different in their TAG structure, on 
lipid metabolism, it would be necessary to measure post- 
prandial ketone bodies, and NEFA levels. 
Recent advances in lipase technology have made it 
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possible to synthesise TAG of known fatty acid composition 
and positional distribution which can be used to study 
effects of fatty acid position on postprandial lipoprotein 
metabolism in man. 
Studies of postprandial lipaemia and of the kinetics 
of NEFA and ketone concentrations following ingestion of 
sn-2 compared with sn-1,3 saturated fatty acid enriched 
TAG's have not previously been conducted in human 
volunteers. Therefore, the aims of the present study were 
to compare the metabolic effects of two oils of identical 
fatty acid composition but differing in the positional 
distribution of their major fatty acids (palmitic and oleic 
acids), on postprandial lipid metabolism in normal 
subjects. Sixteen healthy male volunteers were recruited 
for the study, and the effects of the dietary TAG structure 
on: 
- postprandial CM-TAG, CM-cholesterol and CM and CM-R 
concentrations, 
postprandial plasma GIP and insulin levels, 
postprandial plasma TAG, T-C, LDL-C, HDL-C, apo A-I 
and apo B levels, and 
- postprandial plasma glucose, ketone bodies, and NEFA 
levels 
were investigated. 
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4.2. STUDY DESIGN 
4.2.1. SUBJECTS 
Sixteen healthy male volunteer subjects were recruited 
from the University of Surrey student and staff population. 
The average age was 24.8±2.6 years (mean±SD), ranging from 
21 to 30 years. The average BM1 was 22.7±2.4 kg/m2 ranging 
from 19.0 to 26.6 kg/m2. 
The subjects were all normal, non obese, and the 
exclusion criteria which were used for the selection of the 
subjects were as follows: Subjects age should be between 
18 and 40 years. Their BMI should be between 19 and 27 
kg/m2, and they should not have any previous history of 
endocrine or liver disease, hyperlipidaemia, or known 
alcoholism. Subjects should not exceed alcohol consumption 
of 30 units per week, they should not excercise vigorously 
more than eight hours per week. Finally, they should not 
have been following any form of restricted or modified diet 
or be taking hormone preparations 
in the month preceding the study. 
All subjects were asked to provide written consent to 
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participate in the study, which was approved by the Ethics 
Commitee of the University of Surrey. 
Individual subject details are given in Table 4.1. 
TABLE 4.1 
Structured triacylglycerol study: 
subject details. 
SUBJECT SEX AGE BMI DIETARY 
HABITS 
1 M 21 20.6 Omnivarian 
2 M 30 19.5 Omnivarian 
3 M 23 19.0 Vegetarian 
4 M 29 26.0 Omnivarian 
5 M 27 24.2 Omnivarian 
6 M 24 21.0 omnivarian 
7 M 22 22.6 omnivarian 
8 M 26 26.0 Omnivarian 
9 M 21 23.0 Omnivarian 
10 M 24 24.4 Omnivarian 
11 M 22 22.0 Omnivarian 
12 M 26 19.6 Omnivarian 
13 M 25 21.1 Omnivarian 
14 M 26 23.5 Omnivarian 
15 M 27 26.6 Omnivarian 
16 M 25 24.9 Omnivarian 
4.2.2. MEALS 
The subjects were asked to consume two semi-liquid 
meals on two occasions separated by two weeks. Subjects 
were randomised to receive either the control or the test 
oil meal on the first visit, and received the other meal on 
the second visit. 
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The two meals differed only in their positional 
distribution of the major fatty acids. The fatty acid 
composition and sn-2 positional distribution of the control 
and test oils are given in Table 4. a. in appendix III, and 
illustrated in Figures 4.1 and 4.2 respectively. Triacyl- 
glycerol analysis of the two oils is also given in Table 
4.2. The control oil, abbreviated as "OOP", was a blend of 
natural oils, (87.5% palmoleine, 11% high oleic sunflower 
oil, 1.5% sunflower oil), in which only 5.9% of the total 
palmitate present, was esterified to the sn-2 position of 
the TAG. The test oil, abbreviated as "OPO" was derived by 
enzymic (1,3) interesterification of palm stearine with a 
blend of normal and high oleic sunflower fatty acids, 
followed by solvent fractionation of the resultant TAG 
mixture. Of the 30.4% palmitate present in this oil, 72.7% 
was esterified at the sn-2 position of the TAG molecules 
(Table 4. a). Thus, the TAG structure of the two oils being 
evaluated in this study was fundamentally different, as 
illustrated by the HPLC analysis shown in Table 4.2. 
The preparation and analysis of the two different oils 
was undertaken by Unilever Ltd, Bedford. 
The semi-liquid meal was prepared by mixing 84 g 
powdered meal replacement diet (Carnation Slender), with 
200 ml of water and 40 g of the oil under investigation. 
The mixture was prepared fresh on the day of use and was 
homogenised immediately prior to consumption. The 
composition and ingredients of Carnation slender are given 
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TABLE 4.2 
Structured triacylglycerol study: 
triacylglycerol analysis of control and test oils 
analysed by HPLC. 
TRIACYLGLYCEROL CONTROL OIL TEST OIL 
PPP 0.3 0.3 
POP 12.0 0.9 
OPP 2.8 6.6 
PLnP 8.0 0.0 
PPLIX 1.4 3.1 
POO 43.9 5.8 
OPO 1.0 54.1 
OPLn 0.0 22.8 
POLn 13.6 1.8 
000 12.6 0.8 
>3 double bonds 4.4 4.2 
-P: Palmitic acid 
Ln: Linoleic acid 
-0: Oleic acid 
in Table 4.3 and the calculated nutrient composition of the 
semi-liquid meal, given to each subject, in Table 4.4. 
4.2.3. PROCEDURE 
At 08: 00 hours on each morning of the study, the 
subjects reported to the Clinical Investigation Unit at the 
University of Surrey, where they were seated quietly prior 
to the insertion of an indwelling cannula, for the purpose 
of blood collection. Subjects were fasted overnight and 
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refrained from alcohol consumption on the day prior to the 
study. Following the collection of two fasting blood 
samples (-10 and 0 minutes), the subjects were asked to 
consume the semi-liquid meal; all subjects consumed the 
meal within five minutes. 
TABLE 4.3 
Structured triacylglycerol study: 
nutrient composition and ingredients of Carnation Slender 
used in the test meals. 
NUTRIENT 
Dry weight 
Total Energy 
Protein 
Cabohydrate 
Fat 
CONTENTS PER SACHET 
28. OOg 
97.50kcal 
5.04g 
20.16g 
0.19g 
Ingredients: Skimmed milk powder, dried glucose syrup, 
powdered sugar, lactose, Mineral mix (Magnesium hydroxide, 
sodium chloride, iron orthophosphate, zinc oxide, copper 
gluconate, potassium iodide), flavouring, colours (Beetroot 
red, annatto), thickener (carrugeenan), emulsifier 
(lecithin), vitamin mix (C, E, B6, A, D, B1, B2, niacin, 
calcium pantothenate, folic acid, biotin). 
TABLE 4.4 
Structured triacylglycerol study: 
nutrient composition of the semi-liquid meal. 
WEIGHT( g) ENERGY(kcal) ENERGY() 
Fat 40.0 360 54 
Protein 15.1 60 9 
Carbohydrate 60.5 242 37 
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Postprandial responses to the two meals, containing 
either the control or the test oil, were measured over six 
hours on two separate occasions, with the meals given in 
random order. Apart from the fasting blood samples, 20 ml 
of blood were taken at fifteen minute intervals for the 
first hour, thirty minute intervals for the second hour, 
and at hourly intervals thereafter until the sixth hour 
after the begitrning of the meal. Twelve blood samples 
(approximately 250 ml of blood) were taken on each day of 
the study at the following time points: 
-10,0,15,30,45,60,90,120,180,240,300,360 min. 
The design of the study is given in Figure 4.3. 
The blood samples were derived, as illustrated in 
Figure 4.4, in the following order: 
- 10 ml of blood was transferred in a 10 ml heparin- 
ised tube, and 
- the rest (approximately 10 ml), was transferred in 
another 10 ml heparinised tube. 
The first blood sample was spun immediately at 2500 
rpm for 15 min. (7000 g. min), and the plasma separated was 
divided in LP3 tubes. Analyses of TAG, T-C, LDL-C, HDL-C, 
glucose, apo A-I, apo B, and NEFA were undertaken by a 
research collaborator (Unilever Ltd. ). St. Luke's 
Hospital, Guildford, was responsible for analysis (within 
fo rty eight hours) of ketone bodies, and insulin and GIP 
analyses were carried out by the investigator at the 
University of Surrey. 
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The second blood sample was also spun immediately at 
7000 g. min., and the plasma obtained was transferred to 
another 10 ml heparinised tube. In order to prepare CM's, 
an aliquot of 3.5 g of the plasma was transferred into an 
8 ml polycarbonate tube, and overlayered with 3.5 g of 
saline solution (d=1.006 g/ml). The tubes were subjected 
to preparative ultracentrifugation. The procedure for CM 
separation is given in Chapter 2. The supernatant (CM-rich 
fraction which contains the CM-TAG and possibly a small 
proportion of the VLDL-TAG), was separated from the infra- 
natant (CM-poor fraction which contains other lipoproteins 
than CM), and each of them was put in an LP3 tube, and 
analysed for TAG by the research collaborator (Unilever 
Ltd. ). 
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4.3. METHODS OF ANALYSIS 
Analysis of the following parameters was undertaken: 
- Triacylglycerol in the CM-rich fraction. 
- Triacylglycerol in the CM-poor fraction. 
- Plasma TAG, T-C, LDL-C, and HDL-C. 
- Plasma glucose, insulin, and GIP. 
- Plasma apo A-I, and B. 
- Plasma ketone bodies, and NEFA. 
The analyses, mentioned above, were undertaken in 
Unilever Ltd., apart from the analysis of insulin and GIP 
concentrations. Briefly: 
1. The assay used for TAG in CM-rich and CM-poor 
fractions, as well as in plasma, is a coupled enzymatic 
procedure, using lipase, and glycerol kinase (Boehringer 
Mannheim test kit). 
2. Total cholesterol was measured using a standard 
coupled enzymatic procedure, using cholesterol esterase and 
cholesterol oxidase (Boehringer Mannheim test kit). 
3. LDL-C was calculated from the measured values of 
T-C, HDL-C, and TAG, according to the formula of Friedwald 
et al. (1972). 
4. HDL-C was determined by the phosphotungstic acid/ 
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MgCl2 precipitation method (Boehringer Mannheim test kit). 
5. Plasma glucose was measured by the glucose 
oxidase, and, peroxidase coupled enzymatic procedure 
(Boehringer Mannheim test kit). 
6. Plasma insulin was determined using a radio- 
immunoassay technique (section 2.9). 
7. A radioimmunoassay technique (section 2.8) was 
also used to determine the GIP levels in plasma, (Morgan 
et al., 1978). 
8. Plasma apo A-I and apo B were also measured by 
test kits from Boehringer Mannheim, (immunoturbidimetric 
method). 
9. Ketone bodies were measured in fresh plasma by an 
enzymatic method, using an Encore centrifugal analyser 
(Pearse et al., 1987). 
10. Plasma NEFA were also measured using a Boehringer 
Mannheim enzymatic test kit (NEFA Quick BMY). 
All enzymatic and immunoturbidimetric assays were 
undertaken using a Boehringer Hitachi 704 EC analyser at 
37°C (Boehringer Mannheim Ltd. ). 
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4.4. STATISTICAL ANALYSIS 
The mean and standard deviations for each variable for 
each time point were calculated and plotted as postprandial 
response curves. The area under the curve was calculated 
by meal from a baseline of -10 and 0 min. Differences in 
postprandial responses between the Control and the Test 
oils were tested using a repeated measures design analysis 
of variance, and a Sign test (non-parametric) was used in 
order to determine statistical significance between the two 
meals. This procedure was performed for each of the base- 
lines separately. The difference between the control and 
the Test oil meals was taken to be significantly different 
when p<0.05. 
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4.5. RESULTS 
4.5.1. FASTING LIPID AND HORMONE METABOLITE LEVELS 
Fasting concentrations of TAG, cholesterol, glucose, 
hormones, apolipoproteins, ketone bodies, and NEFA were 
similar on each of the study days (Table 4.5). However, a 
slight fall in cholesterol, TAG, apolipoproteins and NEFA 
levels can be observed at 0 min. compared with -10 min. 
values possibly due to an effect of cannulation on lipid 
clearance rates. All fasting lipid and hormone metabolite 
levels were within the normal range. 
4.5.2. CM-POOR FRACTION TRIACYLGLYCEROL 
Postprandial TAG responses to the Control and Test oil 
meals, in the CM-poor fraction are given in Table 4. b in 
appendix III, and illustrated in Figure 4.5. There was no 
change in the response of TAG in the CM-poor fraction, 
following both Control oil and Test oil meals. TAG levels 
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TABLE 4'. 5 
Structured triacylglycerol study: 
fasting plasma lipid and hormone metabolite levels 
(mean±SD) following meals different in 
fatty acid positional distribution. 
PARAMETER 
" 
CM-PF TAG(mmol/1) 
-10min 
0 
CM-RF TAG(mmol/1)+ 
-10 
0 
Plasma TAG(mmol/1) 
-10 
0 
T-C(mmol/1) 
-10 
0 
LDL-C(mmol/1) 
-10 
0 
HDL-C (mmol/1) 
-10 
0 
Glucose(mmol/1) 
-10 
0 
Insulin(mU/1) 
-10 
0 
GIP (pmol/1) 
-10 
0 
Apo A-I(mg/dl) 
-10 
0 
Apo B(mg/dl) 
-10 
0 
Ketone bodies(µmol/1) 
-10 
0 
NEFA(µmo1/1) 
-10 
0 
CONTROL 
0.32 ± 0.1 
0.28 ± 0.1 
0.53 ± 0.3 
0.40 ± 0.1 
0.93 ± 0.5 
0.75 ± 0.3 
4.78 ± 0.5 
4.47 ± 0.7 
3.03 ± 0.5 
2.84 ± 0.5 
1.32 ± 0.2 
1.26 ± 0.2 
5.01 ± 0.4 
5.08 ± 0.4 
8.30 ± 4.8 
7.50 ± 4.5 
49.60 ± 39.8 
46.70 ± 28.9 
134.90 ± 20.3 
122.70 ± 18.9 
61.70 t 15.9 
54.50 ± 12.1 
0.05 ± 0.13 
0.10 ± 0.06 
966.40 ± 426.8 
934.00 ± 314.9 
Chylomicron-poor fraction 
Chylomicron-rich fraction 
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TEST 
0.36 # 0.1 
0.36 ± 0.1 
0.52 ± 0.2 
0.44 t 0.2 
0.88 ± 0.3 
0.81 ± 0.2 
4.63 ± 0.5 
4.35 ± 0.4 
2.83 ± 0.4 
2.68 ± 0.3 
1.27 ± 0.2 
1.21 ± 0.2 
5.02 ± 0.3 
5.00 ± 0.3 
9.90 ± 6.8 
8.00 ± 3.9 
62.20 ± 49.6 
52.20 ± 42.6 
125.60 ± 20.2 
121.40 ± 18.1 
58.50 ± 18.7 
53.10 ± 14.5 
0.05 ± 0.02 
0.06 ± 0.04 
876.00 ± 436.0 
844.50 ± 379.9 
following the Control oil meal ranged from 0.30±0.1 
mmol/1(mean±SD), to 0.39±0.1 mmol/1 (fasting levels: 
0.32±0.1 mmol/1 and 0.28±0.1 mmol/1), while following the 
Test oil meal ranged from 0.35±0.1 mmol/1, to 0.39± 0.1 
mmol/1 (fasting levels: 0.36± 0.1 mmol/1). 
4.5.3. CM-RICH FRACTION TRIACYLGLYCEROL 
Postprandial TAG levels in the CM-rich fraction, 
following the two meals, are given in Table 4. c, in 
appendix III, and illustrated in Figure 4.6. An increase 
in TAG response to the two meals was observed in the CM- 
rich fraction. However, no statistically significant 
differences were observed, comparing the TAG responses to 
the Control oil meal with those to the Test oil meal. In 
response to the Control oil, TAG levels rose from 0.40± 
0.1 mmol/1 (lowest fasting level), to 0.92±0.4 mmol/1 at 
300 minutes after the beginning of the meal, whereas on the 
Test oil meal day, they rose from 0.44±0.2 mmol/l (lowest 
fasting level), to 0.94±0.4 mmol/1 (300 min. ). CM-rich TAG 
levels did not return to fasting values within the time 
course of the study. 
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Fig. 4.5 Postprandial CM-poor fraction TAG responses to 
oils different in TAG structure (mean+/-SEM, n-16) 
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Fig. 4.6 Postprandial CM-rich fraction TAG responses to 
oils different in TAG structure (mean+/-SEM, n-16) 
TAG(mmol/1) 
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4.5.4. PLASMA TRIACYLGLYCEROL 
Plasma TAG responses to the Control and Test oils are 
given in Table 4. d, in appendix III, and Figure 4.7. 
Plasma TAG levels rose from 0.75±0.3 mmol/l (lowest fasting 
level), to 1.36±0.6 mmol/l (300 min. ), following the 
Control oil meal, whereas, in response to the Test oil 
meal, they rose from 0.81±0.2 mmol/l (lowest fasting 
level), to 1.38± 0.5 mmol/1 (300 min. ). From the fifth 
until the sixth hour, after the beginning of the meal, TAG 
levels tend to decrease slightly in response to both 
Control and Test oil meal days, reaching the levels of 
1.17±0.5 mmol/l, and 1.27± 0.5 mmol/l respectively. 
No statistically significant differences were observed 
in plasma TAG responses following the two meals. 
4.5.5. PLASMA CHOLESTEROL 
Plasma T-C concentrations are given in Table 4. e, in 
appendix III, and illustrated in Figure 4.8. Plasma T-C 
levels were unaffected following both Control and Test oil 
meals. Postprandial plasma T-C values ranged from 4.51± 
0.5 mmol/l (15 min. ), to 4.63±0.5 mmol/l (300 and 360 min. ) 
following the Control oil meal, whereas, following the Test 
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oil meal, plasma T-C levels ranged from 4.47±0.4 mmol/l (15 
min. ), to 4.58±0.5 mmol/1 (180 min. ). 
No statistical difference was observed in T-C levels 
following the Control and the Test oil meals. 
4.5.6. PLASMA LDL-C 
Postprandial plasma LDL-C levels are given in Table 
4. f, in appendix III, and illustrated in Figure 4.9. No 
statistical difference was observed in the plasma LDL-C 
levels, following the Control and the Test oil meals 
either. In particular, postprandial plasma LDL-C levels 
ranged from 2.72±0.4 mmol/l (300 min. ), to 2.89±0.5 mmol/1 
(15 min. ), following the Control oil meal, and from 2.65± 
0.4 mmol/l (300 min. ), to 2.79±0.4 mmol/l (15 and 30 min. ), 
following the Test oil meal. 
4.5.7. PLASMA HDL-C 
Postprandial HDL-C levels are shown in Table 4. g, in 
appendix III, and illustrated in Figure 4.10. Postprandial 
plasma HDL-C levels were identical, following the two 
meals. In response to the Control oil meal, HDL-C levels 
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Fig. 4.7 Postprandial plasma TAG responses to oils 
different in TAG structure (mean+/-SEM, n=16) 
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Fig. 4.8 Postprandial cholesterol responses to oils 
different in TAG structure (mean+/-SEM, ni16) 
CHOLESTEROL(mmol/1) 
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varied from 1.21±0.2 mmol/l (90 min. ), to 1.28±0.2 mmol/l 
(360 min. ), whereas, in response to the Test oil meal, 
postprandial HDL-C levels ranged from 1.17±0.2 mmol/l (180 
min. ), to 1.24±0.2 mmol/l (360 min. ). From the results 
obtained it can be seen that there was no response of HDL-C 
to the two meals, and as a consequence, no statistical 
difference was observed. 
4.5.8. PLASMA GLUCOSE 
Postprandial plasma glucose levels are given in Table 
4. h, in appendix III, and illustrated in Figure 4.11. 
Plasma glucose levels showed similar responses to the two 
meals under investigation. They reached their peak at the 
same time point (30 min. ), having values of 6.15±0.7 mmol/l 
(Control oil meal day), and 6.05±0.1 mmol/l (Test oil meal 
day). From that time point, they started decreasing there- 
after, reaching their lowest value 180 minutes after the 
beginning of the meal (4.59±0.5 mmol/l and 4.58±0.4 mmol/l 
in response to the Control and to the Test oil meal 
respectively). In response to the Control oil meal, there 
was evidence of another smaller peak at 90 min. (5.75±0.6 
mmol/1), although statistical analysis showed that there 
was no significantly different response to the two meals. 
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Fig. 4.9 Postprandial LDL-C responses to oils different in 
TAG structure (mean+/-SEM, n-16) 
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Fig. 4.10 Postprandial HDL-C responses to oils different in 
TAG structure (mean+/-SEM, n-16) 
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4.5.9. PLASMA INSULIN 
Postprandial insulin levels are given in Table 4. i, in 
appendix III, and illustrated in Figure 4.12. There was no 
effect of TAG structure on plasma insulin response. 
Insulin levels rose sharply folowing the meals and reached 
their peak approximately one hour after the begtrning of the 
meal (49.9±25.8 mU/1 at 45 min. following the Control oil 
meal, and 50.8±27.3 mU/1 at 60 min. following the Test oil 
meal). They both started decreasing thereafter, falling to 
their fasting levels 180 minutes after the beggining of the 
meal (11.4±7.1 mU/1, and 11.9±6.9 mU/1 following the 
Control and the Test oil meals respectively). It is note- 
worthy that, following the Control oil meal, insulin levels 
did not fall as sharply as they did following the Test oil 
meal between 60 and 90 minutes, postprandially, which could 
be related to the second smaller peak observed in the 
glucose levels 90 minutes after the begining of the Control 
oil meal. 
4.5.10. PLASMA GIP 
Plasma GIP levels (Table 4. j, in appendix III, and 
Figure 4.13), also rose sharply after the meal, reaching 
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Fig. 4.11 Postprandial glucose responses to oils different 
in TAG structure (mean+/-SEM, n-16) 
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Fig. 4.12 Postprandial insulin responses to oils different 
in TAG structure (mean+/-SEM, n=16) 
INSULIN(mU/I) 
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their peak at 45 minutes (357.4±140.8 pmol/1 following the 
Control oil meal, and 364.1±115.5 pmol/l following the Test 
oil meal) , then declining steadily up to 120 minutes and 
then more slowly for the remaining four hours. However, 
GIP levels were still above fasting concentrations six 
hours after the beginning of the meal (104.4±62.5 pmol/l 
following the Control oil meal, and 105.9±52.4 pmol/l 
following the Test oil meal). 
There was no effect of TAG structure on the plasma GIP 
response, with identical values seen following consumption 
of Control and Test oil meals. 
4.5.11. PLASMA APOLIPOPROTEIN A-I 
Postprandial apo A-I levels are shown in Table 4. k, in 
appendix III, and in Figure 4.14). There was no post- 
prandial response of apo A-I to the two meals. Apo A-I 
postprandial levels ranged from 119.9±14.2 mg/dl (180 
min. ), to 127.6±16.6 mg/dl (300 min. ), following the 
Control oil meal (fasting values: 122.7±18.9 mg/dl and, 
134.9± 20.3 mg/dl), and from 116.5±18.4 mg/dl (240 min. ), 
to 128.9±24.9 mg/dl (360 min. ), following the Test oil meal 
(fasting values: 125.6±20.2 mg/dl and 121.4±18.1 mg/dl). 
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Fig. 4.13 Postprandial GIP responses to oils different in 
TAG structure (mean+/-SEM, n-16) 
GIP(pmol/1) 
150 200 250 
TIME(min) 
Control -1- test 
Fig. 4.14 Postprandial apo A-I responses to oils different 
in TAG structure (mean+/-SEM, n-16) 
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4.5.12. PLASMA APOLIPOPROTEIN B 
There was no postprandial response observed in apo B 
levels following the two meals (Table 4.1, in appendix III, 
and Figure 4.15). Postprandial plasma apo B levels varied 
from 53.1±12.2 mg/dl (360 min. ) , to 56.2± 14.9 mg/dl (30 
min. ), following the Control oil meal (fasting values: 
61.7±15.9 mg/dl and 54.5±12.1 mg/dl), and from 53.0±16.8 
mg/dl (45 min. ), to 56.2±16.4 mg/dl (360 min. ), following 
the Test oil meal (fasting values: 58.5± 18.7 mg/di and 
53.1±14.5 mg/dl). 
4.5.13. PLASMA KETONE BODIES 
The total ketone concentrations (Table 4. m, in 
appendix III, and Figure 4.16), showed a similar pattern 
following the two meals, with an initial decrease in 
concentrations in the first three hours after the beginning 
of both meals (0.017± 0.017 gmol/1 following the Control 
oil meal, and 0.015± 0.019 µmol/l following the Test oil 
meal), and thereafter an increase up to six hours (0.147± 
0.115 µmol/l following the Control oil meal, and 0.097± 
0.057 pmol/1 following the Test oil meal). There was a 
notably sharp rise in ketone body concentrations between 
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Fig. 4.15 Postprandial apo B responses to oils different in 
TAG structure (mean+/-SEM, n-16) 
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Fig. 4.16 Postprandial ketone bodies responses to oils 
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five and six hours following consumption of the Control oil 
meal, but differences between the two meals did not reach 
a level of statistical significance. 
4.5.14. PLASMA NON-ESTERIFIED FATTY ACIDS 
The postprandial NEFA responses (Table 4. n, in 
appendix III, and Figure 4.17), showed a similar pattern to 
the ketone body concentrations over the time course of the 
experiment, and were reciprocally related to those of the 
TAG responses described earlier, so that levels of NEFA 
fell during the first two hours after the beginning of the 
meals returning to the fasting values at approximately four 
hours after the beginning of the meals (854.2±425.2 gmol/l, 
and 992.6± 330.6 gmol/l following the Control and the Test 
oil meals respectively). The fall in NEFA concentrations 
tended to be less marked in response to the Test compared 
with the Control oil meal, although differences in NEFA 
response to the two meals did not reach a level of 
statistical significance. 
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Fig. 4.17 Postprandial NEFA responses to oils different in 
TAG structure (mean+/-SEM, n=16) 
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4.6. DISCUSSION 
This study failed to show any significant differences 
in lipid and non-lipid metabolite and hormone levels, 
following two meals, differing in TAG structure. In 
particular, differences in postprandial TAG response to the 
two meals were not found either in CM-rich fraction or in 
plasma. Furthermore, responses to the meals were similar 
between plasma- and CM-rich fraction-TAG, and TAG levels in 
CM-poor fraction remained fairly constant throughout the 
postprandial phase. The latter indicates firstly that the 
postprandial rise in plasma TAG was due to an increase in 
CM-TAG levels, secondly that VLDL-TAG secretion did not 
increase during the time course of the study, and thirdly 
that until up to the sixth hour the absorption of dietary 
TAG from the gut continued, since concentrations of TAG in 
CM-rich fraction had not started to decline. 
No differences in plasma T-C, LDL-C, and HDL-C levels 
were observed, following the two meals. These observations 
however, were expected, since the meals administered were 
cholesterol-free. Furthermore, postprandial apo A-I, and 
apo B levels also remained constant, and responses were 
unaffected by the TAG structure of the meals. Glucose 
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responded similarly to the two meals with the only excep- 
tion at the ninety minute time point where a second small 
rise in glucose levels was seen following the control oil 
meal. It is noteworthy the fact that a second peak was 
also observed in the insulin response at ninety minutes 
following the same meal. However, overall insulin 
responses were very similar following the control and test 
oil meals and the only reason for the appearance of this 
small peak could be the slight difference in the stomach 
emptying in response to the two meals. However, after 
comparing these differences with the whole time course it 
can be said that it would be unlikely to have any physio- 
logical relevance, a suggestion which can be strengthened 
by the fact that there were no statistical differences 
observed either in the glucose or in the insulin post- 
prandial levels. 
GIP postprandial levels also showed similar responses 
to the two meals, and therefore, it can be assumed that TAG 
structure did not affect GIP levels. It is interesting to 
note that GIP levels remained above fasting concentrations 
six hours after the meal and that this prolonged post- 
prandial GIP response may reflect a response to the rapid 
absorption of carbohydrate (0-60 minutes), followed by a 
stimulation by the more slowly digested fat component of 
the meal (40-360 minutes). 
Ketone bodies as well as NEFA concentrations showed a 
similar pattern over the time course of the experiment, 
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with an initial decrease in concentrations in the first 
three and two hours, respectively, and an increase there- 
after up to six hours. Ketone bodies, however, rose 
sharply between the fifth and the sixth hour following the 
control oil meal. It is also noteworthy that NEFA 
responses were reciprocally related to those of the TAG 
responses. In addition, both ketone bodies and NEFA levels 
started increasing after the third hour from the 
consumption of the meals, when insulin postprandial levels 
reached their fasting values. The fall in NEFA is a chara- 
cteristic postprandial response and probably it is a 
consequence of decreased lipolysis, since an increased 
substrate availability and plasma insulin levels were 
observed. 
It is important to consider why differences in TAG 
response to the two meals were not seen, when data from 
animal studies suggested exactly the opposite. Possible 
postprandial differences in response to the two meals could 
be as a consequence of differences in absorption, 
differences in clearance, or a combination of both. 
Numerous studies have already investigated the effects of 
dietary fat composition and structure on fat absorption. 
Ockner et al. (1972), after using a rat model, concluded 
that palmitic acid consistently required a greater length 
of intestine for its absorption than did linoleic acid, and 
furthermore, even when uptake of the two fatty acids by 
mucosa was similar, palmitate re-esterification was 
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significantly less rapid. However, after using the same 
model, Simmonds et al. (1968), reported an equal absorption 
of palmitic and oleic acids from both emulsions and 
micelles. It has already been reported that the solubility 
of the monoacylglycerols with saturated fatty acids in bile 
salt solution, decreases with chain length, and that on the 
other hand, 2-monopalmitin has been found to have a higher 
solubility than the 1-form (Hofmann and Borgstrom, 1962). 
The same authors observed a high solubility of 1-monoolein 
in bile salt solutions, and an increased solubilization of 
palmitic and stearic acids as the micelle was expanded with 
1-monoolein. It was also noteworthy that 2-monopalmitin 
showed competitive solubilization with monoolein while the 
1-form did not. Furthermore, as it has already been 
mentioned, pancreatic lipase attacks the sn-1 and sn-3 
positions of the TAG molecules yielding 2-monoacyiglycerol 
and free fatty acids. Even though 2-monoacylglycerol can 
be completely absorbed and can be used as the backbone for 
the TAG resynthesis, this does not always happen with the 
free fatty acids formed. It has been suggested that in the 
presence of calcium and magnesium, high melting point TAG 
are poorly absorbed. Mattson et al. (1979), suggested that 
the extent of the absorption of stearic acid depended on 
its position in the TAG molecule and on whether the diet 
contained calcium and magnesium. They also added that when 
stearic-oleic-oleic was fed, the digestion products were 2- 
monoolein and free stearic and oleic acids. In the 
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presence of calcium and magnesium the stearate soap would 
be formed and only half of the stearate would be absorbed. 
In the absence, however, of these cations, the soap would 
not be formed and the free stearic acid would be completely 
absorbed. On the other hand, Tadayyon and Lutwak (1969), 
suggested that when calcium and phosphorus intake is high 
while the other is low, absorption of long-chain saturated 
TAG was decreased, but there was no effect on unsaturated 
TAG. Furthermore, Cheng et al. (1949), gave a value of TAG 
melting point of 50°C, above which magnesium could reduce 
the TAG's digestability. In the present study, the con- 
centration of calcium and magnesium in the semi-liquid meal 
was minimal, and any difference between the absorption of 
palmitic acid and the absorption of oleic acid, due to the 
presence of these compounds, would not be able to be 
observed. 
After comparing the absorption of the fatty acids of 
human milk and infant formulae, using a rat model, 
Tomarelli et al. (1968), reported a linear relationship 
between absorption and the proportion of palmitic acid in 
the sn-2 position and to a lesser extent, for myristic and 
oleic, but not for stearic acid. Furthermore, Filler et 
al. (1969), after feeding eleven newborn infants with 
formulae containing natural lard (palmitic acid primarily 
at the sn-2 position of the TAG molecule), and randomized 
lard (palmitic acid equally distributed among sn-1, sn-2, 
and sn-3 positions of the TAG molecule) came to the 
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suggestion that the presence of greater amounts of 2-mono- 
palmitin could increase the absorption of stearic acid from 
lard due to a more rapid rate, or greater, extent of micel- 
lization. 
The melting point may also be involved in the extent 
of TAG clearance by LPL, from the circulation. Redgrave et 
al. (1988), after using rats as models, came to the 
conclusion that long-chain saturated fatty acids in dietary 
TAG, affect the metabolism of CM. In particular, when 
stearate is in the sn-2 position, compared to the sn-3 
position, TAG hydrolysis and CM remnant clearance was 
retarded. They suggested that 2-monostearin, which is 
formed during the TAG hydrolysis by LPL, has a melting 
point well above body temperature, and that makes the 
particle more rigid; as a result, apo C-II, LPL, or TAG 
could be expelled, and as a consequence the enzymic re- 
action would stop. Furthermore, regarding remnant uptake, 
increased surface rigidity may prevent the binding of 
adequate amounts of apo E so that its interaction with the 
CM-receptor and/or the LDL (apoE/apoB), receptor would be 
modified. This could lead to a decreased clearance of the 
remnant particle. As a result, there should be more mono- 
acylglycerol present in the CM-remnants. However, Mortimer 
et al. (1988), after analysing remnants from liver-excluded 
rats, did not detect any monoacylglycerol. 
The present study was the first human study which 
tried to compare the effects of TAG structure on lipid 
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metabolism, using palmitic and oleic acids as the main 
fatty acids present at sn-2 position in the test and 
control oils respectively. Possible reasons, therefore, 
which could have led to different results between the 
present study and the studies mentioned above could be: 
- the choice of the fatty acids: oleic and palmitic 
acids have generally been found to be well absorbed whereas 
stearic acid has not. Use of stearic acid as the fatty 
acid at sn-2 and sn-1/3 positions, may have yielded greater 
differences between the two meals, 
- absence of calcium, magnesium and phosphorus in the 
meals: A possibility of formation of soaps which could de- 
crease the absorption of the saturated fatty acids, would 
not have been a factor in this study because the meals pro- 
vided were almost free of these cations, 
- the time course of the experiment. As it has 
already been mentioned, it was decided that the effects of 
the TAG structure should be investigated up to six hours 
after the beginning of the meal. However, this time course 
was proven to be too short to allow TAG values to return to 
fasting levels. TAG levels in both CM-rich fraction and 
total plasma were still at plateau levels even at the last 
time point of the experiment, 
- differences in the metabolism between species: Al- 
most all of the previous studies were undertaken using 
animals as models. Even newborn infants have different 
capacity from the adults to absorb dietary fat, which means 
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that differences observed in animals or infants cannot be 
assumed to apply to the human adults as well, 
- the fact that the oils were given as acute meals in 
a semi-liquid form: The possibility that a long-term diet, 
providing the oils under investigation in a more solid 
form, could result in differences in lipid metabolism 
cannot be ruled out, and 
- CM clearance rates were not assayed, and the only 
indication of clearance came from the TAG levels in both 
plasma and the isolated CM-rich fraction. 
As a result, further work needs to be done in the 
following areas: 
- effect of melting point of fatty acids, and 
subsequently of TAG, on fat absorption and CM and CM-R 
clearance rates, 
- effect of the presence of calcium, magnesium, and 
phosphorus in the absorption of fat, using human volunteers 
and dietary TAG differing in structure, 
-a longer postprandial time course experiment in 
order to observe return of lipid, non-lipid metabolites 
and hormone concentrations back to their fasting levels. 
A postprandial period of 12 hours may be the most adequate, 
since it was observed previously, in Chapter 3, that after 
12 hours, postprandial lipid levels fall to their fasting 
values, 
- effect of dietary TAG structure on infant and adult 
lipid metabolism, and comparison of any differences ob- 
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served between infant and adult lipid metabolism following 
administration of the same dietary structured TAG, 
- effect of TAG structure on lipid metabolism, 
following a long-term diet in normal or hyperlipidaemic 
human volunteers. 
- effect of the way that the meals are administered 
(liquid, semi-liquid, solid), which differ or not in TAG 
structure on lipid metabolism, and 
- effect of dietary fatty acid positional distribu- 
tion on CM and CM-R concentrations, possibly by using the 
retinyl palmitate loading technique, which even though it 
provides only an indirect measurement of CM and CM-R 
particles, it is currently the most valid technique. 
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CHAPTER 5 
THE EFFECT OF TEST MEAL 
FATTY ACID COMPOSITION ON 
POSTPRANDIAL BLOOD LIPID AND 
HORMONE RESPONSES 
IN NORMAL SUBJECTS 
5.1. INTRODUCTION 
As has already been discussed, most investigations in 
lipid metabolism have been undertaken using volunteers in 
their fasting state, because it is widely believed that 
fasting lipid values represent better the 24-hour mean, are 
easier to standardise for comparative purposes, and are 
better indicators of the risk of developing CHD. However, 
most people are in the fed-state for a long period during 
the day, as a result of eating meals at frequent intervals. 
It has also been mentioned that Zilversmit (1979), pre- 
sented evidence which showed that in humans and experiment- 
al animals, CM-R can be taken up by arterial walls more 
readily than can LDL-C. 
It is also now generally accepted that the beneficial 
effects of PUFA of the n-6 series (vegetable origin) on 
CHD, relate to the cholesterol-lowering properties of these 
fatty acids. Several epidemiological and clinical studies 
have proven the hypocholesterolaemic actions of these fatty 
acids (Kris-Etherton et al., 1988). However, studies of 
effects of n-6 fatty acids on postprandial lipoprotein 
levels are not extensively reported in the literature. 
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In the case of n-3 fatty acids, although there is 
evidence for protective effects of high intakes against CHD 
development, there is little evidence that this relates to 
the cholesterol-lowering properties of n-3 fatty acids. 
Dyerberg and his collegues reached the conclusion that the 
Eskimos unusual diet could be hypolipidaemic and con- 
sequently, antiatherogenic. In these studies of Iceland 
Eskimo, low incidence of CHD and thrombosis was observed, 
as well as prolonged bleeding times and low levels of 
plasma TAG. What made their findings more interesting was 
the fact that plasma and platelet lipids of Eskimos were 
unusual because they contained high proportions of two 
PUFA's, EPA and DHA, which are both commonly found in large 
proportions in fish oils. Thereafter, numerous studies 
investigated the possible hypolipidaemic effects of fish 
oils in normal and hyperlipidaemic subjects. The main 
effect of fish oils on plasma lipid levels seems to be a 
decrease in the VLDL-TAG fraction. (Nestel et al., 1984; 
Sanders et al., 1985; Illingworth et al., 1984; Phillipson 
et al., 1985; Sullivan et al., 1986; Harris et al., 1988a 
and b; Dart et al., 1989; Deck et al., 1989; Hanninen et 
al., 1989; Harris et al., 1990). Furthermore, Blonk et al. 
(1990), and Sanders (1991), stated that the effects of n-3 
PUFA on plasma lipids are strongly dose-related and, not 
only can they markedly lower plasma TAG and VLDL levels but 
they are also more effective than linoleic and linolenic 
acids at comparable doses. However, fish oils do not seem 
207 
to have any significant effect on T-C and LDL-C when 
consumed at moderate levels of intake (Rogers et al., 1987; 
Sanders et al., 1980; Harris, 1989). A higher fish oil 
intake (24 g/day), has been shown to decrease the levels of 
both LDL and LDL-apo B (Illingworth et al., 1984), but it 
is unlikely that such a high level of fish oil intake would 
be acceptable long-term. 
Numerous studies have already indicated that apo A-I 
and apo B values might be better predictors of the risk of 
developing CHD than cholesterol levels, since the apolipo- 
protein effect was found to be independent of age, presence 
of hypertension or diabetes (Naito, 1988). Nestel et al., 
(1984), observed a reduction in synthesis of VLDL-apo B 
after fish oil supplementation and, since the majority of 
LDL-apo B in normal humans is derived from VLDL-apo B, it 
could be expected that fish oils treatment would decrease 
LDL-apo B levels. However, the effect of fish oils on apo 
B levels is inconsistent. While Phillipson et al. (1985), 
found a decrease in apo B blood levels of type V hyper- 
lipidaemics, and Illingworth et al. (1984), observed a 
decrease in the rate of LDL-apo B synthesis in normals, 
Nestel et al. (1984), reported a decrease in VLDL-apo B, 
and an increase in LDL-apo B. Sullivan et al. (1986), 
found increases in apo B levels in both hypertriglyceri- 
daemic subjects and normals, Deck et al. (1989), reported 
high levels of LDL-apo B in hypertriglyceridaemic patients, 
and Levine et al. (1989), mentioned higher apo B levels in 
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hyperlipidaemics after fish oil administration. It must be 
mentioned at this point that apo B levels usually changed 
in concert with the cholesterol levels of the LDL fraction 
(Sullivan et al., 1986; Decoke et al., 1988; Harris et al., 
1988a and b). As far as apo A-I levels are concerned, they 
seem either to remain unchanged (Phillipson et al., 1985; 
Hanninen et al., 1989; Levine et al., 1989), or to decrease 
(Nestel et al., 1984). 
LPL is a hydrolytic enzyme, present in many tissues, 
which is mainly responsible for the removal of lipoprotein 
triacylglycerol from the circulation, and therefore is an 
important determinant of the clearance of TAG-rich lipo- 
proteins. Herzeberg (1991), reported that PUFA, and in 
particular dietary fish oils, could lead to increased 
activity of LPL in skeletal muscle and heart. In contrast, 
other investigators failed to find any change in post- 
heparin LPL in animals or humans fed fish oils (Harris, 
1988a; Huff and Telford, 1989). Moreover, Melin et al. 
(1991), reported that LPL hydrolyzed eicosapentaenoic and 
arachidonic acid esters at a slower rate than C74-C18 acid 
esters. Therefore, effects of different PUFA on the 
activity of this enzyme must be investigated in order to 
establish a possible mechanism by which fish oils may 
influence the CM and CM-R clearance rates. 
Interest has also increased in recent years in the 
effects of dietary fatty acid composition on GIP and 
insulin concentrations since these two hormones play an 
209 
important role in lipid metabolism and their secretions can 
be influenced by dietary fat content and composition. GIP 
is now widely considered to be one of the main endocrine 
components at the entero-insular axis (Creutzfeldt and 
Ebert, 1985). GIP secretion is dependent on the active 
absorption of nutrients in the gut and stimulates insulin 
secretion by the pancreatic ß-cells when blood glucose 
rises above fasting levels. Kwasowski et al. (1985), 
reported that GIP secretion is stimulated by long-chain 
fatty acids and TAG and not by short- and medium- chain 
fatty acids. Corn oil was found to cause an increase in 
GIP response in adult males (Ross and Shaffer, 1981; 
Williams et al., 1981). It is also generally accepted that 
insulin stimulates LPL activity and several mechanisms by 
which insulin could stimulate LPL activity have been 
suggested. Eckel et al. ( 1987), suggested that insulin 
could stimulate the synthesis of this enzyme in adipocytes, 
and Awald et al. (1988), reported an increase in the levels 
of LPL-specific mRNA. Moreover, recent studies also 
suggest that GIP could directly act on LPL by increasing 
the enzyme's activity in rat adipose tissue explants (Oben 
et al., 1991; Knapper et al., 1993). Furthermore, 
Lardinois et al. (1987), stated that PUFA can increase 
insulin secretion significantly more than SFA meals. 
However, GIP released from the gut, does not stimulate 
insulin secretion when only fat is ingested (Morgan et al., 
1988). 
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The studies mentioned above, have mainly investigated 
the effects of different types of fat on fasting lipid and 
hormone levels, either by putting animals or human subjects 
on diets, or by giving supplements to human volunteers for 
a short period of time, usually between two weeks and two 
months. It is only in the last few years that investiga- 
tors have started to study effects of dietary fat content 
and fatty acid composition on postprandial lipoprotein 
metabolism. 
As a consequence of the increasing evidence for the 
atherogenicity of CM and CM-R, there has been increased 
interest in the effects of dietary fat content and fatty 
acid composition on CM-R clearance. Cohn et al. (1988), 
monitored plasma lipoprotein changes for twelve hours after 
a fat-rich meal. They observed a complex postprandial 
plasma TAG response. with single plasma TAG peaks in some 
subjects, but two or more distinct peaks in others, and 
that males tended to have more marked postprandial trigly- 
ceridaemia than females. The last finding correlates well 
with epidemiological studies which showed that incidence of 
CHD is a more frequent phenomenon in males than in females 
in Westernised countries (Wilson et al., 1987). In a study 
with rats (Groot et al., 1988), it was found that rats fed 
a high palm oil diet had higher postprandial serum TAG 
levels than sunflower seed-fed animals. Levy et al. 
(1991), reported that on a diet rich in PUFA from safflower 
oil, CM were larger in diameter than those from rats which 
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were put on coconut oil, and medium-chain TAG diets. As 
far as the postprandial effects of fish oils are concerned, 
Harris et al. (1988a), reported no difference in the post- 
prandial TAG response between fish oil and saturated fat 
test meals, when subjects followed their usual home diets. 
However, when saturated fat, and fish oil test meals were 
administered during experimental periods of saturated fat, 
and fish oil background diets, it was found that the pre- 
sence of fish oil in the background diet reduced post- 
prandial lipaemia regardless of the type of fat in the test 
meal. Furthermore, in another postprandial study (Brown 
and Roberts, 1991), after chronic treatment, the fish oil 
treated group exhibited mean total, and CM-TAG levels which 
were lower than those of an olive oil-fed group. Moreover, 
both the olive oil- and the fish oil-fed groups had similar 
rises in CM-Retinyl esters during the first two hours, but 
after this time, the postprandial effect of the fish oil- 
fed group was lower than the response of the olive oil-fed 
group. The fact that fish oil tend to lead to less pro- 
nounced postprandial hyperlipaemia compared with olive oil, 
is also supported by the findings of Sanders 1989. 
Weintraub et al. (1988), reported decreased postprandial 
TAG levels with chronic fish oil feeding, but concluded 
that there was little evidence to suggest any acceleration 
in CM-R clearance due to acute meals rich in n-6 PUFA when 
the background diet is rich in SFA. In this study of Wein- 
traub, acute effects of n-3 PUFA on postprandial lipid 
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levels were not measured when the background diet was rich 
in SFA. 
Each of the studies mentioned above are subject to a 
number of criticisms: 
- Cohn et al. (1988) studied only meal fat content 
and did not study the effects of different types of fat, 
and they provided their test meal in the form of a milk- 
shake. 
- Groot et al. (1988), did their study using rats. 
They made semi-synthetic diets providing 30% of energy in 
the form of fat, which is a very high-fat diet for rodent 
animals, and is therefore difficult to compare with the 
approximately 40% fat diet in the average human Western- 
type diet. 
- Levy et al. (1991), also carried out their studies 
in rats and did not look at the effects of fish oils, and 
in addition the diets were emulsified, and infused. 
- In the human study of Harris et al. (1988a) , the 
lipoprotein responses were measured only eight hours post- 
prandially, which would not allow several parameters to 
return to their fasted levels. Moreover, the administra- 
tion of the meal as a liquid formula in the Harris study, 
does not provide a true representation of normal physio- 
logical responses to food, since the response may differ, 
according to the physicochemical form in which the oil is 
provided (Harris, 1989). 
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Brown and Roberts (1991), did not look at the 
effects of PUFA from the vegetable origin or the effects of 
SFA's on postprandial lipid levels, and furthermore, the 
subjects were given, after an overnight fast, a test meal 
containing 81% of energy as fat. 
- Weintraub et al. (1988), in a carefully designed 
study, investigated the chronic effects of different types 
of dietary fat, after placing the subjects for twenty five 
days on three isocaloric diets and measuring the responses 
to a test meal. However, the test meal was high in fat 
(65% of calories), which does not represent the usual 
dietary fat intake. 
It becomes apparent, that there is a lack of studies 
investigating effects of the type of dietary fat on post- 
prandial lipoprotein metabolism, and few studies have inve- 
stigated, simultaneously, effects on lipoproteins, hormone 
concentrations and post-heparin LPL activity. 
The application of the RP loading technique for inve- 
stigating the postprandial lipoprotein metabolism in humans 
is based on the observation that when absorbed, RP is se- 
creted and circulated with " CM and CM-R particles, and 
is finally taken up with remnants by the liver, where it 
enters a storage pool and is not re-secreted in VLDL. How- 
ever, the method has been criticised recently since some 
workers suggest that significant exchange of RP takes place 
between CM and other lipoproteins and that there is rese- 
cretion of RP in VLDL (Krasinski et al., 1991). However, 
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at the present time, RP loading is the only available 
method for following, specifically, the CM and their 
remnants, so that despite its limitations this technique 
has been applied in the present investigation. 
The aim of the present study was to overcome the limi- 
tations of previous studies, with respect to some of the 
points mentioned above: The test meal provided approxi- 
mately 1350kcal, from which approximately 360kcal came from 
fat. RP was used as a marker of CM's and CM's were sepa- 
rated from plasma, in order to reduce the problem of ex- 
change of RP with other lipoproteins which might influence 
the interpretation of the results. 
Male normal human subjects were recruited, they were 
studied eleven hours postprandially, and the test oils were 
incorporated into normal foods, which were given to the 
subjects in the evening, since it is more usual for the 
main meal to be consumed at this time of the day. 
The aims of the present study were therefore to carry 
out a study, under normal physiological conditions, to de- 
termine the effects of three different test oils (corn oil, 
fish oil, and a mixture of oils representing the average 
fat intake in the usual U. K. diet), on: 
- postprandial CM-TAG, CM-CHOL, and CM particles (CM 
and CM-R) clearance rates, 
- response of plasma TAG and cholesterol to the meals 
differing in their fatty acid compositions, 
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- post-heparin lipoprotein lipase activity, since this 
activity is mainly responsible for the hydrolysis of CM- 
and plasma-TAG, 
- investigation of postprandial insulin and GIP 
levels, since they are major factors responsible for the 
stimulation of LPL activity, and 
- serum postprandial apo A-I, and apo B levels, since 
relatively few studies of postprandial apolipoprotein con- 
centrations in response to dietary fatty acids have been 
reported. 
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5.2. STUDY DESIGN 
5.2.1. SUBJECTS 
Eleven healthy male students were recruited for this 
study. Their average age was 22.5 ± 1.4 years(mean ± SD), 
ranging from 21 to 25 years. The average BMI was 23.8 ± 
2.2 kg/m2 (mean ± SD) , ranging from 19.0 kg/m2 to 26.2 kg/m2. 
The subjects were all normal, non-obese and the exclu- 
sion criteria which were used for their selection were as 
follows: Subjects age should be between 18 and 40 years 
old. Their BMI should be between 19 kg/m2 and 27 kg/m2 and 
their habitual dietary fat consumption should not be less 
than 30% and more than 45% of the total energy. They 
should not have any previous history of endocrine or liver 
disease, hyperlipidaemia, or known alcoholism and they 
should not exceed alcohol consumption of 30 units per week. 
Finally, subjects should not exercise vigorously more than 
10 hours per week and should not have been following any 
form of reducing or exclusion diet or be taking dietary 
supplements of evening primrose oil, fish oil, or sunflower 
oil in the month preceding the study. 
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In order to determine the usual daily fat intake of 
the subjects, each subject was requested to complete a food 
diary for three weekdays and one weekend day (Figure 5. a 
and Figure 5. b in appendix IV). 
Ethical consent for the study was obtained from the 
University of Surrey and the Royal Surrey County Hospital 
Ethics Committee. Individual subject details are given in 
Table 5.1, and the instructions given to the subjects 
before the beginning of the study are presented in Figures 
5. c and 5. d in appendix IV. 
TABLE 5.1 
Acute fatty acid study: subject details 
SUBJECT AGE BMI USUAL DIET: 
% ENERGY PROM 
DIETARY FAT 
1 23 26.2 41.0 
2 23 26.1 36.0 
3 22 22.1 37.3 
4 22 19.0 35.3 
5 23 23.6 41.0 
6 25 24.7 45.0 
7 21 21.8 33.0 
8 21 26.0 36.0 
9 22 25.8 40.0 
10 21 24.2 37.0 
11 
IL 
25 23.1 42.0 
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5.2.2. MEALS 
The subjects were asked to consume three test meals in 
random order on three separate occasions. On each day of 
the study food intake was standardised. All subjects were 
provided with a standard breakfast, lunch and snacks (Table 
5.2), and asked to continue with their normal activities. 
At 17: 00 hours, the subjects were asked to consume the test 
meal at the Clinical Investigation Unit in the Royal Surrey 
County Hospital. 
The three test meals differed only in the fatty acid 
composition of the oils used in preparation. The oils 
under investigation were as follows: 
1. Mixed oil. A mixture of palm oil, coconut oil, 
olive oil, and corn oil, designed to represent the current 
fatty acid composition of a typical U. K. diet. 
2. Corn oil, and 
3. Fish oil (MaxEPA), which was provided in a deodor- 
ized form (British Cod Liver Oils). 
Details of the nutrient composition of the test meals 
as well as the fatty acid composition of the three test 
meals, and the fatty acid composition of the individual 
oils which were used to make the mixed oil are given in 
Tables 5.3,5.4, and Table 5.5, respectively. 40 g of the 
oil under investigation were given with a rice based meal: 
20 g in a form of a semi-liquid meal (milk-shake), and 20g 
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TABLE 5.2 
Acute fatty acid study: 
nutrient composition of the standard meals consumed on 
the day of each test meal 
FOOD AMOUNT ENERGY PROTEIN FAT CHO FIBRE 
(g) (kcal) (g) (g) (g) (g) 
Breakfast 
Corn 50.0 178.0 3.9 0.3 42.5 0.5 
flakes 
Milk 115.0 52.5 3.8 1.8 5.7 --- 
Sugar 10.0 40.0 --- --- 10.5 --- 
Wm toast 76.0 163.0 7.0 2.0 31.6 4.4 
L/F 16.0 62.0 1.0 6.5 0.2 --- 
spread 
Orange 150.0 50.0 0.6 --- 12.7 --- 
juice 
Tea 260.0 36.0 1.2 0.6 7.0 --- 
Snack 
Plain 45.0 212.0 2.8 9.4 31.0 1.0 
biscuits 
Tea 260.0 36.0 1.2 0.6 7.0 --- 
Lunch 
Wm bread 190.0 408.0 17.5 4.8 79.0 11.0 
L/F 33.0 128.0 2.0 13.5 0.4 --- 
spread 
Ham 58.0 70.0 10.7 3.0 --- --- 
Tomato 50.0 7.0 0.5 --- 1.4 0.8 
Crisps 25.0 137.0 1.4 9.4 12.3 1.2 
Banana 100.0 47.0 0.7 0.2 11.4 1.8 
Tea 260.0 36.0 1.2 0.6 7.0 --- 
Snack 
Choc. 51.0 251.0 3.5 12.3 34.0 1.1 
biscuits 
Coffee 260.0 36.0 1.2 0.6 7.0 --- 
TOTALS 2009.0 1949.5 60.2 65.6 300.7 21.8 
Nutrient composition was calculated using the food composi- 
tion tables (Paul and Southgate, 1988). 
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TABLE 5.3 
id study: test meal nutrient composition 
FOOD AMOUNT ENERGY PROTEIN FAT CHO FIBRE 
(9) (kcal) (g) (g) (g) (g) 
Evening 
meal 
Basmati 120.0 431.0 8.9 0.6 95.8 --- 
rice 
Red 16.5 19.0 1.0 0.2 2.0 --- 
pepper 
Mushrooms 16.5 2.0 0.3 0.1 --- 0.4 
Onions 16.5 4.0 0.1 --- 0.8 0.2 
Sweetcorn 16.5 13.0 0.5 --- 2.7 0.9 
Peas 16.5 7.0 0.9 --- 0.7 2.0 
Raisins 16.5 41.0 0.3 --- 10.7 --- 
Salad 
Lettuce 20.0 2.4 0.2 0.1 0.2 0.3 
Green 15.0 2.0 0.1 0.1 0.3 0.1 
pepper 
Cucumber 23.0 2.0 0.1 --- 0.4 0.1 
Spring 5.0 1.4 0.1 --- 0.2 --- 
onions 
Water- 10.0 1.4 0.3 --- 0.1 0.3 
cress 
Tomatoes 50.0 7.0 0.5 --- 1.4 0.8 
Wholemeal 70.0 151.0 6.2 2.0 29.0 6.0 
bread 
Salad 
dressing 
Test oil 20.0 180.0 --- 20.0 --- --- 
Lemon 20.0 1.5 --- --- --- 
juice 
Sugar 3.0 12.0 --- --- 3.0 --- 
Black --- --- --- --- --- 
pepper 
Mixed --- --- --- --- --- 
herbs 
Garlic --- --- --- --- '-' 
Milkshake 
Test oil 20.0 180.0 --- 20.0 --- --- 
Slender 84.0 292.0 15.0 0.6 60.5 --- 
plan 
TOTALS 559.0 1349.7 34.5 43.7 207.8 11.1 
Cholesterol content of the meal was negligible apart from 
fish oil the cholesterol content of which was 450mg/lOOg. 
Nutrient composition was calculated using the food composi- 
tion tables (Paul and Southgate, 1988). 
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TABLE 5.4 
Acute fatty acid study: 
fatty acid composition of the three test meals (g/100g). 
FATTY ACID MIXED OIL CORN OIL FISH OIL 
C12: 0 10.7 0.0 0.0 
C14: 0 4.1 0.6 7.1 
C16: 0 24.7 14.0 17.5 
C18: 0 3.2 2.3 4.2 
C20: 0 0. p 0.3 0.0 
C22: 0 Tr Tr 0.0 
C24: 0 Tr Tr 0.0 
C14: 1 0.0 0.0 0.3 
C16: 1 0.6 0.3 9.9 
C18: 1 39.0 30.0 12.9 
C20: 1 Tr 0.2 2.5 
C22: 1 Tr 0.2 1.1 
C18: 2 12.0 50.0 4.2 
C20: 2 0.0 0.0 4.4 
C18: 3 0.5 1.6 0.0 
C20: 4 0.0 0.0 1.6 
C22: 4 0.0 0.0 1.2 
C20: 5(n-3) 0.0 0.0 18.2 
C22: 5 0.0 0.0 2.1 
C22: 6(n-3) 0.0 0.0 12.8 
R 
Tr: Trace 
The fatty acid composition of the three meals was calulated 
using food composition tables (Paul and Southgate, 1988). 
as a salad dressing. The milk-shake was prepared immedia- 
tely before the consumption of the test meal, from three 
"Slenderplan" sachets (Carnation Ltd. ), each one containing 
28 g of meal replacement powder, almost fat free in compo- 
sition. Each sachet provided 97.4 kcal, 5.0 g of protein, 
20.1 g of carbohydrate, and 0.2 g of fat. The meal repla- 
cement powder was reconstituted in 200 ml of water and 20 
g of the test oil, and retinyl palmitate (Roche, Herts), 
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(700 I. U. /kg of body weight) were also added. Whole meal 
bread was given to ensure that all the oil added to the 
salad was consumed. 
TABLE 5.5 
Acute fatty acid study: 
fatty acid composition of mixed oil (g/100g). 
COCONUT : OLIVE : CORN : PALM (1: 1: 0.5: 2) 
PATTY ACID COCONUT OLIVE CORN PALM 
C12: 0 47.7 0.9 0.0 0.2 
C14: 0 15.8 Tr 0.6 1.1 
C16: 0 9.0 12.0 14.0 41.5 
C18: 0 2.4 2.3 2.3 4.3 
C20: 0 1.0 0.4 0.3 0.3 
C22: 0 0.0 0.0 Tr 0.0 
C24: 0 0.0 0.0 Tr 0.0 
C16: 1 0.4 1.0 0.3 0.3 
C18: 1 6.6 72.0 30.0 43.3 
C20: 1 0.0 0.0 0.2 0.0 
C22: 1 0.0 0.0 0.2 0.0 
C18: 2 1.8 11.0 50.0 8.4 
C18: 3 0.0 0.7 1.6 0.3 
Tr: Trace 
5.2.3. PROCEDURE 
Prior to the first test meal, subjects were asked to 
keep a four day food diary. The food consumed was noted 
and subjects were asked to follow the same dietary pattern 
for four days prior to the second and third test meals. 
Subjects were also requested to refrain from excessive 
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alcohol intakes during the period of the study, and not to 
drink any alcohol on the day before each day of study. 
Close contact with volunteers was maintained to ensure 
compliance with instructions. 
Subjects were randomly allocated to receive one of the 
three test meals on each of the three visits. The study 
design is illustrated in Figure 5.1. 
At 09: 00 hours on each study day, a fasting venous 
blood sample was taken from the forearm, in the seated 
position, from each subject. The subjects were then given 
breakfast and a standard pre-prepared lunch, plus snacks to 
be consumed during the day. The subjects were requested 
not to consume any other food. 
The blood samples, approximately 20 ml each, were 
divided in the following order (Figure 5.2): 
-5 ml of blood were transferred to a5 ml tube con- 
taining lithium heparin, 
- 10 ml of blood were transferred to a 10 ml heparin- 
ised tube, and 
- remaining blood was put in a 10 ml plain glass 
bottle. 
The 5 ml heparinised tubes were spun immediately at 
2500 rpm for 15 minutes (7000 g. min. ), and the plasma 
obtained was divided into LP3 tubes, which were then stored 
in a freezer (-20°C), for further analysis of TAG, T-C, 
GIP, and insulin. 
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The 10 ml heparinised tubes were also spun immediately 
at 7000 g. min., and the plasma obtained was transferred to 
another 10 ml heparinised tube. From this plasma, 3.5 g 
were transferred in a 38 ml thick walled Beckman Ultracen- 
trifuge tube, overlayered with 3.5 g saline solution (d= 
1.006 g/ml), and spun for the separation of the CM fraction 
(section 2.3). The obtained CM fraction, was then trans- 
ferred into LP3 tubes and stored at -20°C for further ana- 
lysis of TAG, T-C, and RP. 
Finally, the 10 ml glass tubes were left for an hour 
to stand, then spun at 7000 g. min., and the serum obtained 
separated into LP3 tubes which were then stored at -20°C 
for analysis of Apo A-I, and Apo B. 
At 18: 00 hours on the same day, the subjects were 
transferred to the Investigation Unit at the Royal Surrey 
County Hospital. After a period of rest, subjects were 
cannulated using an indwelling cannula, and two preprandial 
blood samples were taken, 10 and 0 minutes before the con- 
sumption of the test meal. Blood sampling continued for 11 
hours postprandially. Approximately 20 ml of blood were 
taken every half hour for the first hour, and hourly there- 
after, until the end of the study. Fourteen blood samples 
(approximately 300 ml of blood), were taken on each day of 
the study at the following time points: 
-10,0, (meal), 30,60,120,180,240,300,360,420, 
480,540,600, and 660 minutes. 
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Most blood samples were collected with the subjects in 
the supine position, as the study was carried out over- 
night. 
One hour after the collection of the last blood 
sample, 100 I. U. heparin/kg of body weight were injected 
into the mid-arm vein, and two 5 ml blood samples were 
taken, one at 5, and one at 15 min. after the injection of 
the heparin, for analysis of post-heparin LPL. 
The subjects were then given breakfast, and trans- 
ferred back to the University. 
The procedure for separation of the blood samples into 
blood tubes was identical to that described for blood 
samples taken at 09: 00 hours (Figure 5.2). 
In addition, blood samples for the post-heparin LPL 
assay were put into 5 ml heparinised tubes, spun immediate- 
ly at 7000 g. min., and the plasma obtained was transferred 
into two LP3 tubes: one for analysis of LPL, and the other 
one kept as spare. Both LP3 tubes were stored at -20°C. 
These analyses were carried out by another investigator. 
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5.3. METHODS OF ANALYSIS 
The methods used for analysis of 
- Chylomicron-Triacylglycerol 
- Chylomicron-Cholesterol 
- Chylomicron-Retinyl Palmitate 
- Plasma TAG, T-C, GIP, and insulin 
- Serum Apo A-I and B 
- Post-heparin LPL activity 
are described in detail in Chapter 2. Briefly 
1. CM were separated from plasma using an 
ultracentrifugation technique (Grundy, and Mok, 1976) 
(section 2.3). The assays for TAG, and T-C in CM are 
enzymatic colorimetric methods, using glycerol-phosphate 
oxidase, and 4-amino-phenazone (TAG), and cholesterol 
esterase, cholesterol oxidase, and 4-aminophenazone 
(Cholesterol); test kits for both assays were supplied by 
Roche (section 2.4 and 2.5 respectively). 
2. The method for retinyl palmitate analysis is based 
on the Reversed-Phase High-Performance Liquid Chromato- 
graphy procedure described by deRuyter and deLeenheer 
(1979), and modified by Ah-Sing et al. (section 2.2). 
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3. The kit used for TAG and T-C analysis in CM was 
also used for analysis of the same parameters in plasma. 
4. A radioimmunoassay technique was used in order to 
determine GIP levels in plasma (section 2.8). The method 
is described elsewhere (Morgan et al., 1978). 
5. A radioimmunoassay technique was used to determine 
the insulin levels in plasma. A kit was provided by Guild- 
hay, Antisera Ltd., and was used according to manufactu- 
rer's instructions (section 2.9). 
6. Apo A-I, and Apo B were determined by using the 
Cobas-Bio centrifugal analyser. The method is based on 
immuniturbidimetry, and is described by Mount et al., 
(1988) (section 2.6 and 2.7 respectively). 
7. The measurement of post-heparin LPL activity was 
undertaken by another investigator, and is based on a 
method of Nilsson-Ehle and Schotz (1976), modified by 
Knapper et al., (1993) (section 2.10). 
In order to minimise the possibility of systematic 
bias due to assay variability, all samples from one indivi- 
dual, for each of the three diets, were assayed on the same 
day and within the same assay run. 
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5.4. STATISTICAL ANALYSIS 
An SPSS-PC programme was used in an IBM compatible 
computer in order to perform the statistical analysis of 
the data. Comparisons of CM and plasma lipoprotein, apoli- 
poprotein and hormone responses to the three meals were 
carried out using: (i) an analysis of variance repeated 
measures test, and (ii) by calculation of incremental areas 
under the response curves, with analysis of variance used 
to test for differences in response to the three meals, and 
Duncan's range test used to locate and assess the level of 
significance of any differences found. All parameters 
studied were shown to be normally distributed. p<0.05 was 
accepted as the level of statistical significance. 
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5.5. RESULTS 
5.5.1. FASTING LEVELS OF METABOLITES AND HORMONES 
Fasting lipid, hormone, and apolipoprotein levels were 
found to be similar on each of the study days (Table 5.6), 
which suggests that the volunteers were reliable and did 
not alter their habits during the period of the study. 
5.5.2. PLASMA TRIACYLGLYCEROL 
Postprandially, plasma-TAG levels showed a biphasic 
response (Table 5. a, in appendix IV, and Figure 5.3). 
Statistical analysis of the data showed that the post- 
prandial TAG incremental area under the curve was signifi- 
cantly lower (p<0.05), following the fish oil meal, than 
plasma TAG responses following the mixed oil test meal 
(Figure 5.4). 
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The most marked TAG responses to the test meal were 
observed following the mixed oil meal, where sharp peak 
responses were seen at 60, and 300 minutes postprandially 
(1.41±0.20 mmol/1,1.63±0.5 mmol/1 respectively). After 
the fifth hour, TAG levels started falling, and they 
reached their lowest value at the last time point (0.98±0.2 
mmol/1). In response to the corn oil, there was an in- 
crease in TAG levels until the fourth hour, then TAG levels 
remained almost constant until the sixth hour, and then 
they started increasing again, reaching their highest value 
at 420 minutes (1.44±0.7 mmol/1). From that time point the 
levels started dropping until the last time point where 
they reached the value of 0.8±0.1 mmol/1. TAG values 
following the fish oil meal, showed a markedly attenuated 
response compared with the other meals. TAG values reached 
their peak at 60 minutes (1.20± 0.4 mmol/1), they remained 
fairly constant thereafter, until the seventh hour post- 
prandially, and from that time point they started decrea- 
sing, and reached their lowest level at the last time point 
(0.60±0.20 mmol/1). 
5.5.3. CHYLOMICRON-TRIACYLGLYCEROL 
Preprandial, and postprandial CM-TAG concentrations 
are given in Table 5. b, in appendix IV, and shown graphi- 
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Fig. 5.3 Postprandial plasma TAG responses to meals of 
different fatty acid compositions (mean+/-SEM, n-11) 
PLASMA TRIACYLGLYCEROL (mmol/I) 
100 200 300 400 
TIME (min) 
500 600 
mixed oil "ý" corn oil -ý- fish oil 
700 
Fig. 5.4 Postprandial plasma TAG responses to meals of 
different fatty acid compositions (mean+/-SD, n 11) 
___ 
PLASMA TAG INCREMENTAL AREA UNDER THE CURVE(mmol/I x min. ) 
svv 
mixed oil corn oil 
TEST OIL IN THE MEAL 
" p<0.05 compared with lieh oil 
fish oil 
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cally in Figure 5.5. Postprandial CM-TAG levels showed a 
biphasic response following consumption of each of the 
meals, with peaks observed at both one and five hours after 
the consumption of each meal (Figure 5.5). The presence of 
two distinct peaks was most marked following the mixed 
oil, and least following the fish oil test meal. Essen- 
tially, the same pattern of response was seen in the CM as 
in the plasma fraction with highest response to mixed oil 
and lowest response to fish oil meal. 
Analysis of variance repeated measures and calculation 
of incremental areas under the curve failed to show any 
statistical significance in the total CM-TAG response 
between the three meals (Figure 5.6). 
5.5.4. RETINYL PALMITATE 
Retinyl palmitate began to be detected in the CM 
samples approximately three hours after the consumption of 
each test meal (Table 5. c, in appendix IV, and Figure 5.7). 
Statistical analysis of the results showed there was no 
significant difference in CM-retinyl palmitate clearance 
between the three meals, using analysis of variance re- 
peated measures. Comparison of areas and incremental areas 
under the retinyl palmitate response curves, also showed no 
significant differences for the three meals. 
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Fig. 5.5 Postprandial CM-TAG responses to meals 
of different fatty acid compositions (mean+/-SEM, n 11) 
CM-TAG (mmol/I) 
3r 
100 200 300 400 
TIME (min) 
500 600 700 
x mixed oil -6- corn oil - fish oil 
Fig. 5.6 Postprandial CM-TAG responses to meals of 
different fatty acid compositions (mean+/-SD, n 11) 
CM-TAG INCREMENTAL AREA UNDER THE CURVE(mmol/I x min. ) 
mixed oil corn oil 
TEST OIL IN THE MEAL 
fish oil 
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S. S. S. POST-HEPARIN LIPOPROTEIN LIPASE 
Postprandial post-heparin LPL activity levels are 
shown in Table 5. d, in appendix IV, and in Figure 5.8. 
Despite the large inter-personal variations, LPL activity, 
12 hours following the fish oil meal, was found to be 
significantly higher than that following the mixed oil 
meal, for 15 minute sample taken after injection of heparin 
(p< 0.01). LPL activity following the corn oil meal was 
not significantly different to LPL activities following the 
mixed and fish oil meals at both 5 and 15 minutes post- 
heparin. 
5.5.6. PLASMA GIP 
Postprandial GIP levels are given in Table 5. e, in 
appendix IV, and illustrated in Figure 5.9. Plasma GIP 
response to the three test meals was similar with no signi- 
ficant differences shown by the statistical analysis. 
It is interesting to note that a moderate biphasic GIP 
response to meal ingestion was observed with an early peak 
at 60 minutes and a later peak at 180 minutes. As in the 
case of the plasma and CM-TAG responses, the biphasic 
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Fig. 5.7 Postprandial distribution of CM-retinyl palmitate 
after meals containing retinyl palmitate (mean+/-SEM, n=11) 
CM-RETINYL PALMITATE (ug/ml) 
2r 
1.5 
1 
0.5 
100 200 300 400 
TIME (min) 
500 
mixed oil 1- corn oil -- fish oil 
600 700 
Fig. 5.8 Effect of dietary fatty acid composition on 
post-heparin lipoprotein lipase activity (mean+/-SEM, n=11) 
250 LPL(nmol oleate released/min/ml plasma) 
5 15 
O mixed oil 
p'O. 01 compared with fish oil (15 minutes) 
5 15 
TIME (min) 
I 
5 
corn oil fish oil 
15 
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nature of the response was most marked in response to the 
mixed oil meal and least in response to the fish oil meal. 
5.5.7. PLASMA INSULIN 
Preprandial and postprandial insulin levels are given 
in Table 5. f in appendix IV, and illustrated in Figure 
5.10. Insulin responses were similar between the three 
test meals and no significant differences were observed. 
5.5.8. PLASMA CHOLESTEROL 
Postprandial plasma total cholesterol (T-C) levels 
remained fairly constant throughout the eleven hour period 
and, moreover, no statistically significant differences 
were observed between the three groups. Preprandial and 
postprandial T-C levels are given in Table 5. g, in ap- 
pendix IV, and in Figure 5.11. The two preprandial T-C 
levels (at -10, and o minutes) were approximately similar, 
and furthermore, from the postprandial plasma T-C levels 
observed, it is clear that there was no response in T-C to 
the three test meals. T-C levels ranged from 3.42±0.39 
mmol/1 to 3.92±0.58 mmol/l, following the mixed oil meal, 
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Fig. 5.9 Postprandial GIP responses to meals of 
different fatty acid compositions (mean+/-SEM, n-11) 
GIP (pmol/I) 
400 r 
300 
200 
100 
011II 
0 100 200 300 400 500 600 700 
TIME (min) 
-- ' mixed oil -0 corn oil --e fish oil 
Fig. 5.10 Postprandial insulin responses to meals of 
different fatty acid compositions (mean+/-SEM, n"11) 
INSULIN (mU/1) 
100 200 300 400 
TIME (min) 
500 
mixed oil ý corn oil fish oil 
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from 3.32± 0.68 mmol/1 to 3.93± 0.53 mmol/l, following the 
corn oil meal, and from 3.48± 0.58 mmol/1 following the 
fish oil meal. 
5.5.9. CHYLONICRON-CHOLESTEROL 
The CM-CHOL levels remained fairly constant throughout 
the eleven hours (Table 5. h in appendix IV, and Figure 
5.12). The preprandial levels were also similar. No 
significant differences in CM-CHOL concentrations were 
observed following the three test meals. 
5.5.10. SERUM APOLIPOPROTEIN A-I 
Preprandial and postprandial apo A-I levels are given 
in Table 5. i, in appendix IV, and in Figure 5.13. The 
results obtained in this study failed to show any stati- 
stically significant difference in the apo A-I levels in 
response to the three test oil meals. There was no change 
in response to the test meals, with fasting (Table 5.6), 
and postprandial levels very similar in all study days. 
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Fig. 5.11 Postprandial plasma cholesterol responses to meals 
of different fatty acid compositions (mean+/-SEM, n=11) 
PLASMA CHOLESTEROL (mmol/I) 
5r 
4 
3 
2 
1 
oll1I 
0 100 200 300 400 500 600 700 
TIME (min) 
mixed oil -0 - corn oil fish oil 
Fig. 5.12 Postprandial CM-cholesterol responses to meals of 
different fatty acid compositions (mean+/-SEM, n 11) 
CM-CHOLESTEROL (mmol/I) 
1.6 r 
1.4 
1.2 
0.8 
0.6 
0.4 
0.2 
"- 
0 100 200 300 400 
TIME (min) 
500 
mixed oil 0 corn oil 6 fish oil 
600 700 
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5.5.11. SERUM APOLIPOPROTEIN B 
Preprandial as well as postprandial apo B levels are 
given in Table 5. j in appendix IV, and in Figure 5.14. No 
differences in response to the three meals were observed 
and there was also no change in apo B in response to any of 
the test meals. 
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Fig. 5.13 Postprandial apolipoprotein A-I responses to 
meals of different fatty acid compositions (mean+/-SEM, n 11) 
APOLIPOPROTEIN A-I (mg/dI) 
180 - 
160 
140 
120 
100 
80 
60 
40 
20 
0 
0 100 200 300 400 
TIME (min) 
500 
mixed oil -G- corn oil ý, fish oil 
600 700 
Fig. 5.14 Postprandial apolipoprotein B responses to meals 
of different fatty acid compositions (mean+/-SEM, n-11) 
APOLIPOPROTEIN B (mg/dI) 
100 r 
80 
60 
40 
20 
0 
0 100 200 300 400 
TIME (min) 
500 
mixed oil e corn oil -ý- fish oil 
600 700 
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5.6. DISCUSSION 
The rationale for undertaking this study was the 
interest in comparing the blood lipid and hormone responses 
of male human subjects, under normal physiological condi- 
tions, to test meals of different fatty acid compositions. 
The most important findings of this study can be 
summarized as follows: 
- lower postprandial plasma TAG response to the fish 
oil test meal than to the mixed oil test meal (p<0.05), 
- higher post-heparin LPL activities at twelve hours 
after the test meal in response to the fish oil than the 
mixed oil meal (p<0.01), and 
- no significant difference in CM particles clearance, 
measured by the RP clearance, in response to the three test 
meals. 
Apart from the findings mentioned above, which will be 
discussed later, a few other interesting observations can 
also be made: 
- the pattern of CM-TAG response to the test meals was 
similar to the plasma-TAG response. TAG values reached a 
peak at 60 minutes postprandially, for both plasma and CM 
and a second more marked and prolonged peak occur d between 
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300 and 360 minutes after the beginning of the meals. Both 
fractions, therefore, exhibited a biphasic response. 
Furthermore, there was a strong trend towards lower CM-TAG 
responses to the fish oil meal than to the mixed oil meal, 
- there was no change in either plasma-, or CM- chole- 
sterol concentration in response to the three test meals, 
- plasma GIP as well as plasma insulin levels peaked 
at the same time (60 minutes); however, GIP returned to 
fasting levels more slowly than did the insulin values (540 
min. (GIP), versus 300-360 min. (insulin)]. Furthermore, 
baseline (early evening) preprandial GIP levels were much 
higher than the morning fasting GIP levels and this can be 
explained by the fact that the subjects were in a late 
postprandial state, before consumption of the meal. It is 
interesting to note that there was a moderate biphasic 
pattern of GIP secretion similar to the TAG response 
pattern, and 
- apolipoproteins did not show any change in con- 
centration in response to the % test meals. 
The mechanisms underlying the effect of dietary fatty 
acid composition on plasma TAG clearance needs explanation. 
In order to answer these questions it is important to con- 
sider the processes involved in the absorption of dietary 
fat and the factors which determine its clearance from the 
circulation. Lower postprandial TAG levels following con- 
sumption of meals containing fish oils could be because of: 
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- reduced rate of absorption and/or re-synthesis of 
TAG rich in n-3 fatty acids in the enterocyte, 
- increased rate of clearance of n-3 containing plasma 
TAG, 
- decreased VLDL synthesis and/or secretion from the 
liver and, thereby, reduced competition for clearance 
between endogenous and dietary fat, and 
-a combination of the reasons stated above. 
Some workers believe that a good indicator of the rate 
of absorption and re-esterification of dietary fatty acids 
in the enterocyte is the time of appearance of RP in the 
circulation, and, as a consequence, the presence of CM-TAG. 
In the present study, RP levels started rising three hours 
after the meal, and they were not present at all, at 60 
minutes postpradially. Therefore, the pattern of RP levels 
measured in this study could lead to the conclusion that 
TAG from the meals under investigation, did not enter the 
circulation before the third hour after the beginning of the 
meal when RP levels began to rise. It could also be seen 
that there was a trend towards a lower RP levels in re- 
sponse to the mixed than to the corn and fish oil test 
meals in the early postprandial stage which could suggest 
reduced absorption of SFA versus PUFA. However, there are 
certain points to be considered as far as the reliability 
and the accuracy of the use of RP, both as a marker for 
dietary TAG entry and as a marker for CM particle 
clearance. Firstly, Krasinski et al. (1990), suggested 
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that there may be a slower rate of RP absorption compared 
with dietary TAG absorption which automatically makes the 
RP measurement an unreliable indicator of the rate of 
dietary TAG absorption. Secondly, in our laboratory we 
found that the intra-assay variation at low concentrations 
of RP is high (32.1% at RP levels less than 0.2 gg/ml), so 
that detection of possible differences at the early and 
late postprandial stages, when concentrations found are in 
this low range, could prove to be very difficult. 
It is important to note the occurrence of a higher peak 
in plasma- and CM-TAG at 60 minutes after the consumption 
of the mixed oil than the corn and fish oil meals. Bottino 
et al. (1967), suggested that the configuration of TAG con- 
taining n-3 PUFA's could prevent their interaction with 
lipolytic enzymes (in this case pancreatic lipase), via 
steric hinderance. They showed that the in vitro hydro- 
lysis of whale oil TAG by pancreatic lipase was delayed. 
However, the same authors mentioned that in whale oil, the 
n-3 PUFA's are present in 1- and 3- positions of the TAG 
molecule whereas in fish oil, they are in the position 2-. 
Since, therefore, pancreatic lipase is only active in 1-, 
and 3- positions, this observation may have little rele- 
vance in the present study. Moreover, although Chen et al. 
(1987), reported slower absorption rates of fish oil than 
corn oil, when these oils were infused in rat models, Cher- 
nenko et al. (1989), failed to show any difference between 
the absorption of fish and vegetable oil using the same 
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model. However, the in vitro studies cannot completely 
mimic the in vivo conditions in which other factors, such 
as enzymes and gastrointestinal hormones, are also involved 
in fat absorption. Another possible reason for lower TAG 
levels in the first hour in response to fish oils, could be 
inhibition of resynthesis of TAG, during the formation of 
CM in the enterocyte. It has already been observed that n- 
3 PUFA's inhibit TAG synthesis in the liver via their 
effects on diacylglycerol acyltransferase (Rustan et al., 
1988a). Since this enzyme is also the key enzyme in TAG 
resynthesis in the enterocyte, during fat absorption, it 
could be suggested that inhibition of resynthesis of TAG 
rich in n-3 PUFA's in the enterocyte could be due to a 
possible effect of these fatty acids on diacylglycerol 
acyltransferase. However, Harris, (1989), mentioned that 
effects of n-3 fatty acid intake on enterocyte TAG re- 
synthesis is unlikely to become apparent in postprandial 
TAG levels after a single test meal, and is only likely to 
be an important factor in determining postprandial lipaemia 
after chronic treatment with fish oil. Therefore, the 
possibility that the resynthesis process could have been 
inhibited by the fish oil, present in one of the test meals 
may not be an adequate explanation. The cause of the rise 
in TAG levels at 60 minutes in both plasma and CM and the 
reason needs explanation. A possible reason could be a 
better mobilisation and entry into circulation of already 
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existing CM from the previous meal, a response which was 
more marked following the mixed oil test meal. 
A further explanation for the overall lower post- 
prandial TAG levels observed in response to the fish oil 
test meal could be increased clearance due to an increase 
in the rate of lipolysis, via LPL activity, or from facili- 
tation of the interaction of the CM, rich in n-3 PUFA's, 
with this enzyme, or from greater interaction of CM with 
LPL due to reduced substrate competition from VLDL. 
The results of the present study support the first 
possibility, since higher levels (p<0.01), of post-heparin 
LPL activity were observed following the fish oil than 
following the mixed oil test meal, even twelve hours after 
the beginning of the meal. In contrast, Harris et al. 
(1988), reported no effect of a fish oil diet on the LPL 
activity of post-heparin plasma. However, post-heparin 
lipolytic activity was determined in fasting plasma samples 
in the Harris study (blood samples were collected before 
the fat tolerance tests). As far as the second possibility 
is concerned, Chen et al. (1987b), reported no effect of n- 
3 PUFA's on the rate at which CM are catabolised in vitro, 
and in vivo, using rats as their model. However, Demacker 
et al. (1991), reported that CM produced on a diet rich in 
SFA's appear to be poorer substrate for LPL in vitro, and 
are catabolized more slowly in vivo than CM produced on a 
diet rich in PUFA's. Similarly, recent studies in rats, 
have suggested that not only the composition of dietary 
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fat, but also the structure of TAG could affect CM clear- 
ance (Mortimer et al., 1988; Redgrave et al., 1988). LPL 
acts primarily in 1- and 3- positions of the TAG molecule. 
It is also mentioned that the melting point of 2-monoacyl- 
glycerol could affect the hydrolysis of TAG by LPL (Red- 
grave et al., 1988). Fish oils are rich in EPA and DHA in 
sn-2 position, corn oil is rich in linoleic acid, and the 
mixed oil used in this study was rich in lauric acid and 
palmitic acid, both having melting points well above the 
body temperature. Therefore, the CM rich in 2-mono- 
palmitin, or 2-monolaurin could become rigid and expel LPL 
from its surface, which could, as a consequence, decrease 
the rate of TAG clearance in the mixed oil group. As far 
as the third possibility is concerned (greater interaction 
of CM with LPL due to reduced substrate competition from 
VLDL), there are numerous studies which provided evidence 
that fish oils may reduce VLDL-TAG synthesis and/or secre- 
tion. (Harris et al., 1984; Nestel et al., 1984; Sanders 
et al., 1985; Conor, 1986). In the present study, there is 
an indication that the synthesis and/or secretion of VLDL- 
TAG may have been inhibited, from the fourth hour after the 
begining of the meal, by the fish oil, since plasma TAG 
levels are higher following the mixed oil than following 
the fish oil meal; therefore, the possibility of greater 
interaction of CM with LPL due to reduced substrate compe- 
tition from VLDL cannot be ruled out entirely. One point, 
however, suggests that this possibility should be consi- 
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dered critically: in order that the reduced-VLDL competi- 
tion mechanism could explain the reduced postprandial 
lipaemia, it should have to be assumed that LPL, is 
approximately saturated at TAG levels of 1.5 mmol/l (since 
these were the peak levels found in the present study), and 
it becomes less saturated at 1.0 mmol/l. However it has 
been reported that LPL does not approach saturation until 
levels of 5 mmol/l are reached. (Brunzell et al., 1973). 
In summary, the present study showed that postprandial 
plasma-TAG response levels were lower following the fish 
than to the mixed oil test meal (p<0.05); a possible reason 
for this was the increased post-heparin LPL lipolytic acti- 
vity which was observed in response to the fish oil test 
meal (p<0.01). 
In order to investigate possible mechanisms which 
could affect LPL activity, postprandial GIP and insulin 
levels were observed in response to the three test meals. 
GIP, a gastrointestinal hormone, the secretion of which is 
affected by dietary fat composition, and which stimulates 
directly (Knapper et al., 1993), and/or indirectly (via 
stimulation of insulin secretion), LPL activity, did not 
show different responses to the three test meals, which can 
also explain the fact that the peak insulin levels were 
similar in all the three groups. 
Studies showed that insulin can stimulate LPL activity 
in adipose tissue in a dose- and time-dependent manner for 
up to six hours (Sadur and Eckel, 1982). Therefore, high 
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LPL levels after twelve hours from a meal may not be due to 
insulin stimulation, since insulin returned to fasting 
levels approximately five hours after the beginning of each 
meal. In addition, adipose tissue LPL remains stimulated 
during the fed state. In the present study, LPL was 
measured twelve hours after the meal, a fact which makes it 
very unlikely that this activation of LPL represents 
insulin stimulation. Other investigators have failed to 
detect any changes in post-heparin LPL after treating 
animals or humans with fish oils (Harris et al., 1988; Huff 
and Telford, 1989). Herzberg and Rogerson (1989), reported 
an increase in LPL in the skeletal muscle and heart, but 
not in adipose tissue of rats fed fish oil compared with 
corn oil and tallow. It can be assumed that since adipose 
tissue LPL was not altered with fish oil, its contribution 
to post-heparin LPL may have masked any changes in muscle 
LPL (Herzberg, 1991). The findings of the present study do 
not support entirely this idea but they could support the 
possibility that, since muscle LPL is more active in fasted 
state and the subjects were in their fasted state when the 
blood sample for assaying LPL was taken, the increase in 
muscle LPL activity following the fish oil meal could have 
been so pronounced that it was detected in spite of pos- 
sible no change in adipose tissue LPL activity. 
Furthermore, by accepting the possibility of a 
decrease in TAG synthesis in the liver, following the fish 
oil test meal, another mechanism for shortening the resi- 
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dence time in the circulation can also be accepted: a de- 
creased VLDL particle size (poor in TAG), could be the 
reason for these dense particles to leave the VLDL density 
range faster than normal VLDL, simply by entering the cir- 
culation at a smaller size (Harris, 1989). 
CM-TAG postprandial levels were higher following the 
mixed oil than following the fish oil test meal but they 
did not reach statistical significance. However, CM-TAG 
values were more variable than plasma TAG and this almost 
certainly reflects the imprecision of the method, used for 
the separation of CM fraction. Ultracentrifugation cannot 
completely separate CM and VLDL particles so that VLDL-TAG 
may have been present in the supernatant, and CM-TAG could 
have been lost into the infranatant, since good separation 
of the CM fraction depends on the ability of the investi- 
gator to effectively remove the CM fraction. The RP 
results also suggest that CM particles (CM and CM-R) do not 
seem to clear faster in response to fish oil since the 
distribution of RP in CM after the three test meals was 
almost the same. However, the RP assay is subject to 
further critisism, firstly because of the high variability 
of the results, and secondly because of the fact that RP 
can be found up to nine or more hours after fat ingestion 
in other lipoprotein particles (Berr and Kern Jr., 1984; 
Krasinski et al., 1990). We tried to overcome the problem 
of the RP exchange between other lipoprotein fractions, by 
isolating a CM fraction and assaying RP only in the CM 
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fraction. However, as it has already been mentioned, it 
cannot be certain that the CM fraction isolated was not 
contaminated with other lipoprotein particles. Further- 
more, it is almost certainly not the case that all CM-R 
were isolated in the CM fraction which was measured here. 
Thus, this study has not been able to measure CM and/or CM- 
R clearance with any degree of certainty, and other 
approaches are necessary to shed further light on effects 
of dietary fatty acids on the clearance of CM particles as 
opposed to their effects on CM-TAG. 
Finally, cholesterol and apolipoprotein levels were 
not affected by the consumption of the test meals, since 
postprandial levels were similar to their fasted values. 
The findings of this study tend to support the findings of 
Lardinois et al. (1988), who reported similar T-C levels 
following tolerance test meals with fats derived from satu- 
rated (cocoa butter), monounsaturated (olive oil), or poly- 
unsaturated (corn oil, and fish oil) sources. However, in 
some other studies, an effect on T-C and apolipoproteins 
was observed, but that was due to high fish oil composition 
of the background diet (Harris et al., 1990; Weintraub et 
al., 1988). 
As a conclusion, this study supports the view that n-3 
fatty acids reduce postprandial lipaemia, since lower post- 
prandial plasma- levels were observed following a meal rich 
in n-3 fatty acids compared with a mixed fatty acid meal. 
An increase in post-heparin LPL was also observed following 
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the fish oil meal, which indicates that one reason for the 
lower TAG values was an increase in the rate of their 
hydrolysis by LPL. However, the mechanisms responsible are 
not completely clear. A decrease in TAG synthesis and/or 
TAG secretion by the liver or decrease rate of CM-TAG 
synthesis in the enterocyte cannot be ruled out either. 
However, the results suggest that the effects are not 
mediated by hormone mechanisms since GIP and insulin levels 
did not differ following the meals under investigation. 
Further work needs to be done in numerous areas concerning: 
- postprandial effects of fish oils in TAG synthesis 
and VLDL secretion by the liver, 
- investigation of the reasons for the early plasma- 
and CM-TAG peaks observed in this study. This could in- 
clude measurement of the fatty acid composition of the CM- 
TAG for the early and late peaks in response to meals of 
different fatty acid composition, 
-a more detailed study of effects of fish oils on LPL 
activity, 
-a development of a more reliable and valid method 
than RP assay, in order to assess the time of entry of CM 
into the circulation, and to determine the CM and CM-R 
clearance rates. 
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CHAPTER 6 
EFFECT OF DIETARY 
FATTY ACID COMPOSITION ON 
IN VITRO EX VIVO 
HEPATIC LIPOGENESIS AND 
POSTPRANDIAL LIPID AND 
HORMONE RESPONSES 
IN RATS 
6.1. INTRODUCTION 
From the results obtained in previous chapters 
(Chapters 3 and 5), it becomes apparent that the most pro- 
found effect of fish oil administration is the decrease in 
fasting and postprandial TAG levels observed in normal 
human subjects. In Chapter 3, fasting and postprandial TAG 
responses to standard test meals were found to be reduced 
significantly when normal subjects were given fish oil 
supplements for six weeks. In Chapter 5, the postprandial 
TAG response to a test meal rich in fish oil was found to 
be significantly lower than the postprandial TAG response 
to a meal which was rich in saturated fatty acids. In both 
studies, the reduction in postprandial response was most 
apparent in the late postprandial phase (between 180 and 
420 minutes postprandially). Numerous studies support the 
view that the most profound effect of n-3 PUFA on plasma 
lipid levels is a decrease in TAG concentrations (Sanders 
et al., 1983; Harris et al., 1988a; Deck and Radack, 1989; 
Harris, 1989; Connor and Connor 1990). In the case of n-6 
PUFA's, although researchers have shown a decrease in T-C 
and LDL-C concentrations, when these fatty acids are 
substituted isocalorically for SFA's, effects on TAG, VLDL- 
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C, and HDL-C are not found to be consistent (Ahrens et al., 
1957; Shepherd et al., 1980). Thus, the metabolic effects 
of n-3 PUFA appear to be quite distinct from those of the 
n-6 PUFA and further studies are required to elucidate the 
different pathways in the metabolism of these two classes 
of PUFA. 
One of the possible mechanisms which could influence 
both plasma fasting and postprandial TAG levels is the rate 
of hepatic lipid synthesis. The liver plays a major role 
in lipid metabolism. In humans, it is the major site of 
fatty acid synthesis from acetyl-CoA, and these provide the 
acyl groups for synthesis of VLDL-TAG, the major circula- 
ting source of endogenous TAG. 
Numerous studies have been conducted in animals in 
order to investigate the effects of saturated versus 
polyunsaturated fatty acids on hepatic lipid synthesis. 
Many studies have been carried out in vivo so that results 
obtained reflect all possible influences on rates of 
hepatic lipogenesis, including the circulating concentra- 
tions of lipogenic hormones, and prevailing nutritional 
conditions (Triscari et al., 1978; Wong et al., 1984; 
Nassar et al., 1986; Strum-Odim et al., 1987; Herzberg and 
Rogerson, 1988; Lakshman et al., 1988; Yeo and Holub, 
1990). Others have studied hepatic lipogenic rates in 
vitro, and have therefore measured the net capacity for 
lipid synthesis under standardised incubation conditions 
with varying fatty acids as substrates (Yang and Williams, 
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1978; DeSchrijver and Privett, 1982; Wong et al., 1985; 
Nossen et al., 1986; Strum-Odim et al., 1987; Wong and 
Nestel, 1987; Rustan et al., 1988a and b; Lang and Davis, 
1990). All the studies mentioned above, support the 
conclusion that dietary fish oils, or n-3 PUFA's, decrease 
hepatic TAG synthesis and/or secretion. The only exception 
to this is the in vivo study of Lakshman et al. (1988), 
which reported a decrease in liver cholesterol, but not TAG 
synthesis, in rats fed fish oils, compared with those fed 
a control diet over a period of six weeks. Many of the in 
vivo studies have been concerned with comparing effects of 
different types of dietary oils (tallow, safflower oil, 
corn oil, fish oil), on hepatic lipogenesis. In vitro 
studies have included investigations of different fatty 
acids (palmitic, oleic, linoleic, EPA, and DHA) on lipid 
synthesis in cultured hepatocytes, and have studied effects 
of varying amounts of the fatty acids added to the incuba- 
tion media. However, there have been few studies which 
have investigated rates of lipogenesis in vitro, in liver 
obtained from animals previously fed different dietary oils 
(in vitro ex vivo studies). Therefore, it is difficult to 
distinguish at present, effects of n-3 PUFA which may be 
due to differing effects of these fatty acids on hormone 
secretions and on the metabolism of circulating lipids by 
other tissues, e. g. adipose tissue. In addition, most of 
the existing studies, which have investigated effects of 
dietary fatty acids on in vivo rates of hepatic lipoge- 
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nesis, have not placed sufficient emphasis on the need to 
ensure comparable rates of food intake in the different 
dietary groups. Therefore, a pair-feeding study is needed 
in order to exclude any possible interference of altered 
food consumption on lipid synthesis. This is particularly 
important because a number of studies have commented on the 
fact that animals find fish oils unpalatable. Finally, 
most studies of effects of dietary fatty acid composition 
on hepatic lipogenesis, have been conducted only on animals 
fasted overnight. Since animals such as rats are nocturnal 
feeders, this means that most studies have been conducted 
on animals fed very limited amounts of food over the 
previous 24 hours. A study in which animals are in the 
fed-state is needed to determine whether effects of n-3 
PUFA are seen in fed as well as fasted animals. There is 
a lack of animal studies which have investigated hepatic 
lipogenesis in the postprandial state. Such studies may be 
particularly important for interpreting the data for 
effects of fish oils on plasma postprandial TAG levels in 
human subjects. 
In addition to the need for studies to be conducted in 
the fed state, which is the important state for hepatic TAG 
synthesis and VLDL secretion, there is also a need to study 
effects of dietary fatty acid intake on the response of 
hepatic lipid synthesis to the major lipogenic hormones. 
Although previous chapter (Chapter 5) has shown no effect 
of fish oil feeding on postprandial GIP and insulin concen- 
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trations, it is possible that these dietary fatty acids may 
influence lipogenic response to hormone action. It is well 
known that insulin is the main regulatory hormone 
controlling hepatic VLDL production (Gibbons, 1990). How- 
ever, effects of insulin on hepatic lipogenesis have not 
been systematically studied in relation to possible 
influences of diet on the extent of insulin-stimulated 
lipogenesis. Robinson et al. (1978), suggested that 
insulin may be the regulator of lipogenesis in the rat 
mammary gland, and Sadur and Eckel (1982), reported a 
stimulation of adipose tissue LPL activity in humans due to 
insulin stimulation. Notably, Begum et al. (1982), 
observed fat-feeding effects on the adipocyte plasma 
membranes, which are involved in the generation of the 
insulin-dependent activation of pyruvate dehydrogenase. 
These authors showed a decrease in insulin binding 
following consumption of high-fat diets, and concluded this 
may be secondary to altered membrane fatty acid composi- 
tion. Sun et al. (1977), also observed an apparent 
reduction in the number of insulin binding sites associated 
with fat-feeding as compared to glucose feeding, which was 
responsible for the reduced insulin binding to membranes 
from rats fed the high-fat diet. Thus, although insulin is 
classicaly accepted as the main hormone regulator of 
hepatic lipogenesis, the nature and extent of its effects 
in vivo and in vitro appear to be dependent upon the 
dietary state of the animal (in vivo) or the precise 
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incubation conditions (in vitro). 
Bottomley and Garcia-Webb (1987), pointed out that 
even though insulin stimulated lipogenesis in isolated rat 
hepatocytes, the choice of substrate used may be an 
important factor in determining the level of response 
measured. Some workers have suggested that insulin may 
suppress VLDL secretion; for example, Durrington et al. 
(1982), observed a reduced rate of VLDL-TAG secretion 
accompanied by an increase in cellular TAG, after addition 
of insulin to medium containing rat hepatocytes, but 
Pullinger and Gibbons (1985), suggested that the rate of 
hepatic VLDL-TAG secretion is not necessarily coupled to 
the rate of de novo lipogenesis. Furthermore, although 
Witters et al. (1979), reported an insulin stimulated 
acetyl-CoA carboxylase in isolated rat hepatocytes, which 
showed equal responsiveness in either fasted or fed (low- 
fat, high-carbohydrate diet) states, Salati and Clarke 
(1986), showed that acetyl-CoA carboxylase was inhibited by 
FFA in hepatocytes, a condition which might be expected to 
prevail in the fasted animal. 
GIP, as it has already been mentioned, is stimulated 
by fat ingestion in man (Falko et al., 1975). It is also 
shown that GIP inhibits glucagon-induced glycogenolysis in 
liver and potentiates the effects of insulin on incorpora- 
tion of fatty acids into TAG in adipose tissue (Beck, 
1989). Furthermore, Wasada et al. (1981), concluded that 
GIP exerts an effect upon the clearance of CM-TAG, since, 
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in GIP infused dogs, the rise in plasma TAG was signifi- 
cantly below that of control non-treated animals. Starich 
et al. (1985), found that adipocytes incubated with GIP 
developed increased insulin receptor affinity, and GIP po- 
tentiated insulin-mediated glucose uptake. Beck (1989), 
also suggested a possible mechanism by which GIP acts in 
adipose tissue through the facilitation of the passage of 
fatty acids through the adipocyte membrane. Data of Hart- 
mann et al. (1986), also suggest that GIP exerts direct 
effects on hepatic glycogen metabolism predominantly in a 
situation where insulin is simultaneously present. 
Furthermore, Beck and Max (1986), mentioned that insulin is 
necessary so that GIP-induced enhancement of fatty acid 
entry into the adipocyte be sufficient. These data demon- 
strate the interdependence of these hormones on one an- 
other's actions. On the other hand, Service et al. (1990), 
indicated that under conditions of hyperinsulinaemia and 
euglycaemia, GIP did not influence hepatic and extrahepatic 
insulin action. 
There have been no studies of effects of GIP, or GIP 
together with insulin on hepatic lipid metabolism despite 
the proposed central role of these hormones in the regula- 
tion of lipid homeostasis. It becomes apparent, from what 
has mentioned above, that there is a lack of research not 
only on effects of dietary oils on hepatic lipogenesis 
under controlled nutritional conditions, but also on 
effects of insulin, GIP, and the interaction of these 
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hormones on hepatic lipid synthesis. In particular, 
possible effects of GIP in hepatic lipogenesis and possible 
influence of GIP on insulin-stimulated lipid synthesis have 
not been studied. 
As a result, the present study was designed in order 
to: 
- compare the effects of three different dietary oils 
(corn oil, fish oil, and a mixture of oils replicating the 
U. K. dietary fatty acid intake), on hepatic lipogenesis in 
pair-fed rats, with tissue removed from animals in the 
postprandial state, 
- investigate effects of dietary fatty acid composi- 
tion, on plasma lipid (T-C, TAG), and hormone (insulin, 
GIP), concentrations, in animals in the postprandial state, 
- investigate possible stimulatory effects of insulin 
and GIP, separately and in combination, on hepatic lipoge- 
nesis under the dietary and nutritional conditions des- 
cribed above. 
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6.2. STUDY DESIGN 
6.2.1. ANIMALS 
6.2.1.1. PRELIMINARY STUDY 
In order to establish whether or not animals from 
different dietary groups consumed different amounts of 
diets, a preliminary study was carried out. Twelve adult 
male rats, of the Wistar Albino strain, were divided in 
three groups of four. They were housed in stainless steel 
cages and were allowed free access to water. The mean 
weights of animals on entry to the study were: 233.0±67.8 
g (mean±SD) , in the group fed the diet rich in saturated 
fatty acids (mixed oil group), 228.2± 31.4 g in the corn 
oil group, and 230.5±43.8 g in the fish oil group. Data 
from this study is presented in the results section. 
6.2.1.2. MAIN STUDY 
Thirty male Wistar Albino rats were randomly allocated 
into three groups of ten, and kept in stainless steel 
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cages, and allowed free access to water. The mean weight 
was 312.3±25.0 g (mean±SD) in the mixed oil group, 307.8± 
47.1 g in the corn oil group, and 300.5±44.1 g in the fish 
oil group. 
6.2.2. DIETS 
The following dietary conditions apply to both the 
preliminary and main study protocols. Each of the dietary 
groups consumed a 5% (w/w) fat semi-synthetic diet, pro- 
viding 10% of the energy from fat. The diets differed in 
their fatty acid composition, containing either a mixture 
of oils (42% saturated fatty acids, 43% monounsaturated 
fatty acids, and 16% polyunsaturated fatty acids, to mimic 
the U. K. current dietary composition of fatty acids), corn 
oil, or fish oil. The % compositions of the diets (w/w), 
were: 60% maize starch, 20% casein, 4% solca floc, 5% vita- 
min/mineral mixture, (supplied by Special Diets Services, 
Essex), 5% sucrose, 5% of the appropriate oil, and 0.2% 
methionine (Sigma Chemical Co., Poole, Dorset). The com- 
positions of the diets are tabulated in Table 6.1, the de- 
tailed fatty acid compositions in Table 6.2, and the com- 
position of the vitamin/mineral mixture is shown in Table 
6.3. 
As far as the preliminary study is concerned, rats 
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were fed ad libitum for the first week, and after observing 
TABLE 6.1 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
composition of the diets. 
Dietary 
component 
Mixed oil 
diet 
( loo) 
Corn oil 
diet 
( loo) 
Fish oil 
diet 
( 100 ) 
Starch 60.0 60.0 60.0 
Sucrose 5.0 5.0 5.0 
Casein 20.0 20.0 20.0 
Solka floc 4.0 4.0 4.0 
Coconut oil 1.1 --- --- 
Olive oil 1.1 --- 
Corn oil 0.6 5.0 --- 
Palm oil 2.2 --- --- 
Fish oil --- --- 5.0 
Methionine o. 2 0.2 0.2 
Vit/Min. mix 5.0 5.0 5.0 
a tendency towards lower food consumption in the corn oil 
group (Table 6. a in appendix V and Figure 6.1), the rats 
were pair-fed for one month, during which time the average 
food intake of the rats was identical (Table 6. a in 
appendix V, and Figure 6.2). It must also be mentioned at 
this point that the semi-synthetic diets did not cause any 
weight loses in the rats, and the average daily weight gain 
in the three dietary groups was approximately the same 
(Table 6. a in appendix V, and Figure 6.3). 
Since the results in the preliminary study indicated 
a consistent trend towards lower food consumption in the 
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corn oil group, the pair-feeding technique was used in the 
main study in order to assure that the food intake was 
TABLE 6.2 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
fatty acid composition of the diets (g/100g). 
Fatty acid Mixed oil 
diet 
corn oil 
diet 
Fish oil 
diet 
C12: 0 10.7 --- 
C14: 0 4.1 0.6 7.1 
C16: 0 24.7 14.0 17.5 
C18: 0 3.2 2.3 4.2 
C20: 0 0.5 0.3 --- 
C22: 0 --- --- --- 
C24: 0 --- --- --- 
C14: 1 --- --- 0.3 
C16: 1 0.6 0.3 9.9 
C18: 1 39.0 30.0 12.9 
C20: 1 --- 0.2 2.5 
C22: 1 --- 0.2 1.1 
C18: 2 12.0 50.0 4.2 
C20: 2 --- --- 4.4 
C18: 3 0.5 1.6 --- 
C20: 4 --- --- 1.6 
C22: 4 --- --- 1.2 
C20: 5 --- --- 18.2 
C22: 5 --- --- 2.1 
C22: 6 --- --- 12.8 
The dietary fatty acid composition was calculated using the 
food composition tables (Paul and Southgate, 1988). 
equal in all dietary groups. Three animals were randomnly 
allocated to each dietary group daily over a period of ten 
consecutive days, until all 30 animals were on one of the 
three diets. The animals were maintained on the experimen- 
270 
tal diet for two weeks. During the dietary period water 
was supplied ad libitum. Diets were prepared weekly and 
stored at 4°C. The food pots were changed daily, and daily 
TABLE 6.3 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
composition of the vitamin/mineral mixture 
Nutrient Concentration in 
diet 
Units 
Vitamin A 5.0 miu/kg 
Vitamin D3 1.0 miu/kg 
Vitamin E 25.0 g/kg 
Vitamin B2 5.0 g/kg 
Vitamin K 10.0 g/kg 
Nicotinic acid 10.0 g/kg 
Calcium 10.0 g/kg 
Pantothenate 
Polic acid 0.5 g/kg 
Vitamin B, 5.0 g/kg 
Vitamin B6 5.0 g/kg 
Biotin 20.0 mg/kg 
Vitamin B12 5.0 mg/kg 
Vitamin C 20.0 g/kg 
Inositol 100.0 g/kg 
Moline 100.0 g/kg 
P-Aminobenzoic 50.0 g/kg 
acid 
Potassium 5000.0 µg/kg 
Iron 50.0 g/kg 
Cobalt 0.5 g/kg 
Manganese 50.0 g/kg 
Copper 10.0 g/kg 
Zinc 20.0 g/kg 
Iodine 0.5 g/kg 
Magnesium 1000.0 pg/kg 
Sodium Chloride 5000.0 µg/kg 
Phosphorus 5000.0 µg/kg 
Calcium 7000.0 gg/kg 
According to manufacturers details. 
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Fig. 6.1 Preliminary hepatic Ilpogenesis 
study: average daily food intake of rata 
before pair-feeding (mean. /-SD, n"4) 
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Fig. 6.3 Preliminary hepatic Npogenesis 
study: average daily weight gain of pair 
fed rats (mean'/-SD, n"4) 
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Fig. 6.2 Preliminary hepatic Iipogenesis 
study: average daily food Intake of rats 
during pair-feeding (mean-/-SD, n-4) 
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food intakes, as well as weekly body weights, were recorded 
for all the animals. The average daily food intake in each 
dietary group, the average daily weight gain of rats and 
their average liver weights immediately after the sacrifice 
are illustrated in Figures 6.4,6.5 and 6.6 respectively, 
and given in appendix V in Table 6. b. 
6.2.3. PROCEDURE 
The study design is given in Figure 6.7. One rat from 
each dietary group was put on the diet each day for ten 
consecutive days. The dietary period lasted for two weeks. 
Apart from pair-feeding, the animals were also meal-fed on 
the evening prior to sacrifice in order to ensure that 
animals were in the fed state at the time of removal of the 
liver (09: 00 hours). This involved removing one animal 
from each dietary group, into a separate cage at 09: 00 
hours on the morning of the day prior to sacrifice. Food 
was given (equivalent to the total amount eaten for the 24 
hour period of the preceeding day) at 17: 00 hours for 
consumption during the night prior to sacrifice. The 
animals were anaesthetised under ether, and blood was taken 
by cardiac puncture. Blood samples were centrifuged at 
2500 rpm for 15 minutes, using a bench centrifuge, and the 
separated plasma was stored at -20°C for further analysis 
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Fig. 6.4 Main hepatic Upogenesis 
study: average dally food intake of pair 
fed rats (mean. /-SD, n-10) 
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Fig. 6.5 Main hepatic Iipogenesis 
study: average daily weight gain of pair 
led rats (means/-SD, n"10) 
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Fig. 6.6 Main hepatic lipogenesis 
study: average liver weights after 
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of cholesterol, TAG, insulin and GIP. After the blood 
collection, rats were sacrificed by cervical dislocation 
and the liver was dissected, weighed,, and put directly in 
incubation medium, which was kept at 37°C. Rates of basal, 
insulin (4 nM)-, GIP (6 nM)-, and insulin+GIP (4 nM+6 M)- 
stimulated [U-i4C) glucose incorporation in liver total 
lipids, and lipid subfractions (cholesterol, free fatty 
acids, TAG, and phospholipids) were assayed as described in 
Chapter 2 (sections 2.1.4 and 2.1.5). 
6.3. METHODS OF ANALYSIS 
Analysis of the following parameters was carried out: 
incorporation of [U-14C]glucose in liver total 
lipids, TAG, cholesterol, free fatty acids, and 
phospholipids, and 
plasma TAG, cholesterol, insulin, and GIP. 
The methods used for the analyses mentioned above, are 
described in detail in Chapter 2 (section 2.1). Briefly: 
After incubating (section 2.1.4) liver pieces (approx- 
276 
imately weighing 200 mg), with 1.5 gCi [U-'4Cjglucose for 3 
hours, at 37°C in a shaking water bath, under an atmosphere 
of 95% 02 and 5% CO2, using different incubation media 
(basal -no hormone present- 4 nM insulin, 6 nM GIP, and 4 
nM insulin +6 nM GIP), the Bligh and Dyer (1959) lipid 
extraction procedure was used to separate the lipids from 
the liver pieces (section 2.1.5). Radioactivity was 
measured in a beta radiation counter as described ( section 
2.1.5. ). 
TLC was used to separate the lipid classes (TAG, 
cholesterol, free fatty acids, and phospholipids), from the 
total lipids, using silica gel plates (0.25 mm), and a 
mobile phase of hexane/diethyl ether/acetic acid (80/20/1) 
(section 2.1.5). It has to be mentioned at this point that 
even though the mobile phase was the appropriate one for 
the separation of the lipid classes, and had achieved good 
separation in the validation experiments (Chapter 2), 
during the period of this experimental dietary study, 
separation of lipid classes was not optimal. In particular 
the phospholipid fraction remained at the origin and 
although this spot was removed and counted, the data 
obtained should be interpreted cautiously, since some 
contamination from the aqueous phase as well as from a 
small fraction of the other lipid classes, may also 
contribute to the counts measured here. The difficulties 
with the TLC separation were subsequently thought to be due 
to the high laboratory temperature at the time of the study 
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which may have caused evaporation of the mobile phase. 
Automated enzymatic colorimetric tests were used to 
determine plasma TAG and cholesterol concentrations 
(chapter 2, sections 2.4 and 2.5 respectively). 
Plasma immunoreactive insulin was measured by a double 
antibody radio immunoassay technique (section 2.9), using 
antiserum supplied by Guildhay Antisera (Guildford Surrey). 
A crystalline mouse/rat insulin standard was used (Novo 
Industria, Copenhagen). It was reconstituted to 1 mg/ml in 
0.4 M phosphate buffer (pH 7.4), and 150 gl aliquots were 
frozen to -20°C until use. On the day of the assay, the 
standard was defrosted and diluted to give a top standard 
of 200 ng/ml and serially diluted, as described in section 
2.9.2. 
Plasma immunoreactive GIP was measured by a double 
antibody radioimmunoassay technique (section 2.8) using 
antiserum which was raised against natural porcine GIP 
(Morgan et al., 1978). 
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6.4. STATISTICAL ANALYSIS 
Tabulated results are presented as mean values and 
standard deviations. Data in Figures are given as mean 
values with their standard errors to facilitate clarity of 
presentation. 
Comparisons of rates of lipogenesis and of lipid and 
metabolite concentrations, between the three dietary groups 
were carried out and differences between groups identified 
using analysis of variance, and the Duncan's range test was 
applied to locate and assess the level of significance of 
any differences found. In the case of the lipogenesis 
measurements, logarithmic transformation was carried out to 
normalize data distribution since the heteroscadacity for 
some of the measures was unacceptably high. Ap value 
lower than 0.05 (p<0.05), was taken as the lowest level of 
statistical significance. 
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6.5. RESULTS 
6.5.1. INCORPORATION OF (U-14C]GLUCOSE INTO HEPATIC 
TOTAL LIPIDS 
Incorporation of [U-14C]glucose in hepatic total 
lipids, in the three dietary groups is given in Figure 6.8 
and in Table 6. c in appendix V). 
The fish oil diet significantly reduced the levels of 
basal incorporation of [U-14C]glucose into hepatic total 
lipids compared with the mixed oil diet (p<0.05), (127.7± 
34.8 nmol/g wet tissue in the mixed oil dietary group and 
62.2±27.3 nmol/g wet tissue in the fish oil dietary group). 
Although there was a strong trend for basal levels of incor- 
poration to be lower in the corn oil than the mixed oil 
group these differences just missed reaching a level of 
statistical significance (p<0.07). 
Insulin and GIP alone did not stimulate hepatic lipo- 
genesis in any of the dietary groups, although there were 
trends towards higher levels in insulin treated tissue in 
the corn and fish oil groups. However, the presence of 
both hormones in the incubation media enhanced the incor- 
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Fig. 6.8 Effect of dietary fatty acid 
composition on hepatic lipid synthesis. 
(mean+/-SEM, n=9). 
INCORPORATED IU-"CIGLUCOSE (nmol/g wet tissue) 200 -1 
B 
ME 
I GIP I+GIP BI GIP I+GIP B 
INCUBATION MEDIUM 
Mixed oil group L-1 
I GIP I"GIP 
Corn oil group Fish oil group 
B" Basal, I. Insulin 
" pcO. 06 from B In mixed oil group " p<0.06 from 9 in same group "" p, 0.01 Irom 8 in same group 
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poration of [U-14C)glucose, which, in the corn oil dietary 
group increased from a basal of 77.8±25.0 nmol/g wet tissue 
to 165.0±73.3 nmol/g wet tissue (p<0.01), and in the fish 
oil dietary group from a basal of 62.2±27.3 nmol/g wet 
tissue to 130.5±50.3 nmol/g wet tissue (p<0.05). 
6.5.2. INCORPORATION OF [U-14C]GLUCOSE INTO HEPATIC 
TRIACYLGLYCEROL 
Incorporation of [U-14C]glucose into hepatic TAG, in 
the three dietary groups is given in Figure 6.9 and in 
Table 6. d in appendix V. 
The fish oil diet significantly reduced the basal 
incorporation of [U-14C)glucose into hepatic TAG compared to 
the mixed oil diet (p<0.01), (5.60±2.89 nmol/g wet tissue 
in the mixed oil dietary group, and 0.79±0.25 nmol/g wet 
tissue in the fish oil group). There was a similar trend 
towards lower levels in the corn oil group which did not 
reach a level of statistical significance. 
Insulin and GIP alone did not stimulate incorporation 
of [U-14C]glucose into hepatic TAG in any dietary group. 
However, the presence of both hormones in the incubation 
buffer, increased the incorporation of the label into 
hepatic TAG from a basal level of 2.66±0.93 nmol/g wet 
tissue to 11.22±6.89 nmol/g wet tissue (p<0.005), in the 
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corn oil group. In the same dietary group, levels of 
incorporation in the insulin+GIP treated tissue were also 
significantly higher than in the presence of either insulin 
(p<0.01), or GIP (p<0.05) alone. Although there was a 
trend towards higher levels of incorporation of (U-14C] 
glucose for insulin+GIP treated tissues for both mixed and 
fish oil groups, the differences did not reach statistical 
significance. 
6.5.3. INCORPORATION OF [U-14C]GLUCOSE INTO HEPATIC 
CHOLESTEROL 
Incorporation of [U-14C]glucose into hepatic chole- 
sterol, in the three dietary groups, is given in Figure 
6.10 and in Table 6. e in appendix V. 
The fish oil diet significantly decreased incorpora- 
tion of the (U-14C]glucose in hepatic cholesterol compared 
to the corn oil diet (p<0.05), (0.74±0.52 nmol/g wet 
tissue, in the fish oil dietary group, and 1.90±0.69 nmol/g 
wet tissue in the corn oil dietary group). A trend was 
observed, towards lower hepatic cholesterogenesis in the 
fish oil dietary group (0.74±0.52 nmol/g wet tissue), than 
in the mixed oil group (1.56±1.08 nmol/g wet tissue). 
Insulin increased hepatic cholesterogenesis in the 
mixed oil dietary group, increasing the [U-14C]glucose 
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Fig. 6.9 Effect of dietary fatty acid 
composition on hepatic triacylglycerol 
synthesis (mean+/-SEM, n=7*) 
16 
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incorporation into hepatic cholesterol from a basal level 
of incorporation of 1.56±1.08 nmol/g wet tissue to 4.35± 
3.13 nmol/g wet tissue (p<0.05). On the other hand, al- 
though there was a trend for higher levels in GIP treated 
tissues, GIP did not significantly stimulate hepatic chole- 
sterogenesis in any of the dietary groups. This may be 
partly because of the high degree of intertissue variation, 
most noteworthy in the mixed oil group. 
In the presence of both hormones, hepatic cholestero- 
genesis was stimulated in the mixed oil group from a basal 
of 1.56±1.08 nmol/g wet tissue to 4.64±2.79 nmol/g wet 
tissue (p<0.05), and in the fish oil group from 0.74±0.52 
nmol/g wet tissue to 3.59±2.14 nmol/g wet tissue (p<0.05). 
In the corn oil group, a trend was observed towards higher 
(U-14C)glucose incorporation, in the presence of both 
hormones, but this was not statistically significant. 
6.5.4. INCORPORATION OF [U-14C]GLUCOSE INTO HEPATIC 
FREE FATTY ACIDS AND PHOSPHOLIPIDS 
Incorporation of [U-14C]glucose into free fatty acids 
is given in Figure 6.11 and in Table 6. f in appendix V. 
Incorporation of the label into hepatic phospholipids 
is given in Figure 6.12 and in Table 6. g in appendix V. 
Statistical analysis showed that the diet fed did not 
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Fig. 6.11 Effect of dietary fatty acid 
composition on hepatic free fatty acid 
synthesis (mean+/-SEM, n=7") 
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Fig. 6.12 Effect of dietary fatty acid 
composition on hepatic phospholipid 
synthesis (mean+/-SEM, n=7) 
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have any significant effect on rates of (U-14C)glucose 
incorporation into hepatic free fatty acids and phospho- 
lipids. In addition, insulin and GIP did not have any 
significant effect on stimulation of hepatic fatty acid and 
phospholipid synthesis. Although trends are evident, the 
degree of intertissue variation, particularly in the case 
of the incorporation into fatty acids, precludes any 
definitive conclusions being drawn. 
6.5.5. PLASMA TRIACYLGLYCEROL AND CHOLESTEROL LEVELS 
Plasma TAG and cholesterol levels are given in Figures 
6.13 and 6.14 respectively, and in Table 6. h in appendix V. 
The fish oil diet significantly decreased TAG levels 
compared to mixed oil and corn oil diets (p<0.05). In 
particular, TAG levels in the mixed oil dietary group were 
1.31±0.74 mmol/l, in the corn oil dietary group 0.89±0.36 
mmol/1 and in the fish oil dietary group were 0.58±0.19 
mmol/l. 
Plasma cholesterol levels were similar between the 
three diets. 
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Fig. 6.13 Effect of dietary fatty acid 
composition on plasma triacyiglycerol 
concentration (mean+/-SEM, n"9") 
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Fig. 6.14 Effect of dietary fatty acid 
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concentration (mean+/-SEM, n"9*) 
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6.5.6. PLASMA INSULIN AND GIP LEVELS 
Plasma insulin and GIP levels in the three dietary 
groups are given in Figures 6.15 and 6.16 respectively and 
in Table 6. h in appendix V. 
Plasma insulin concentrations were significantly 
higher in the mixed oil dietary group, than in the other 
two dietary groups (p<0.001). In particular, plasma 
insulin levels were 12.1±8.3 ng/ml in the mixed oil dietary 
group, 2.6±1.9 ng/ml in the corn oil dietary group, and 
1.9±0.9 ng/ml in the fish oil dietary group. 
The three diets did not significantly alter plasma GIP 
concentrations. 
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Fig. 6.15 Effect of dietary fatty acid 
composition on plasma insulin 
concentration (mean+/-SEM, n-9*) 
INSULIN (ng/mI) 
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Fig. 6.16 Effect of dietary fatty acid 
composition on plasma GIP concentration 
(mean+/-SEM, n-9*) 
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6.6 DISCUSSION 
In the present study the pair-feeding technique was 
used because a small trend towards lower food intake was 
observed in the group fed the corn oil diet, during the 
preliminary study. From the beginning of the pair-feeding 
periods, in both the preliminary and main studies, the 
average daily food intakes and weight gains were similar in 
all dietary groups. In addition, the average liver weights 
after the sacrifice were also similar. As a consequence, 
differences observed in [U-14C]glucose incorporation into 
hepatic lipids, as well as differences in plasma TAG and 
insulin levels, between the dietary groups should not be 
credited to different food intakes, or to different growth 
rates in the three groups of animals. 
The main findings of the present study are as follows: 
- lower rates of incorporation of [U-14C]glucose into 
hepatic total lipids (p<0.05) and hepatic TAG (p<0.01) in 
the fish oil dietary group, compared to the mixed oil 
dietary group, 
- increased rates of incorporation of (U-14C]glucose, 
into hepatic total lipids in the presence of insulin and 
GIP, compared to the rates of basal incorporation in the 
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fish oil (p<0.05), and corn oil, groups (p<0.01). In 
addition, in the corn oil group, the presence of both 
hormones markedly increased the incorporation of the label 
into hepatic TAG compared to basal (p<0.01), insulin 
(p<0.01), and GIP (p<0.05) incubations, 
- lower incorporation of the label into hepatic chole- 
sterol, in the fish oil dietary group, compared to the corn 
oil group (p<0.05), 
- increased incorporation of CU_14C] glucose, in the 
presence of insulin and GIP, into hepatic cholesterol in 
mixed oil and fish oil dietary groups, compared to rates of 
the basal incorporation in these groups (p<0.05 in both 
instances), 
- increased incorporation of the label, in the 
presence of insulin, into hepatic cholesterol, in the mixed 
oil dietary group, compared to the rates of basal incorpo- 
ration in the same group (p<0.05), 
- significantly lower plasma TAG concentrations in the 
fish oil dietary group, compared to both other groups 
(p<0.05), and significantly higher plasma insulin concen- 
trations in the mixed oil dietary group, compared to both 
other groups (p<0.001). 
Apart from the findings described above, which 
summarise effects of dietary fatty acids on pathways of 
lipid synthesis in the liver, it is important to note that 
except in one case (hepatic cholesterogenesis in the mixed 
oil dietary group), insulin or GIP alone did not stimulate 
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lipogenesis. It is also noteworthy that the corn oil diet 
did not have any significant effect on rates of hepatic 
lipogenesis compared to the diet which was rich in SFA. 
However, a trend was observed, towards lower (U-14C)glucose 
incorporation in the hepatic total lipids and TAG, compared 
to the rates of incorporation found in the mixed oil 
dietary group. 
There are a number of comments regarding the rates of 
incorporation of the labelled precursor into individual 
lipid classes which require emphasis: 
- rates of incorporation of the label were highest in 
the phospholipid fraction and there was no effect of either 
diet or hormones on incorporation into this lipid. How- 
ever, it must be remembered that methodological difficul- 
ties were encountered with the TLC separation carried out 
on the samples from this study. Therefore, care must be 
taken in interpreting the significance of the phospholipid 
data in particular, 
- rates of incorporation of the label were lowest in 
the free fatty acid fraction and values obtained were 
highly variable, reflecting the irreproducibility of the 
assay particularly when measuring very low rates of 
incorporation. 
The results obtained in the present study suggest that 
the decrease in plasma TAG, due to a diet rich in fish 
oils, can in part be attributed to a decrease in hepatic 
total lipid synthesis. Haug and Hostmark (1987) also 
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observed a decrease in plasma TAG in rats fed fish oil 
diets (22% w/w for 4 weeks) compared to plasma TAG in rats 
fed diet rich in coconut oil. The same investigators 
observed a decrease in plasma cholesterol, VLDL and 
phospholipid levels, increased hepatic TAG and cholesterol 
concentrations, and decreased LPL and hepatic lipase 
activities in the same dietary group. They concluded that 
the reduction in plasma lipids in rats fed fish oils was 
caused by a reduction in hepatic output and not by an 
increase in clearance due to inceased LPL activity. On the 
other hand, Lakshman et al. (1988), observed a decrease in 
plasma TAG and cholesterol concentrations, but no effect on 
liver TAG and cholesterol contents in rats fed fish oil 
diets (28% for 6 weeks). Lottenberg et al. (1992), after 
feeding rats with diets rich in olive oil and fish oil (10% 
w/w) and a control diet (4% fat w/w), for 2 weeks, 
observed, after comparing the fish oil group with the 
controls, an increase in plasma cholesterol and no change 
in plasma TAG. Levy et al. (1991), observed an increase in 
CM diameter, and in adipose tissue LPL activity in rats fed 
a diet rich in safflower oil compared with rats fed diet 
rich in coconut oil for 3 months. 
In order to determine the mechanisms by which fish 
oils decrease plasma TAG, Wong et al. (1984), perfused 
livers from male rats fed either a control diet (5% w/w/ 
fat) or diets supplemented with 15% (w/w) fish or safflower 
oils for two weeks. Rates of hepatic lipogenesis followed 
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the order: control>saff lower oil>fish oil. Secretion of 
newly synthesized fatty acids in VLDL was inhibited by both 
of the PUFA-supplemented diets with the greater suppression 
observed in livers from animals fed fish oil. On the other 
hand, the hepatic secretion of VLDL-TAG mass was depressed 
in animals fed the fish oil supplemented diet. In 1985, 
Wong et al. observed, in hepatocytes from fish oil-fed rats 
(15% w/w for 18 days), a lower production and secretion of 
TAG than in cells from safflower oil-fed rats for the same 
time period. In addition, after incubating hepatocytes 
from chow fed rats with oleate, linolenate, arachidonate, 
EPA, and DHA, observed almost total suppression of TAG 
formation with the latter n-3 PUFA. 
The studies described above looked at the effects of 
fish oils in plasma lipids and hepatic lipogenesis when the 
animals were in the fasted state. The results of the 
present study support the proposal that fish oil diets de- 
crease plasma TAG through a suppression of hepatic lipoge- 
nesis and demonstrate that this applies to tissue removed 
during the postprandial state. Plasma cholesterol levels 
did not differ between the dietary groups, even though 
hepatic cholesterogenesis was lower in the fish oil group 
than in the corn oil group (p<0.05), with a similar trend 
compared with the mixed oil group (not significant). A 
possible reason for this may be a decrease in secretion 
rates of VLDL from rats fed corn oil diets. Another 
possible reason for the observed trend towards higher 
295 
hepatic cholesterol synthesis in the mixed oil group, and 
the significant increase in the corn oil group, compared to 
fish oil dietary group, may also be the higher intake of 
dietary cholesterol in the fish oil concentrate (approxima- 
tely 4.5 mg/day) which might be expected to suppress endo- 
genous synthesis in the fish oil group. Therefore, in 
future work, caution should be taken to ensure that the 
dietary cholesterol intake in all dietary groups is the 
same. 
In the present study hepatic phospholipid synthesis 
did not differ between the three dietary groups. Yeo and 
Holub (1990), observed no difference in the incorporation 
of (3H]glycerol into hepatic phospholipids from rats fed 
diets rich in either linoleic acid (LO), or fish oils (FO) 
(10% w/w), for 3 weeks. However, the incorporation of the 
label into TAG relative to total phospholipids decreased 
from 2: 1 in the LO group to 0.9: 1 in the FO group. Other 
investigators suggest that phospholipid fatty acid composi- 
tion depends on the type of dietary fatty acid fed (Nassar 
et al., 1986), or the type of fatty acid supplemented in 
the incubation medium (Strum-Odin, 1987). The latter 
workers suggested that hepatic lipogenesis depends on the 
type of fatty acid supplemented in the medium, with poly- 
enoic fatty acids [20: 5 (n-3)>20: 4/18: 2 (n-6)] suppressing 
hepatic TAG production. 
Another possible reason for the lower plasma TAG 
values with a fish oil diet is the decrease in intestinal 
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absorption of fish oils. The present study did not look at 
this aspect of lipid metabolism; however, results of Herz- 
berg et al. (1992), ruled out decreased intestinal 
absorption as a mechanism for the hypotriglycerolaemic 
effect of fish oils. 
In summary, the present study suggests that a fish oil 
diet decreases plasma TAG levels, partly through a decrease 
in hepatic TAG synthesis. Although hepatic cholesterogene- 
sis was also lower in the fish oil group plasma cholesterol 
levels were not altered possibly due to the presence of 
cholesterol in the fish oil concentrate. Rates of hepatic 
phospholipid and fatty acid synthesis were not changed by 
fish oil feeding but an alteration in phospholipid fatty 
acid composition cannot be ruled out and was not measured 
in this study. 
The decrease in hepatic total lipid and TAG synthesis 
following the fish oil diet compared to the diet which was 
rich in SFA can be attributable to a number of mechanisms: 
- decreased acetyl-CoA carboxylase and malic enzyme 
(Iritani et al., 1980a), PAP (March et al., 1987), and 
acyl-CoA: 1,2 diacylglycerol acyltransferase (Rustan et 
al., 1988; March et al., 1987), 
- increased membranes fluidity (Muriana et al., 1992) 
which may provoke the inactivation of A9- (Garg et al., 
1988c), A6-, and AS- desaturases (Garg et al ., 1988a, and 
1988b; Muriana et al., 1992), 
- increased fatty acyl-CoA oxidase activity, and as a 
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consequence shift from lipogenesis to ß-oxidation in 
peroxisomes (Yamazaki et al., 1987), and ketogenesis 
(Bergseth et al., 1986). 
These effects of fish oils on enzyme activities and 
membrane fluidity seem to be consistent in the literature 
when rats are in the fasting state. There is a lack of 
research looking at these pathways in response to fish oil 
feeding in the postprandial state. However, in the present 
study, it is possible to conclude that the 2 week fish oil 
diet would have enabled sufficient time for dietary in- 
fluence on both membrane fluidity and enzyme activities. 
Although further discussion of these mechanisms is beyond 
the scope of the aims of the present study, further work in 
these areas appears warranted. 
Effects of fish oils on cholesterogenesis and lipid 
clearance are conflicting: 
- some workers suggest that fish oils do not affect 
free cholesterol synthesis but only its esterification by 
reducing the acyl-CoA: cholesterol acyltransferase activity 
(Rustan et al., 1988b), and others observed increased liver 
microsomal acyl-CoA: cholesterol acyltransferase and HMG- 
CoA reductase activities in the fish oil group compared to 
an olive oil group (Muriana et al., 1992). Some of these 
conflicting results may be due to failure to control for 
dietary cholesterol intake as in the case of the present 
study, 
- the other mechanisms by which n-3 PUFA may decrease 
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plasma TAG is through increased CM- and VLDL-TAG clearance, 
through effects on LPL. A co-investigator measured adipose 
tissue LPL activity and LPLmRNA levels in some of the 
animals of each dietary group of the present study. Al- 
though there was a trend towards higher LPL activity in 
fish oil fed animals, this was not statistically signifi- 
cantly different. However, LPLmRNA was elevated in fish 
oil fed animals, suggesting increased synthesis of the 
enzyme. Melin et al. (1991), suggested that LPL hydrolyzes 
EPA at a slower rate than the C14.18 esters whereas HL 
increases the lipolytic rate of 20: 5 and 20: 4 esters of 
both tri- and diacylglycerols. On the other hand, in our 
human study (Chapter 5), postheparin LPL activity was 
increased following the fish oil test meal, whereas Haug 
and Hostmark (1987), observed a reduction in both LPL and 
HL in rats fed a fish oil-rich diet compared to the rats 
fed a coconut oil-rich diet. in view of the findings of 
the co-investigator, the present study cannot rule out the 
possibility that at least some of the TAG-lowering effects 
of fish oils may be due to concomitant activation and/or 
increased production of LPL. 
With respect to effects of the lipogenic hormones, the 
present study has reported for the first time lipogenic 
effects of GIP, in the presence of insulin, on both total 
lipids, TAG and cholesterol, in some of the dietary groups. 
In order to clearly interpret the complex effects of these 
lipogenic hormones on hepatic lipid synthesis, it is impor- 
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tant to consider each of the lipid fractions separately, 
since effects of hormones on total lipids will reflect the 
varying responses of each fraction to hormone action. 
Importantly, the fraction which showed the greatest incor- 
poration of label, showed the least response to hormone 
action (phospholipids) and this will have masked effects of 
hormone action on total lipid incorporation. In general 
terms the most imporrnt observations were: 
- significant stimulation of cholesterogenesis by 
insulin+GIP together, in both mixed and fish oil treated 
animals, with a similar strong trend in corn oil group 
animals. This effect would therefore appear to be inde- 
pendent of diet, 
- in mixed oil group animals, insulin alone produced 
a marked cholesterogenic response which was not further 
increased by addition of GIP, 
- significant stimulation of incorporation into hepa- 
tic TAG in presence of insulin+GIP, compared with basal, 
insulin and GIP treated tissues in the corn oil group, 
- in mixed oil group animals, there was a strong and 
linear trend towards increasing rates of incorporation into 
hepatic TAG with hormone additions, thus basal<insulin<GIP< 
insulin+GIP. However, none of the differences was signifi- 
cant, and 
- in fish oil group animals, all rates of incorpora- 
tion into hepatic TAG were low and hormone additions had no 
significant effect. 
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Clearly, these are important findings since they 
suggest that the secretion of GIP in response to dietary 
fat may have important physiological effects on the 
subsequent processing of endogenous and exogenous lipid 
substrates in the liver. However, this was only a pre- 
liminary study, and further work to confirm the findings 
could not be conducted due to time constraints. Further 
work is needed to confirm and extend these investigations. 
In addition, emphasis needs to be placed on improving the 
reliability of the assay. 
The results are of particular interest because of 
observations by members of the same research group which 
show that whilst GIP has little effect on LPL activity in 
the absence of insulin, it potentiates insulin action when 
added to incubation media at the same concentrations as 
used in the present study (Knapper et al., 1993). It is 
also worth mentioning that adipose tissue removed from the 
animals studied as part of the present investigation, was 
taken by another investigator who measured rates of incor- 
poration of acetate into adipocyte lipids. Markedly higher 
rates of insulin stimulated acetate incorporation (six-fold 
compared to other groups) were seen in the adipose tissue 
from animals fed the fish oil diet. (Beetty, 1992). These 
data suggest further work is required to determine effects 
of dietary fatty acids on insulin sensitivity. 
One of the most important and surprising findings of 
the present study was the significantly higher levels of 
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insulin in mixed oil fed animals compared with both groups 
of animals fed PUFA-rich diets. A possible interpretation 
of these findings is that mixed oil fed animals were deve- 
loping a degree of insulin resistance and this may relate 
to effects of dietary fatty acids on membrane phospholipid 
fatty acid composition. Alteration in insulin receptor 
number and affinity has been reported in response to 
dietary fat modification. In their review, Tepperman and 
Tepperman (1985), mentioned that changes in liver plasma 
membrane cholesterol content and phospholipid pattern can 
influence insulin response as well as contribute to binding 
changes. Increased unsaturation of plasma membrane phos- 
pholipids of Ehrlich ascites cells in mice, produced by 
dietary manipulation, was associated with an increase in 
insulin receptor number and a decrease in binding affinity; 
increased saturation, on the other hand, was associated 
with a decrease in receptor number and an increase in 
affinity (Ginsberg et al., 1982). 
The mechanism for the enhanced lipogenic responses in 
the presence of insulin and GIP require further study and 
is consistent with reports of insulin and GIP effects in 
other tissues. In the rat adipocyte, GIP increased insulin 
receptor affinity and potentiated insulin-mediated glucose 
uptake (Starich et al., 1985). Beck and Max (1986), 
reported that GIP enhanced the insulin-stimulated fatty 
acid incorporation into adipose tissue and they suggested 
that GIP may act by favouring the insulin binding to its 
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receptor on fat cells. In addition, Hartmann et al. 
(1986), reported that GIP exerts direct metabolic effects 
on hepatic glycogen metabolism, predominantly when insulin 
is simultaneously present. GIP alone (1 nM), reduced 
glycogen-dependent glycogenolysis slightly, but, when 
infused simultaneously at low insulin concentrations (0.1 
nM), which by itself did not significantly affect glucose 
output, it suppressed hepatic glucose production. They 
concluded, that since GIP also directly stimulates TAG 
uptake, this gut peptide seems to act as an anabolic 
hormone. In addition, Dupre et al. (1973), suggested that 
porcine GIP administered intravenously together with 
glucose in normal man, leads to potentiation of insulin 
secretion and improvement of glucose tolerance. However, 
Service et al. (1990), suggested that physiological 
elevations of GIP do not alter hepatic and extrahepatic 
insulin action in glucose metabolism in normal subjects and 
Chap et al. (1985), reported that the augmented hepatic 
uptake of glucose after oral glucose, does not appear to be 
mediated by GIP. In the present study, dietary induced 
alteration of membrane phospholipid composition in combi- 
nation with the GIP in the incubation medium may have 
altered effects offnsulin in hepatic lipogenesis. 
As a conclusion, in the present study, a fish oil diet 
decreased hepatic lipogenesis and postprandial plasma TAG 
levels compared with a diet rich in saturated fatty acids, 
and insulin and GIP together had a stimulatory effect on 
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hepatic lipogenesis, both on pathways of TAG and chole- 
sterol synthesis. The diet which was rich in SFA increased 
drastically the postprandial plasma insulin levels. If the 
latter findings are confirmed then they could lead to a 
better understanding of the potential role of diets high in 
SFA in the aetiology of NIDDM. 
The present study has not looked at the effects of 
dietary modifications on enzyme activities which are 
involved in lipogenesis and therefore, more work needs to 
be done in this area, especially with the animals being in 
the postprandial state. In addition, research into effects 
of n-3 dietary fatty acids on postprandial LPL activity and 
the mechanism of these effects are also needed. 
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CHAPTER 7 
OVERALL DISCUSSION 
As has already been mentioned (Chapter 1), CHD is one 
of the major causes of death in westernized countries. 
Numerous factors have been implicated in the development of 
atherogenesis and one of the most widely discussed is the 
nutritional habits of individuals. SFA have long been 
considered as one of the adverse dietary factors which 
could increase the risk of development of CHD. All current 
dietary guidelines for European and North American 
countries suggest that as a means of protecting against CHD 
there should be a decrease not only in the total amount of 
dietary fat eaten, but that in particular saturated fat 
intake shouldbemarkedly decreased. The question which 
continues to remain is that since SFA are thought to 
increase the risk of atherogenesis, are there other dietary 
fatty acids whose increased intake could decrease risk of 
CHD? 
In the middle of this century a number of studies were 
undertaken which showed that PUFA of the n-6 series 
decrease T-C levels, and possibly risk of CHD. In 
addition, in 1970's Dyerberg and Bang, in their studies, 
showed that the incidence of CHD in Eskimo population was 
low and they correlated this with the high dietary intake 
of another PUFA (the n-3), in Eskimo diet. Would the 
latter findings therefore provide the answer, to the 
dietary fat-CHD relationship, and if so what mechanisms are 
involved? 
It is these questions which provided the basis for the 
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studies undertaken and described in this thesis. 
Currently, one of the methods used to assess the risk of 
CHD is the measurements of fasting lipid levels. Fasting 
samples can be obtained easily and T-C, LDL-C, and HDL-C 
determinations require only a small blood sample to be 
taken. However, although this is usually a simple and 
practical approach to risk assessment, it may not 
necessarily be the most appropriate one. The early claim 
that the CHD risk could be assessed by measuring simply the 
fasting T-C level was questioned when it was suggested that 
different lipoprotein particles contribute in different 
ways to the development of atherogenesis. It was 
recognised that the two fractions of cholesterol, LDL-C and 
HDL-C have different functions, and that whilst high LDL-C 
is associated with increased CHD, high HDL-C is associated 
with decreased risk. However, measurements of these 
parameters, even though better indicators than fasting 
lipid levels, they may still be an inadequate means of 
assessing risk in relation to disturbance in lipoprotein 
metabolism. There are many individuals who suffer from 
myocardial infarctions, who have normal LDL-C and/or HDL-C 
levels. Other investigators have suggested that the 
protein moieties of these lipoprotein fractions could be 
better predictors of risk of developing CHD. Apo A-I and 
apo B levels began to be measured and these studies have 
made the area of CHD and lipoprotein risk factors in plasma 
even more unclear. Even nowadays, it would be very easy 
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for someone to correlate a myocardial infarction incident 
with high apo B levels, but nobody can suggest that a 
subject with normal T-C and LDL-C but elevated apo B levels 
has an increased risk for developing CHD. 
In 1979, the most important year in research 
concerning the postprandial lipid metabolism, Zilversmit 
suggested that postprandial lipoprotein particles could 
affect the development of atherogenesis. In particular, he 
reported that CM and CM-R could be taken up by the arterial 
wall. However, at the time it seems that no other workers 
in the field paid attention to these important findings, 
because most researchers were still concentrating on the 
measurements of fasting lipid levels. It took 
approximately ten more years before investigators began to 
look at the effects of dietary fat on postprandial 
lipoprotein metabolism and the implications of CM and their 
remnants to CHD. 
The work described in this thesis has attempted to 
shed more light on the effects of dietary fatty acid 
composition, and dietary TAG structure, on postprandial 
lipid metabolism, in healthy volunteers and NIDDM patients. 
As far as effects of dietary TAG structure are 
concerned (Chapter 4), this study failed to show any 
difference in postprandial lipid metabolism following 
consumption of standard test meals whose TAG differed in 
their fatty acid positional distribution. However, this 
study provides only limited data since only acute test 
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meals were administered to the volunteers, and therefore, 
the possibility of different results being obtained when 
such TAG are fed long-term should not be excluded. In 
addition, different fatty acids behave differently, and 
because only palmitic and oleic acids were present in the 
oils studied in this investigation, effects of positional 
distribution of other fatty acids on postprandial lipid 
metabolism cannot be ruled out. Nevertheless, this was the 
first time that a study of effects of TAG structure on lipid 
metabolism had been carried out in human volunteers. 
Although no major findings were obtained, the results made 
an important contribution to the developing body of 
knowledge in this area, and this work has been accepted for 
publication. 
Effects of dietary fatty acid composition on post- 
prandial lipid metabolism have been extensively 
investigated in this thesis. The results described in 
Chapter 3 showed a pronounced plasma TAG lowering effect of 
fish oils given in moderate doses to normal human 
volunteers for six weeks. In particular, fasting TAG 
levels and postprandial TAG responses to a test meal were 
found to be lower after a fish oil supplementation period 
but there was also evidence that in some subjects fasting 
T-C and LDL-C levels were raised in response to fish oil 
supplementation (Chapter 3, Study II). In Study I (Chapter 
3), fasting TAG levels were decreased in normal subjects, 
but postprandial TAG responses were not significantly 
309 
different. In the NIDDM patients, no statistical 
significance was observed in any of the lipid parameters 
measured and indeed there was a trend towards a higher 
postprandial TAG response to a standard test meal following 
the fish oil supplementation period. Another major 
observation from Chapters 3 and 4 which proved to be 
crucial for the designs of future human postprandial 
studies, was that a short postprandial period of 3-6 hours 
was not adequate. Plasma TAG levels were found to reach 
peak values at approximately 5-7 hours and did not return 
to fasting levels until 10-11 hours postprandially. As a 
result longer postprandial time periods were used in the 
later studies and were found to give much more useful and 
and detailed information. 
Following the results of the former study (Chapter 3), 
a more extensive study was designed (Chapter 5), in order 
to investigate effects of acute dietary fatty acid 
composition on postprandial lipoproteins. In this study 
effects of three oils were investigated: mixed oil (which 
replicated current U. K. dietary fatty acid intake), corn 
oil (n-6 PUFA rich), and fish oil (n-3 PUFA rich). The 
major findings of this study were the significantly lower 
postprandial TAG responses to the fish oil meal and the 
higher LPL activity 12 hours after the consumption of the 
fish oil meal compared with the mixed oil meal. 
Furthermore, there was a strong trend towards a lower CM- 
TAG response to the fish oil meal. 
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Insulin and GIP responses remained unaltered to meals 
of different fatty acid composition. It is noteworthy that 
throughout this thesis in each of the studies undertaken, 
no effects of dietary fatty acid composition, or of TAG 
structure on insulin and GIP postprandial responses were 
noted (Chapters 4, and 5). This is surprising since much 
has been reported, in animals, on effects of fatty acid 
intake on GIP secretion in particular (Morgan et al., 
1988). This thesis has not provided evidence that these 
effects are observed in humans under physiological 
conditions of testing. 
Finally, in order to assess some of the mechanisms 
which could be involved on the effects of fish oils on 
fasting and postprandial TAG levels, their effects, when 
fed long term, on in vitro hepatic lipogenesis was 
investigated using the rat model (Chapter 6). It was found 
that fish oil feeding decreased hepatic TAG synthesis in 
the postprandial state, and that in vitro in the presence 
of physiological levels of insulin and GIP, 
cholesterogenesis was increased independently of the 
dietary fatty acids fed. Furthermore, insulin and GIP 
stimulated hepatic TAG synthesis in the corn oil fed 
animals and there was a trend in the same direction, which 
did not reach a level of statistical significance, in the 
other two dietary groups. This is the first time that 
stimulatory effects of insulin and GIP together, on hepatic 
lipogenesis have been reported and may be of physiological 
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significance. It should be noted that the method used to 
assess the incorporation of the substrate into hepatic 
lipids did not always provide acceptable levels of 
repeatability and reliability. The investigator spent a 
considerable time on the development and assessment of this 
technique but did not resolve all the methodological 
problems within the time scale allocated to this study. It 
is concluded that more consistent and possibly important 
original findings would have been obtained had these 
difficulties been resolved satisfactorily. 
Possible mechanisms which could be involved in the 
effects of fish oils on postprandial TAG levels are 
discussed in detail in the discussion sections of the 
individual experimental chapters. Overall it is concluded 
that feeding fish oils may reduce fasting and postprandial 
plasma lipid levels through effects on both clearance of 
endogenous and exogenous TAG and through inhibitory effects 
on hepatic TAG (VLDL) synthesis. In particular, changes in 
receptor binding and in enzyme synthesis, and in membrane 
phospholipid composition which could affect activities of 
enzymes and receptors involved in lipid metabolism, have 
been suggested as possible sites for these effects. 
The area of postprandial lipid metabolism remains 
incompletely investigated and there is not yet available a 
method which can directly measure CM and CM-R 
concentrations. The RP loading technique has drawbacks 
which are discussed in Chapter 5. An assay measuring apo 
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B-48 levels could prove an important break-through in 
investigations concerning CM and CM-R metabolism, and 
measurements of this protein in the CM-poor and CM-rich 
fractions could also assess the accuracy of the CM 
separation technique via ultracentrifugation. The claim 
that some of the CM can remain in the intestinal cells and 
not pass into the circulation, also needs more 
investigation (Chapter 5) as well as the effects of dietary 
fatty acid composition on the TAG re-esterification in the 
same cells. Some of these problems may well be resolved by 
coinvestigators who are attempting to develop an assay for 
apo B-48 and by others in the same research group who wish 
to study enterocyte lipid synthesis in humans using stable 
isotopes. Furthermore, effects of fish oils on LPL 
synthesis is an area which needs further investigation not 
only in the fasting but also in the postprandial state. A 
coinvestigator in the group has developed the method for 
measuring LPLmRNA and used this to study adipose tissue LPL 
gene expression in the animal experiment described in 
Chapter 6. An important finding by this researcher was 
that animals fed fish oil showed increased LPLmRNA, 
consistent with an effect of n-3 PUFA on LPL synthesis. 
These findings have been accepted for publication. It is 
important that consistent results have been obtained with 
respect to effects on the LPL enzyme, in both animal and 
human studies in this thesis. 
However, mechanisms involved in the postprandial TAG- 
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lowering effect of fish oils should also be investigated in 
human subjects. Animal models are adequate for preliminary 
studies but animals do not have identical pathways of lipid 
metabolism to humans, and, as a consequence, feeding human 
subjects with isotopically labelled lipids and 
investigating their distribution in plasma CM, VLDL, LDL, 
and HDL, would give further information about effects of 
fish oils on lipid metabolism. 
Two potentially adverse aspects of fish oil feeding in 
humans should be mentioned at this point: firstly the 
observation that fish oil supplementation could 
significantly increase fasting T-C and LDL-C levels 
(Chapter 3), and secondly the fact that fish oils contain 
fatty acids which are highly unsaturated and liable to 
peroxidation which could have implications in the 
development of atherogenesis. As far as the first 
observation is concerned, it was mentioned in the 
discussion in Chapter 3, that the fish oil concentrate 
contained some cholesterol which may have been the reason 
for the increased fasting T-C and LDL-C levels which were 
observed, following the fish oil supplementation period 
(Study II). However, other investigators have reported 
similar findings (Harris, 1989), and a decrease in VLDL 
particle size, which results in increased conversion of 
VLDL to LDL has been suggested to be responsible for this 
effect. This effect has meant that some workers are more 
cautious in suggesting a fish-oil rich diet as a means of 
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decreasing plasma lipid levels, especially in hyper- 
lipidaemics with raised LDL levels. 
The high degree of unsaturation of fish oil fatty 
acids could also play an important adverse role in the 
development of atherogenesis. Numerous investigators have 
shown that lipoprotein particles rich in PUFA are more 
fluid than ones rich in SFA, and that even the LDL 
particles of subjects fed diets rich in n-3 fatty acids are 
less atherogenic because their transition temperature is 
decreased and their fluidity increased (Harris, 1989). 
However, there is one question which still remains 
unanswered. Highly polyunsaturated fatty acids are known 
to be more susceptible to peroxidation and production of 
free radicals. The recent implication of oxidised LDL in 
atherogenesis (Chapter 1), has directed attention at 
potentially adverse effects of diets rich in PUFA. It is 
not known whether the physiological levels of antioxidants 
(especially vitamins C and E), present in the plasma, are 
adequate to prevent these undesirable effects and further 
studies are required in this area. 
Since there are many questions unanswered and the 
effects of fish oils on lipid metabolism are still 
controversial, it has been suggested that a shift towards 
diets containing more "neutral" lipids, such as oleic acid, 
could be proved beneficial. It has already been observed 
that populations consuming diets rich in olive oil have a 
low incidence of CHD. It has also been suggested that 
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olive oil does not raise fasting T-C levels, and that 
people in Mediterranean countries have, on average, lower 
serum lipid levels (Kafatos, et al., 1991). Furthermore, 
olive oil has a high a-tocopherol content and its uniquely 
high MUFA content may prove to be an important nutritional 
defence against lipid peroxidation (Kafatos and Comas, 
1991). As a consequence, more work needs to be done, 
especially on the effects of olive oil on postprandial 
lipid metabolism in populations with different background 
diets, specifically in populations whose diets are rich in 
MUFA. This will be the future area of research which the 
investigator will follow as the result of a successful 
application to the EC for funding. The development of 
appropriate techniques for studies in human volunteers, and 
the original findings reported here, provided an important 
foundation for the successful implementation of the planned 
study. 
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APPENDIX I 
CHAPTER 2 
TABLE 2. a 
Validation experiment for the hepatic lipogenesis study: 
effect of incubation time on incorporation of 
CU-14C]glucose in rat liver total lipids. 
Incubation time Incorporated [U-74C]glucose 
(min. ) (nmol/g wet tissue) 
0 
60 
120 
I80 
240 
300 
0.0 
117.7 
227.2 
247.9 
197.2 
163.1 
TABLE 2. b 
Validation experiment for the hepatic lipogenesis study: 
viability experiment. 
Time before the begining 
of the incubation. 
(min. ) 
Incorporated (U-14C)glucose 
(nmol/g wet tissue) 
0 
30 
90 
120 
180 
0.0 
284.5 
384.6 
249.2 
199.7 
353 
TABLE 2. c 
Validation experiment for the hepatic lipogenesis study: 
effect of difffZrent insulin concentrations on 
incorporation of FU- Clglucose in rat liver total lipids. 
Hormone Concentration orporated Inf 
(nmol/1) ` [U- C]glucose 
(nmol/g 
wet tissue) 
Insulin 1 161.9 
2 209.9 
4 240.0 
8 
-- 
185.1 
Basal 
---- --- 
172.7 
r 
TABLE 2. d 
Validation experiment for the hepatic lipogenesis study: 
effect of diaferent GIP concentrations on 
incorporation of [U- C]glucose in rat liver total lipids. 
Hormone Concentration 
(nmol/1) 
In? 9rporated 
[U- C]glucose 
(nmol/g 
wet tissue) 
GIP 
Basal 
1 
3 
6 
10 
91.0 
180.0 
412.9 
90.4 
354.8 
TABLE 2. e 
Validation experiment for the hepatic lipogenesis study: 
effect of both ijsulin and GIP concentrations on 
incorporation of [U-`C]glucose in rat liver total lipids. 
Hormone 
Insulin + GIP 
Basal 
Concentration Inýyorporated 
(nmol/1) Eu- C]glucose 
(nmol/g 
wet tissue) 
2+3 204.0 
4+6 378.8 
8+ 10 72.0 
354.8 
354 
TABLE 2 .f 
Triacylglycerol and cholesterol assays: 
assays variables. 
VARIABLE SETTINGS 
TRIACYLGLYCEROL CHOLESTEROL 
Units mmol/1 (3) mmol/1 (3) 
Calculation factor 0 0 
Standard 1 2.2 7.8 
Standard 2 2.2 7.8 
standard 3 2.2 7.8 
Limit 8 18.1 
Temperature °C 37 37 
Type of analysis 5 5 
Wavelength 500 500 
Sample lot 3 4 
Diluent lot 40 30 
Reagent lot 300 350 
Incubation time 0 0 
Starting reagent volume 0 0 
Time of first reading 10 1 
Time interval 360 300 
Number of readings 2 2 
Blanking mode 1 1 
Printout mode 1 1 
355 
TABLE 2. g 
Apolipoproteins A-I and B assays: 
assays variables. 
VARIABLES SETTINGS 
APO A-I APO B 
Units mg/dl (10) mg/dl (10) 
Calculation factor 1000 1000 
Standard 1 99 80 
Standard 2 148 120 
Standard 3 204 160 
Limit 0 0 
Temperature °C 25 25 
Type of analysis 5 5 
Wavelength 340 340 
Sample lot 5 30 
Diluent lot 20 50 
Reagent lot 200 200 
Incubation time 0 0 
Starting reagent volume 0 0 
Time of first reading 5 5 
Time interval 600 600 
Number of readings 2 2 
Blanking mode 1 1 
Printout mode 1 1 
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TABLE 3. a 
STUDY I: chronic fish oil supplementation study. 
Plasma Apo A-I levels (mean ± SD), of healthy volunteers 
before and after fish oil supplementation. 
TIME (min) APO A-I (m d1) 
Pre Post 
0 156.6 f 53.9 148.4 t 62.4 
15 150.2 ± 33.4 141.8 ± 42.0 
30 149.2 ± 33.1 156.7 ± 36.7 
45 136.8 ± 24.6 144.8 ± 42.6 
60 145.0 ± 40.0 111.1 ± 41.2 
90 142.3 ± 27.4 142.8 ± 62.4 
120 153.4 ± 48.8 150.0 ± 52.6 
150 133.6 ± 46.3 142.7 ± 55.2 
180 150.3 ± 42.8 149.2 ± 66.7 
210 155.3 ± 43.3 121.8 ± 30.2 
TABLE 3. b 
STUDY I: chronic fish oil supplementation study. 
Plasma apo A-I levels (mean ± SD), of NIDDM's 
before and after fish oil supplementation. 
TIME (min) APO A-I (m dl) 
Pre Post 
0 137.8 ± 45.8 139.8 ± 42.0 
15 144.2 ± 49.7 105.7 ± 44.7 
30 129.8 ± 49.3 122.5 ± 48.4 
45 126.1 ± 47.8 110.7 ± 51.5 
60 128.8 ± 49.9 104.2 ± 37.5 
90 130.1 ± 47.1 96.0 ± 43.3 
120 120.8 ± 51.5 106.4 ± 49.9 
150 114.5 ± 42.3 106.7 ± 41.5 
180 118.2 ± 32.6 103.1 ± 53.2 
210 129.1 ± 33.9 114.2 ± 55.7 
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TABLE 3. C 
STUDY I: chronic fish oil supplementation study. 
Plasma apo B levels (mean ± SD), of healthy volunteers 
before and after fish oil supplementation. 
TIME (min) APO B (m dl) 
Pre Post 
0 82.7 ± 32.9 84.1 ± 34.3 
15 70.2 ± 33.9 77.0 ± 36.4 
30 77.5 ± 22.8 80.1 ± 16.9 
45 76.6 ± 31.3 83.7 ± 28.6 
60 73.0 ± 25.5 90.0 ± 23.8 
90 78.6 ± 27.0 92.0 ± 24.0 
120 82.0 ± 36.6 72.7 ± 24.8 
150 76.7 ± 35.6 75.8 ± 24.4 
180 93.8 ± 38.3 68.4 ± 27.3 
210 76.0 ± 39.0 81.2 ± 33.2 
TABLE 3. d 
STUDY I: chronic fish oil supplementation study. 
Plasma apo B levels (mean ± SD), of NIDDM's 
before and after fish oil supplementation. 
TIME (min) APO B (m dl) 
Pre Post 
0 136.4 ± 32.5 145.8 ± 36.8 
15 130.8 ± 34.5 134.1 ± 39.3 
30 130.5 ± 35.5 137.5 ± 19.4 
45 119.2 ± 27.1 132.8 ± 37.5 
60 118.0 ± 30.8 134.5 ± 26.3 
90 121.1 ± 20.8 126.4 ± 20.0 
120 118.0 ± 18.4 125.3 ± 35.0 
150 118.3 ± 24.9 121.1 ± 32.4 
180 125.4 ± 43.6 122.7 ± 30.4 
210 127.1 ± 28.0 123.7 ± 30.4 
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TABLE 3. e 
STUDY I: chronic fish oil supplementation study. 
Plasma TAG levels (mean ± SD), of healthy volunteers 
before and after fish oil supplementation. 
TIME (mia) TAG (IIImo1 1) 
Pre Post 
0 1.23 ± 0.54 0.68 ± 0.19 
15 1.00 ± 0.44 0.68 ± 0.17. 
30 1.12 ± 0.40 0.70 ± 0.15 
45 1.28 ± 0.63 0.72 ± 0.15. 
60 1.28 ± 0.59 0.75 ± 0.19 
90 1.36 ± 0.65 0.78 ± 0.24. 
120 1.40 ± 0.68 0.85 ± 0.35 
150 1.67 ± 0.83 0.95 ± 0.43 
180 1.68 ± 0.94 0.99 ± 0.37 
210 1.81 ± 1.10 1.04 ± 0.42 
- p<0.05 compared to the pre-fish oil supplementation level. 
TABLE 3. f 
STUDY I: chronic fish oil supplementation study. 
Plasma TAG levels (mean ± SD), of NIDDM's 
before and after fish oil supplementation. 
TIME (min) TAG (mmol/1) 
Pre Post 
0 2.32 ± 1.45 3.08 ± 1.72 
15 2.17 ± 1.40 2.49 t 1.45 
30 2.38 ± 1.51 2.44 t 1.39 
45 2.44 ± 1.34 2.58 f 1.55 
60 2.47 ± 1.36 2.57 f 1.50 
90 2.55 ± 1.41 2.95 f 1.57 
120 2.70 ± 1.45 3.26 f 1.65 
150 2.78 ± 1.41 3.33 t 2.04 
180 3.00 t 1.49 3.72 ± 2.02 
210 3.24 ± 1.74 3.91 ± 1.91 
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TABLE 3. q 
STUDY II: chronic fish oil supplementation study. 
Plasma apo A-I levels (mean ± SD), of healthy volunteers 
before and after fish oil supplementation. 
TIME (min) APO A-I (m dl) 
Pre Post 
-10 118.2 ± 26.3 125.5 ± 16.4 
0 128.8 ± 11.6 134.1 ± 28.1 
30 121.3 ± 25.2 118.8 ± 20.0 
60 125.6 ± 16.7 140.5 ± 21.4 
90 120.3 ± 17.7 124.3 ± 23.2 
120 130.5 ± 19.2 126.0 ± 28.7 
150 128.5 ± 20.4 122.6 ± 16.4 
180 134.6 ± 25.6 126.6 ± 26.8 
240 130.3 ± 21.1 125.0 ± 26.4 
300 142.0 ± 31.1 124.6 ± 27.5 
360 120.0 ± 30.8 120.3 ± 19.0 
420 117.6 ± 23.0 116.6 f 26.9 
480 109.6 ± 28.8 124.6 ± 25.0 
540 122.6 ± 29.6 126.6 t 31.5 
600 114.8 ± 15.0 115.8 t 15.8 
660 120.5 ± 15.1 116.8 ± 16.5 
720 126.3 ± 28.0 123.2 t 18.9 
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TABLE 3. h 
STUDY II: chronic fish oil supplementation study. 
Plasma apo B levels (mean ± SD) of healthy volunteers 
before and after fish oil supplementation. 
TIME (min) APO B (m dl) 
Pre Post 
-10 51.0 ± 19.4 67.3 ± 28.3 
0 51.5 ± 21.1 68.8 ± 26.6 
30 53.0 ± 19.2 61.6 t 21.1 
60 50.0 ± 20.3 61.7 ± 20.8 
90 49.8 ± 19.1 59.5 ± 22.4 
120 50.8 ± 23.1 58.5 ± 21.2 
150 52.6 ± 21.0 57.0 ± 23.1 
180 49.0 ± 17.9 58.0 ± 19.5 
240 52.1 ± 15.9 61.0 ± 25.5 
300 57.0 ± 21.6 59.8 ± 17.8 
360 52.8 ± 16.7 54.8 ± 17.6 
420 49.6 ± 18.4 57.5 ± 22.8 
480 49.0 ± 16.2 57.6 ± 19.2 
540 50.8 ± 18.1 57.1 ± 21.4 
600 51.0 ± 15.7 51.8 ± 17.8 
660 51.0 ± 14.2 52.0 ± 17.9 
720 52.3 ± 18.1 58.5 ± 23.5 
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TABLE 3. i 
STUDY II: chronic fish oil supplementation study. 
Plasma TAG levels (mean ± SD), of healthy volunteers 
before and after fish oil supplementation. 
TIME (min) TAG (mmol 1) 
Pre Post 
-10 0.82 ± 0.09 0.68 ± 0.17 
0 0.95 ± 0.28 0.72 ± 0.33 
30 1.17 ± 0.19 0.89 ± 0.31 
60 1.07 ± 0.20 0.90 ± 0.22 
90 0.99 ± 0.24 0.79 ± 0.21 
120 0.89 ± 0.29 0.76 ± 0.26 
150 0.93 ± 0.24 0.88 ± 0.32 
180 1.08 ± 0.43 0.81 ± 0.21 
240 1.27 ± 0.33 0.85 ± 0.18 
300 1.13 ± 0.13 0.85 ± 0.18 
360 0.83 ± 0.16 0.72 ± 0.20 
420 0.72 ± 0.13 0.52 ± 0.09 
480 0.56 ± 0.13 0.45 ± 0.15 
540 0.52 ± 0.11 0.43 ± 0.13 
600 0.49 ± 0.13 0.48 ± 0.24 
660 0.56 ± 0.11 0.46 ± 0.11 
720 0.59 ± 0.11 0.44 ± 0.12 
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TABLE 4. a 
Structured triacylglycerol study: 
fatty acid composition and sn-2 positional distribution 
of the control (OOP), and test (OPO), oils. 
OVERALL FAME(%) sn-2 POSITION 
(% total FA's) 
Patty Control Test Control Test 
acid oil oil oil oil 
C14: 0 0.9 1.0 0.4 1.9 
C16: 0 29.9 30.4 5.9 72.7 
C16: 1 0.3 0.1 0.2 0.0 
C18: 0 3.4 3.2 0.5 6.9 
C18: 1 50.0 51.5 68.2 14.7 
C18: 2 13.4 13.3 24.2 3.6 
C18: 3 0.3 0.1 0.4 0.0 
Fatty acid methyl esters 
TABLE 4. b 
Structured triacylglycerol study: 
plasma triacylglycerol levels (mean ± SD) in 
chylomicron-poor fraction following meals different in 
fatty acid positional distribution. 
Time (min. ) TAG (mmol 1) 
Control Test 
15 0.30 ± 0.1 0.35 ± 0.1 
30 0.32 ± 0.1 0.36 f 0.1 
45 0.32 ± 0.1 0.36 ± 0.1 
60 0.35 ± 0.1 0.39 ± 0.1 
90 0.38 ± 0.1 0.37 f 0.1 
120 0.38 ± 0.1 0.39 ± 0.1 
180 0.36 ± 0.1 0.39 ± 0.1 
240 0.39 ± 0.1 0.38 ± 0.1 
300 0.38 ± 0.1 0.39 ± 0.1 
360 0.34 ± 0.1 0.36 ± 0.1 
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TABLE 4. c 
Structured triacylglycerol study: 
plasma triacylglycerol levels (mean ± SD) in 
chylomicron-rich fraction following meals different in 
fatty acid positional distribution. 
Time (min. ) TAG (mmol 1) 
Control Test 
15 0.48 ± 0.3 0.49 ± 0.2 
30 0.66 ± 0.5 0.56 ± 0.2 
45 0.71 ± 0.5 0.63 ± 0.2 
60 0.69 ± 0.5 0.67 ± 0.2 
90 0.75 ± 0.3 0.78 ± 0.3 
120 0.80 ± 0.4 0.82 ± 0.3 
180 0.82 ± 0.4 0.92 t 0.4 
240 0.79 ± 0.4 0.86 ± 0.3 
300 0.92 ± 0.4 0.94 ± 0.4 
360 0.80 ± 0.4 0.91 ± 0.4 
TABLE 4. d 
Structured triacylglycerol study: 
plasma triacylglycerol levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) TAG (mmol 1) 
Control Tost 
15 0.77 ± 0.4 0.84 ± 0.3 
30 0.99 ± 0.6 0.92 ± 0.2 
45 1.04 ± 0.6 1.00 ± 0.3 
60 1.12 ± 0.5 1.06 ± 0.3 
90 1.17 ± 0.5 1.13 ± 0.4 
120 1.18 ± 0.5 1.21 ± 0.4 
180 1.16 ± 0.5 1.31 ± 0.5 
240 1.19 ± 0.5 1.25 ± 0.4 
300 1.36 ± 0.6 1.38 ± 0.5 
360 1.17 ± 0.5 1.27 ± 0.5 
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TABLE 4. e 
Structured triacylglycerol study: 
plasma cholesterol levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) T-C (mmol/1) 
Control Test 
15 4.51 ± 0.5 4.47 ± 0.4 
30 4.60 ± 0.4 4.51 ± 0.5 
45 4.56 ± 0.5 4.48 ± 0.5 
60 4.52 ± 0.5 4.45 ± 0.5 
90 4.55 ± 0.5 4.53 ± 0.5 
120 4.54 ± 0.5 4.46 ± 0.5 
180 4.58 ± 0.5 4.58 ± 0.5 
240 4.58 ± 0.5 4.53 ± 0.6 
300 4.63 ± 0.5 4.55 ± 0.5 
360 4.63 ± 0.5 4.57 ± 0.6 
TABLE 4. f 
Structured triacylglycerol study: 
plasma LDL-C levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) LDL-C (mmol 1) 
Control Test 
15 2.89 ± 0.5 2.79 ± 0.4 
30 2.84 ± 0.5 2.79 ± 0.4 
45 2.81 ± 0.5 2.74 ± 0.4 
60 2.80 ± 0.5 2.69 ± 0.4 
90 2.75 ± 0.5 2.68 ± 0.4 
120 2.76 ± 0.5 2.63 f 0.4 
180 2.75 ± 0.5 2.70 f 0.5 
240 2.75 ± 0.4 2.68 t 0.5 
300 2.72 ± 0.4 2.65 t 0.4 
360 2.74 ± 0.4 2.68 t 0.4 
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TABLE 4. g 
Structured triacylglycerol study: 
plasma HDL-C levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) HDL-C (mmol 1) 
Control Test 
15 1.22 ± 0.2 1.22 ± 0.2 
30 1.27 ± 0.2 1.23 ± 0.2 
45 1.24 ± 0.2 1.21 ± 0.2 
60 1.22 ± 0.2 1.19 ± 0.2 
90 1.21 ± 0.2 1.22 ± 0.2 
120 1.25 ± 0.2 1.19 ± 0.2 
180 1.25 ± 0.2 1.17 ± 0.2 
240 1.22 ± 0.2 1.95 ± 0.2 
300 1.27 ± 0.2 1.18 ± 0.2 
360 1.28 ± 0.2 1.24 ± 0.2 
TABLE 4. h 
Structured triacylglycerol study: 
plasma glucose levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) GLUCOSE (mmol/1) 
Control Test 
15 5.72 ± 0.6 5.52 ± 0.5 
30 6.15 ± 0.7 6.05 ± 1.1 
45 5.85 t 0.8 5.79 ± 0.8 
60 5.44 t 0.7 5.48 ± 1.0 
90 5.75 ± 0.6 5.19 ± 1.2 
120 5.21 ± 0.5 5.15 ± 0.8 
180 4.59 ± 0.5 4.58 ± 0.4 
240 4.67 ± 0.4 4.68 ± 0.3 
300 4.82 ± 0.3 4.78 ± 0.4 
360 4.86 ± 0.3 4.77 ± 0.3 
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TABLE 4. i 
Structured triacylglycerol study: 
plasma insulin levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) INSULIN (mII 1) 
Control Test 
15 27.7 ± 26.7 24.4 ± 14.2 
30 49.9 ± 25.8 47.4 ± 26.5 
45 49.7 ± 26.2 50.8 ± 27.3 
60 40.7 ± 20.1 41.1 ± 27.5 
90 39.9 ± 23.8 33.9 ± 17.4 
120 26.6 ± 20.0 28.0 ± 32.4 
180 11.4 ± 7.1 11.9 ± 6.9 
240 7.7 ± 4.5 8.2 ± 5.4 
300 7.2 ± 3.7 7.4 ± 3.5 
360 5.5 ± 2.7 7.0 ± 4.7 
TABLE 4. j 
Structured triacylglycerol study: 
plasma GIP levels (mean t SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) GIP ( moi 1) 
Control Teat 
15 212.3 ± 92.3 200.9 ± 96.2 
30 327.1 ± 154.7 319.2 ± 118.5 
45 357.4 ± 140.8 364.1 ± 115.5 
60 344.0 ± 97.4 330.2 ± 94.8 
90 314.9 ± 88.3 317.7 ± 96.5 
120 245.6 ± 77.9 239.9 ± 87.8 
180 213.3 ± 63.9 231.1 ± 110.9 
240 212.6 ± 60.7 209.6 ± 80.4 
300 195.2 ± 79.9 159.1 ± 51.7 
360 104.4 ± 62.5 105.9 ± 52.4 
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TABLE 4. k 
Structured triacylglycerol study: 
plasma apolipoprotein A-I levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) APO A-I (m dl) 
Control Test 
15 120.8 ± 17.3 125.5 ± 32.7 
30 124.3 ± 21.2 125.1 ± 26.9 
45 123.8 ± 15.8 123.0 ± 17.7 
60 123.2 ± 17.2 123.8 ± 17.3 
90 124.8 ± 21.3 125.8 ± 20.8 
120 121.6 ± 19.1 122.6 ± 24.5 
180 119.9 ± 14.2 122.1 ± 18.3 
240 124.7 ± 16.1 116.5 ± 18.4 
300 127.6 ± 16.6 119.8 ± 17.7 
360 123.4 ± 18.6 128.9 ± 24.9 
TABLE 4.1 
Structured triacylglycerol study: 
plasma apolipoprotein B levels (mean t SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) APO B (m dl) 
Control Test 
15 53.8 ± 13.7 54.9 ± 22.4 
30 56.2 ± 14.9 55.4 ± 18.4 
45 55.1 ± 13.9 53.0 ± 16.8 
60 55.3 ± 13.1 55.0 ± 15.4 
90 56.6 ± 14.7 55.8 ± 17.6 
120 54.1 ± 13.1 54.1 ± 17.0 
180 53.3 ± 15.3 56.0 ± 18.2 
240 55.8 ± 13.9 55.2 ± 18.7 
300 54.8 ± 13.3 54.8 ± 17.9 
360 53.1 ± 12.2 56.2 ± 16.4 
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TABLE 4. m 
Structured triacylglycerol study: 
plasma ketone bodies levels (mean ± SD) following 
meals different in fatty acid positional distribution. 
Time (min. ) KETONE BODIES ( moi 1) 
Control Test 
15 0.067 t 0.048 0.057 t 0.027 
30 0.040 t 0.030 0.055 t 0.021 
45 0.034 ± 0.020 0.042 ± 0.010 
60 0.032 ± 0.018 0.034 ± 0.015 
90 0.018 ± 0.013 0.027 ± 0.020 
120 0.036 ± 0.078 0.014 ± 0.016 
180 0.017 ± 0.017 0.015 ± 0.019 
240 0.053 ± 0.057 0.059 ± 0.023 
300 0.059 ± 0.046 0.082 ± 0.047 
360 0.147 ± 0.115 0.097 ± 0.057 
TABLE 4. A 
Structured triacylglycerol study: 
plasma non-esterified fatty acid levels (mean ± SD) 
following meals different in 
fatty acid positional distribution. 
Time (min. ) NEFA ( mol 1) 
Control Test 
15 790.0 ± 288.1 742.4 ± 325.4 
30 818.2 ± 290.0 732.1 ± 282.4 
45 612.5 ± 268.1 770.4 ± 349.1 
60 652.5 ± 285.2 733.2 ± 338.7 
90 659.0 ± 332.8 853.0 ± 338.1 
120 639.8 ± 293.3 729.0 ± 357.2 
160 811.2 ± 308.6 823.0 ± 418.8 
240 854.2 ± 425.2 992.6 ± 330.6 
300 901.4 ± 452.3 1117.7 ± 378.1 
360 
1 
1000.3 ± 346.6 1034.1 ± 403.5 
11 
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Figure 5. a 
FOOD DIARY 
INSTRUCTIONS 
Please record ALL food eaten and drinks taken over a four 
day period, including one weekend day. 
QUANTITIES 
Use standard household measures to describe the quantity of 
each food item eg. 
ITEM AMOUNT 
meat pie 3 inch round 
chips (fried) 1/4 standard size plate 
gravy 4 tables oons 
FOOD TYPE 
Please indicate the type of food eaten, 
eg. brown, white or wholemeal bread 
skimmed, semi-skimmed or whole milk 
butter, margarine, low fat spread, etc. 
Include - all beverages, eg. tea, coffee (stating whether 
milk or sugar added), soft drinks and alcohol. 
all snacks, eg. sweets, biscuits, cakes 
all sauces, dressings, pickles etc, using brand 
names where possible. 
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Figure 5. b 
FOOD DIARY RECORD 
DAY and DATE 
MEAL ITEMS 
(describe fully) 
AMOUNT EATEN 
(household measure) 
BREAKFAST 
MID MORNING 
LUNCH 
MID AFTERNOON 
EVENING MEAL 
SUPPER 
ADDITIONAL 
SNACKS 
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Figure 5. c 
The effects of meal fatty acid composition on 
postprandial lipid levels and hormone concentrations 
INSTRUCTIONS FOR VOLUNTEERS 
There are some guidelines for your part in the study: 
Now much will I earn? 
Volunteers will earn £15 for each night of the study 
ie. £45. Three days meals and snacks will also be provided. 
What will I have to do? 
Volunteers will be asked first of all to keep a food diary 
for four days prior to the study, in order to assess the 
general content of their usual diet. 
On the day before each study, the volunteer will be 
requested not to consume alcohol. 
The next morning, the subject will attend the Clinical Unit 
to give a fasting blood sample. A 24 hour recall of the 
foods eaten the previous day will also be taken. 
The subject must not eat before attending this session. 
A breakfast will then be provided. All subsequent meals 
and snacks for the whole day will also be supplied. The 
subject must not consume any additional food, and must eat 
everything that is given to them. Likes, dislikes, and 
appetite will be taken into consideration. 
Volunteers will then be transferred to the Royal Surrey 
Hospital at 6pm. Transport will be arranged. A cannula, 
which is a fine hollow tube, will then be inserted into the 
arm, to allow blood samples to be taken, with minimum 
discomfort. Two samples will be taken, 10 minutes and 
immediately before being given the evening meal. Blood 
samples will then be taken at various intervals throughout 
the night. The investigation will finish at lam the 
following morning. Entertainment will be provided! 
This procedure will be repeated three times in total, to 
complete the investigation. 
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Figure 5. d 
INSTRUCTIONS FOR STUDY DAYS 
1. A fasting blood sample will be required on the morning 
of the study. A time and place will be finalised 
beforehand. Please do not have anything to eat before this 
blood sample is taken. A breakfast will be provided 
afterwards. 
Please also have NO ALCOHOL the evening before the study, 
and keep to moderate amounts in the few days preceeding the 
study. THIS IS VERY IMPORTANT!! 
2. In the morning you will also be asked to recall your 
food intake for several days before hand. Please be aware 
of what you are eating and try to remember it. This is so 
that the next time the study is carried out, to standardize 
conditions, you eat approximately the same food as before. 
3. A packed lunch and snacks will be provided for you to 
eat throughout the day. Please eat all of this and do not 
eat or drink anything extra, except tea and coffee. 
4. At 6pm, you will be taken to the hospital for 
cannulation, as explained in the previous handout. After 
an initial blood sample is taken, a meal will be provided, 
with the test oil. Further blood samples will be taken 
throughout the night. 
MENU FOR THE STUDY 
Breakfast 
Lunch 
Evening meal 
Snacks 
= 
Toast and cereal 
Tea or coffee 
Orange juice 
Ham sandwiches 
Crisps/peanuts 
Apple 
"Stir fry" vegetables 
Rice 
(salt and pepper to taste) 
Green salad with test oil 
Wholemeal bread 
Milkeshake made with test oil 
Tea or coffee with plain/chocolate 
digestives 
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TABLE 5. a 
Acute fatty acid study: 
plasma triacylglycerol concentrations (mean ± SD) following 
meals of different fatty acid compositions (n=11). 
TIME(min) PLASMA-TAG 
(mmol 1) 
Mixed oil corn oil Fish oil 
-10 1.00 t 0.2 0.84 t 0.2 0.94 t 0.4 
0 1.02 ± 0.2 0.94 ± 0.5 0.88 ± 0.3 
30 1.04 ± 0.2 1.03 ± 0.5 1.01 t 0.3 
60 1.41 ± 0.2 1.14 ± 0.5 1.20 ± 0.4 
120 1.24 ± 0.3 1.19 ± 0.5 1.20 ± 0.4 
180 1.27 ± 0.4 1.18 ± 0.4 1.10 t 0.4 
240 1.46 ± 0.3 1.34 ± 0.5 1.10 ± 0.3 
300 1.63 ± 0.5 1.32 ± 0.3 1.10 ± 0.4 
360 1.61 ± 0.4 1.31 ± 0.5 1.18 t 0.4 
420 1.34 ± 0.3 1.44 ± 0.7 1.17 t 0.3 
480 1.28 ± 0.4 1.10 ± 0.4 0.99 t 0.2 
540 1.17 ± 0.3 0.92 ± 0.2 0.82 t 0.2 
600 1.02 ± 0.2 0.80 ± 0.2 0.73 t 0.1 
660 0.98 ± 0.2 0.80 ± 0.1 0.60 t 0.2 
TABLE 5. b 
Acute fatty acid study: 
chylomicron-triacylglycerol concentrations (mean ± SD) 
following meals of different fatty acid compositions 
(n=11). 
TIME (min) CM-TAG (mmol1) 
Mixed oil corn oil Fish oil 
-10 1.29 ± 0.73 1.07 ± 0.74 0.95 ± 0.49 
0 1.36 ± 0.80 1.32 ± 1.29 1.08 ± 0.52 
30 1.56 ± 0.80 1.39 ± 0.89 1.45 ± 0.95 
60 2.51 ± 1.03 1.83 ± 0.98 1.67 ± 0.70 
120 1.88 ± 0.80 1.72 ± 1.00 1.69 ± 0.72 
180 1.55 ± 0.60 1.63 ± 0.69 1.49 ± 0.72 
240 1.97 ± 0.87 2.08 ± 0.89 1.27 ± 0.67 
300 2.42 ± 0.97 2.27 ± 1.10 1.53 ± 1.12 
360 2.39 ± 1.14 2.24 ± 1.06 1.76 ± 1.00 
420 2.09 ± 0.90 2.16 ± 1.39 1.70 ± 0.80 
480 1.79 ± 0.87 1.55 ± 0.85 1.25 ± 0.58 
540 1.53 ± 0.74 0.97 ± 0.22 0.83 f 0.41 
600 1.13 ± 0.58 0.87 ± 0.19 0.72 f 0.37 
660 1.12 ± 0.53 0.85 ± 0.32 0.62 f 0.24 
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TABLE 5. c 
Acute fatty acid study: 
distribution of retinyl palmitate in chylomicrons 
(mean ± SD) following meals containing Retinyl Palmitate 
and differing in fatty acid composition (n=11). 
TIME(min) CM-RP( ml) 
Mixed oil Corn oil Fish oil 
0 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
30 0.04 ± 0.10 0.17 ± 0.28 0.05 ± 0.12 
60 0.03 ± 0.06 0.04 ± 0.06 0.08 ± 0.14 
180 0.48 ± 0.35 0.90 ± 0.63 0.96 ± 0.62 
300 1.24 ± 0.81 1.60 ± 0.93 1.41 ± 0.98 
420 1.32 ± 1.15 1.24 ± 0.92 1.33 ± 0.75 
540 0.49 ± 0.47 0.30 ± 0.27 0.53 ± 0.28 
660 0.28 ± 0.33 0.18 ± 0.20 0.26 ± 0.22 
TABLE 5. d 
Acute fatty acid study: 
post-heparin lipoprotein lipase activity (mean ± SD) 
following meals of different fatty acid compositions 
(n=11). 
TIME 
(min) 
Mixed oil 
LPL 
(nmol oleate 
release/min/ml 
plasma) 
Corn oil Fish oil 
5 124.8±46.3 129.7±35.3 
15 161.8±33.4 186.6±41.2 
161.2±33.4 
223.4±39.8 
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TABLE 5. e 
Acute fatty acid study: 
plasma GIP concentrations (mean ± SD) following meals 
of different fatty acid compositions (n=11). 
Time(min) GIP( mol l) 
Mixed oil corn oil Fish oil 
-10 210.4 ± 64.5 196.8 ± 88.1 248.0 ± 84.8 
0 191.8 ± 52.1 182.0 ± 75.0 242.7 ± 87.2 
30 306.9 ± 70.2 332.8 ± 73.3 312.9 ± 69.3 
60 345.4 ± 69.0 355.5 ± 75.1 324.8 ± 57.9 
120 307.1 ± 58.2 311.7 ± 57.2 289.7 ± 68.9 
180 327.0 ± 54.9 337.8 ± 53.4 297.1 ± 66.3 
240 277.5 ± 55.8 312.8 ± 57.8 267.9 ± 40.9 
300 248.3 ± 60.9 229.0 ± 55.5 233.8 ± 45.9 
360 185.8 ± 55.8 175.8 ± 65.0 172.5 ± 48.0 
420 143.9 ± 45.0 151.6 ± 55.8 146.5 ± 48.1 
480 116.4 ± 36.6 121.4 ± 39.2 126.5 ± 43.2 
540 90.4 ± 24.7 93.4 ± 46.0 82.5 ± 21.4 
600 76.4 ± 18.0 84.4 ± 35.1 80.7 ± 28.4 
660 66.8 ± 22.0 77.2 ± 27.2 72.0 ± 26.3 
TABLE S. f 
Acute fatty acid study: 
plasma insulin concentrations (mean ± SD) following meals 
of different fatty acid compositions (n=11). 
TIME(min) INSULIN(mU 1) 
Mixed oil Corn oil Fish oil 
-10 7.35 ± 5.2 14.00 ± 17.0 22.10 ± 17.2 
0 7.28 ± 3.5 15.90 ± 21.2 20.90 ± 11.7 
30 52.80 ± 29.9 54.30 ± 35.7 59.20 ± 35.0 
60 63.46 ± 29.0 60.40 ± 43.9 61.30 ± 17.6 
120 59.98 ± 43.8 52.60 ± 41.2 44.00 ± 22.1 
180 41.20 f 28.1 29.90 ± 17.7 32.40 ± 15.6 
240 30.00 ± 24.4 23.90 ± 13.9 24.40 ± 21.1 
300 12.50 ± 7.4 13.60 ± 7.5 17.79 ± 13.1 
360 10.58 ± 6.5 11.80 ± 11.4 10.30 ± 6.8 
420 9.43 ± 4.8 10.50 ± 5.7 11.15 ± 6.9 
480 8.57 ± 5.4 10.00 ± 4.2 10.56 ± 7.1 
540 9.37 ± 7.5 10.30 ± 7.3 10.60 ± 6.9 
600 8.67 ± 6.2 9.79 ± 6.0 10.05 ± 4.9 
660 6.28 ± 3.4 10.37 ± 5.7 12.30 ± 11.7 
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TABLE 5. q 
Acute fatty acid study: 
plasma cholesterol concentrations (mean ± SD) following 
meals of different fatty acid compositions (n=ll). 
TIME(min) PLASMA-CHOL. 
(mmol 1) 
Mixed oil corn oil Fish oil 
-10 4.06 ± 0.62 3.89 ± 0.58 3.91 ± 0.50 
0 3.92 ± 0.58 3.76 ± 0.47 3.97 ± 0.60 
30 3.82 ± 0.67 3.77 ± 0.58 3.98 ± 0.61 
60 3.87 ± 0.58 3.87 ± 0.57 3.69 ± 0.77 
120 3.68 ± 0.57 3.79 ± 0.59 3.69 ± 0.76 
180 3.75 ± 0.56 3.93 ± 0.53 3.76 ± 0.54 
240 3.72 ± 0.51 3.61 ± 0.67 3.77 ± 0.63 
300 3.64 ± 0.51 3.46 ± 0.62 3.49 ± 0.58 
360 3.42 ± 0.59 3.32 ± 0.68 3.58 ± 0.55 
420 3.62 ± 0.47 3.54 ± 0.54 3.60 ± 0.53 
480 3.55 ± 0.58 3.35 ± 0.71 3.48 ± 0.58 
540 3.56 ± 0.46 3.57 ± 0.55 3.61 ± 0.58 
600 3.44 ± 0.39 3.50 ± 0.51 3.60 ± 0.59 
660 3.61 ± 0.50 3.53 ± 0.55 3.51 ± 0.58 
TABLE 5. h 
Acute fatty acid study: 
chylomicron-cholesterol concentrations(mean ± SD) following 
meals of different fatty acid compositions (n=11). 
TIME(min) CM-CHOL. 
(mmol 1) 
Mixed oil corn oil Fish oil 
-10 1.09 ± 0.57 1.17 ± 0.54 1.17 ± 0.44 
0 1.07 ± 0.33 1.15 ± 0.73 1.23 ± 0.39 
30 1.18 ± 0.42 1.25 ± 0.59 1.14 ± 0.55 
60 1.24 ± 0.39 1.27 ± 0.60 1.27 ± 0.49 
120 1.23 ± 0.43 1.15 ± 0.43 1.23 ± 0.60 
180 1.15 ± 0.32 1.27 ± 0.41 1.20 ± 0.45 
240 0.97 ± 0.42 1.14 ± 0.35 1.12 ± 0.39 
300 1.21 ± 0.46 1.12 ± 0.44 1.09 ± 0.49 
360 1.09 ± 0.46 0.98 ± 0.40 1.08 ± 0.43 
420 1.23 ± 0.41 1.06 ± 0.37 0.99 ± 0.36 
480 1.31 ± 0.37 1.16 ± 0.35 1.01 ± 0.39 
540 1.17 ± 0.39 1.05 ± 0.27 1.06 ± 0.41 
600 1.00 ± 0.44 1.13 ± 0.42 0.85 ± 0.26 
660 0.93 ± 0.41 1.08 ± 0.38 0.83 ± 0.28 
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TABLE 5. i 
Acute fatty acid study: 
serum apolipoprotein A-I concentrations (mean ± SD) 
following meals of different fatty acid compositions 
(n=11). 
TIME(min) APO A-I(mg/dl) 
Mixed oil corn oil Fish oil 
-10 143.8 ± 49.4 126.4 ± 38.3 119.4 ± 27.5 
0 122.3 ± 30.8 128.6 ± 37.0 118.5 ± 31.5 
30 135.0 ± 40.3 124.7 ± 34.5 123.5 ± 31.2 
60 123.0 ± 29.0 108.9 ± 35.3 109.9 ± 21.1 
120 124.5 ± 30.3 125.8 ± 47.3 123.8 ± 41.4 
180 127.6 ± 28.7 129.0 ± 38.5 117.9 ± 30.2 
240 130.6 ± 32.0 117.6 ± 30.9 122.1 ± 21.7 
300 127.2 ± 26.3 113.6 ± 29.8 123.0 ± 34.5 
360 123.0 ± 29.5 108.7 ± 31.6 104.7 ± 24.1 
420 128.2 ± 27.6 114.8 ± 35.8 106.4 ± 31.6 
480 109.5 ± 25.9 109.6 ± 36.0 123.0 ± 30.6 
540 118.9 ± 26.8 112.0 ± 37.4 116.6 ± 28.5 
600 119.2 ± 31.6 120.1 ± 35.1 116.5 ± 37.1 
660 126.2 ± 23.7 112.7 ± 33.7 112.7 ± 26.2 
TABLE 5. j 
Acute fatty acid study: 
serum apolipoprotein B concentrations (mean ± SD) following 
meals of different fatty acid compositions (n=11). 
TIME(min) APO B(m dl) 
Mixed oil corn oil Fish oil 
-10 73.2 ± 16.9 60.1 ± 17.4 59.3 ± 21.9 
0 63.5 ± 17.9 63.7 ± 21.3 55.9 ± 21.4 
30 66.0 ± 18.2 57.8 ± 20.9 61.7 ± 27.4 
60 61.4 ± 21.8 52.6 ± 25.8 55.7 f 26.4 
120 55.6 ± 15.5 61.1 ± 21.8 64.2 t 28.0 
180 63.6 ± 19.9 59.2 ± 23.0 59.6 ± 21.8 
240 62.1 ± 17.0 55.0 ± 17.6 60.6 ± 26.3 
300 62.4 ± 24.8 53.4 ± 20.2 60.2 ± 26.3 
360 57.9 ± 15.5 52.5 ± 19.5 62.3 f 26.1 
420 63.4 ± 19.4 57.2 ± 18.8 53.4 ± 19.5 
480 53.2 ± 21.6 48.5 ± 23.1 57.3 ± 21.5 
540 60.8 ± 19.3 54.6 ± 20.3 58.7 ± 23.6 
600 55.7 ± 13.9 56.8 ± 19.2 63.3 ± 25.4 
660 64.1 ± 25.0 50.2 ± 24.3 55.1 ± 24.2 
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APPENDIX V 
CHAPTER 6 
TABLE 6. a 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
average food intakes and gain in weight in the 
preliminary study. 
PARAMETER MIXED OIL 
GROUP 
CORN OIL 
GROUP 
FISH OIL 
GROUP 
Average daily food 19.0 ± 2.0 16.0 ± 2.2 17.2 ± 4.3 
intake before 
pair-feeding 
(g/rat/day) 
Average daily food 15.6 ± 2.4 16.8 ± 2.4 16.6 ± 2.1 
intake during 
pair-feeding 
(g/rat/day) 
Average daily 2.5 ± 1.5 2.3 ± 0.4 2.3 ± 0.9 
weight gain of 
rats (g/rat/day) 
TABLE 6. b 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
average food intake, rats weight gain, and liver weights in 
main study. 
PARAMETER MIXED OIL 
GROUP 
CORN OIL 
GROUP 
FISH OIL 
GROUP 
Average daily food 20.7 ± 1.5 20.8 ± 1.5 20.1 ± 1.4 
intake (g/rat/day) 
Average daily 3.4 ± 0.8 3.4 ± 1.2 3.9 ± 1.4 
weight gain of 
rats (g/rat/day) 
Average liver 15.0 ± 1.8 13.9 ± 1.8 14.2 ± 1.8 
weights after 
sacrifice (g) 
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TABLE 6. c 
Effect of dietary fatty acid composition on 
hepatic 
t4lipogenesis 
in rats: 
incorporation of [U- C]glucose in liver total lipids, 
under different incubation conditions 
following two week pair-fed diets containing 
mixed, corn or fish oil (mean±SD, n=9). 
INCUBATION 
MEDIUM 
INCORPORATED [U-14C] GLUCOSE 
(nmol g wet tissue) 
Mixed oil corn oil Fish oil 
diet diet diet 
Basal 127.7±34.8* 77.8±25.0` 62.2±27.3 
Insulin(4nM) 139.3±51.0 125.2±43.9 96.3±63.1 
GIP(6nM) 74.5±31.9 92.1±42.8 80.5±30.0 
4nM Insulin+ 110.5±59.6 165.0±73.3 130.5±50.3 
6nM GIP 
p<0.05 from basals in fish oil dietary group. 
- p<O. 01 from incubation in the presence of insulin and GIP 
(same dietary group). 
-° P<o. 05 from incubation in the presence of insulin and GIP 
(same dietary group). 
384 
TABLE 6. d 
Effect of dietary fatty acid composition on 
hepatic lipýWenesis in rats: 
incorporation of CU- C)glucose in hepatic TAG 
under different incubation conditions 
following two week pair-fed diets containing 
mixed, corn, or fish oil (mean±SD, n=7). 
INCUBATION 
MEDIUM 
INCORPORATED [U-14Cj GLUCOSE 
(nmol wet tissue) 
Mixed oil Corn oil Fish oil 
diet diet diet 
Basal 5.60±2.89* 2.66±0.93+ 0.79±0.25 
Insulin(4nM) 6.95±4.30 2.21±1.63 1.59±2.13 
GIP(6nM) 8.02±9.78 2.77±1.84 0.84±0.58 
4nM Insulin+ 10.97±6.68 11.22±6.89 2.61±3.42 
6nM GIP 
p<0.05 from basal in the fish oil dietary group. 
- p<0.05 from incubation in the presence of insulin and GIP 
A (same dietary group). P<0.01 from incubation in the presence of insulin and GIP 
** (same dietary group). -- p<0.05 from incubation in the presence of insulin and GIP 
(same dietary group). 
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TABLE 6. e 
Effect of dietary fatty acid composition on 
hepatict. ipogenesis in rats: 
incorporation of [U- C]glucose in hepatic cholesterol 
under different incubation conditions 
following two week pair-fed diets containing 
mixed, corn or fish oil (mean±SD, n=7). 
INCUBATION 
MEDIUM 
INCORPORATED (U-14C] GLUCOSE 
(nmol wet tissue) 
Mixed oil corn oil Fish oil 
diet diet diet 
Basal 1.56±1.08 1.90±0.69k 0.74±0.52 
Insulin(4nM)  4.35±3.13 3.02±1.43 1.19±0.89 
GIP(6nM) 3.58±4.25 2.94±1.39 1.22±0.78 
4nM Insulin+ 4.64±2.79` 4.57±2.51 3.59±2.14r* 
6nN GIP 
p<0.05 from basal in the same dietary group. 
p<0.05 from basal in the same dietary group. 
p<0.05 from basal in the fish oil dietary group. 
- p<0.05 from basal in the same dietary group. 
TABLE 6. f 
Effect of dietary fatty acid composition on 
hepatic lipggenesis in rats: 
incorporation of [U- c]glucose in hepatic FFA 
under different incubation conditions 
following two week pair-fed diets containing 
mixed, corn, or fish oil (mean±SD, n=7). 
INCUBATION 
MEDIUM 
INCORPORATED [U-14C] GLUCOSE 
(nmol/g wet tissue) 
Mixed oil corn oil Fish oil 
diet diet diet 
Basal 0.98±0.85 1.13±0.94 0.80±0.42 
Insulin(4n}) 1.48±0.52 1.18±1.18 2.75±0.14 
GIP MIX) 2.49±2.20 1.15±1.15 1.64±1.45 
4nM Insulin+ 1.48±0.23 2.10±1.69 2.30±1.18 
6nM GIP 
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TABLE 6. g 
Effect of dietary fatty acid composition on 
hepati54lipogenesis in rats: 
incorporation of [U- Cjglucose in hepatic phospholipids 
under different incubation conditions 
following two week pair-fed diets containing 
mixed, corn, or fish oil (mean±SD, n=7). 
INCUBATION 
MEDIUM 
INCORPORATED (U-14C] GLUCOSE 
(nmol wet tissue) 
Mixed oil corn oil Fish oil 
diet diet diet 
Basal 38.00±26.13 48.07±16.90 47.27±18.66 
Insulin(4nM) 36.75±19.14 42.45±16.14 45.39±19.50 
GIP(6n1) 33.89±30.26 38.04±13.55 32.17±16.14 
4nM Insulin+ 40.09± 9.31 54.98±29.32 48.11±23.63 
6nN GIP 
TABLE 6. h 
Effect of dietary fatty acid composition on 
hepatic lipogenesis in rats: 
effect on plasma lipid and hormone levels 
following two week pair-fed diets containing 
mixed, corn, or fish oil (mean±SD, n-9). 
PARAMETER 
ASSAYED 
MIXED OIL 
DIET 
CORN OIL 
DIET 
FISH OIL 
DIET 
Cholesterol 1.18±0.36 1.20±0.23 1.11±0.20 
(mmo1/1) 
TAG (mmol/1) 1.31±0.74 0.89±0.36 0.58±0.19+ 
Insulin * 12.10±8.30 2.60±1.90 1.90±0.90 
(ng/ml) 
GIP (pmol/l) 126.30±36.40 130.30±33.00 103.50±21.40 
p<0.01 compared to other dietary groups. 
- p<0.05 compared to other dietary groups. 
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